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SUMMARY?
Cancer?is?one?of?the?most?fatal?diseases?in?humans,?accounting?for?13?%?of?all?deaths?
worldwide? through? the? destruction? of? healthy? tissue? and? organs? by? uncontrolled?
proliferation.? The?most? life?threatening? step? during? tumor? progression? is? reached? when?
cancer? cells? leave? the?primary? tumor?mass? to? invade? the? surrounding? tissue? and? colonize?
distant?organs.?This?process?of?metastasis? includes?dissemination? throughout? the?body?by?
entering? the? blood? ?? or? lymphatic? system? to? reach? distant? organs? and? form? secondary?
tumors.?To?infiltrate?the?surrounding?tissue,?single?motile?tumor?cells?leave?the?tumor?mass?
by?breaking?down?cell?cell?contacts,?in?a?process?called?epithelial?to?mesenchymal?transition?
(EMT).?EMT?is?a?complex?molecular?and?cellular?program?enabling?epithelial?cells?to?abandon?
their?differentiated?phenotype,? including?cell?cell?adhesion?and?cell?polarity,?and?to?acquire?
mesenchymal?features?and?invasive?properties.??
One?of?the?most?prominent?inducers?of?EMT?is?transforming?growth?factor???(TGF?),?
which? can? suppress? tumor? formation? by? growth? inhibition? but? also? promotes? tumor?
progression? and? metastasis? in? advanced? tumors.? To? dissect? the? molecular? mechanism?
underlying?the?complex?process?of?EMT?and?understand?the?dual?role?of?TGF??during?cancer?
progression?we?established?different? in?vitro?EMT?model? systems? to? identify?a?global?EMT?
gene?expression?signature.?By?analyzing?the?commonly?altered?gene?expression?profiles?we?
identified? the? transcription? factor? forkhead? box? protein? F2? (Foxf2),? neural? cadherin? (N?
cadherin)?and?various?cancer?stem?cell?associated?genes,?to?be?upregulated?during?the?EMT?
process.?
Our? study? revealed? that? Foxf2? upregulation,? although? not? required? to? gain?
mesenchymal? markers,? is? essential? for? the? disruption? of? cell? junctions? and? the?
downregulation? of? epithelial?markers? in?NMuMG? cells? treated?with? TGF?.?We? show? that?
during?EMT,? Foxf2? regulates? the?expression?of? the?E?cadherin?mediators? zinc? finger?E?box?
binding? homeobox? 1? and? 2? (ZEB1? and? ZEB2)? and? the? inhibitor? of? differentiation? 2? (Id2),?
leading? to? transcriptional? repression? of? the? CDH1? gene.? Loss? of? E?cadherin? results? in? the?
disruption?of?the?polarity?complex,?a?prerequisite?for?the?dissociation?and?invasion?of?cancer?
cells.??
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Furthermore,? our? investigations? disclose? that? Foxf2? upregulation? is? required? for?
TGF??mediated? apoptosis? in? NMuMG? cells? by? two? major? routes:? direct? transcriptional?
activation? of? the? pro?apoptotic? BH?3? only? protein?Noxa? and? negative? regulation? of? EGFR?
mediated? survival? signaling? through? the? repression? of? its? ligands? Betacellulin? and?
Amphiregulin.?Substantiating?the?dual?function?of?Foxf2?during?EMT?found?by?its?implication?
in?cell?survival?and?cell?motility,?we?show?that?high?expression?of?Foxf2?correlates?with?good?
prognosis? in? early?non?invasive? stages?of? tumor?development,?but?with?poor?prognosis? in?
patients?with?advanced?breast?cancer.??
In?contrast?to?Foxf2,?our?studies?revealed?that?the?expression?of?the?well?established?
mesenchymal?marker?N?cadherin?is?not?required?to?induce?EMT?in?NMuMG?cells.?Moreover?
we?show?that?N?cadherin?function?is?not?essential?to?maintain?the?mesenchymal?state?and?its?
depletion?does?not? induce?the?reverse?mesenchymal?to?epithelial?transition.? In?addition,?N?
cadherin?downregulation?has?no? impact?on? the?motility?of?mesenchymal? cells?nor?on? the?
neurite? formation?of?pancreatic? tumor?cells.?These?data? indicate? that?N?cadherin?acts?as?a?
marker?protein?without?evident?function?during?the?EMT?process.?
In?addition? to?our?studies?on?Foxf2?and?N?cadherin,?we?show? that?EMT? leads? to?an?
increase? in?resistance?to?anoikis?and?the?capacity?to?form?mammospheres?which? is?thought?
to? correlate? with? cancer? stemness? and? tumorigenicity.? However,? we? could? not? detect? a?
defined?cancer?stem?cell?subpopulation?using?cell?surface?markers?nor?a?general?increase?of?
marker?expression? in?mesenchymal?cells.?These?results?question?whether?the?correlation?of?
EMT? and? cancer? stemness? is? intrinsic? to? certain? systems? or?whether? the? commonly? used?
surface?markers?are?inadequate?to?generally?detect?cancer?stem?cells.?
In? summary?we? identified? the? transcription? factor? Foxf2? as? important? regulator? of?
EMT?displaying?a?dual?function? in?promoting?apoptosis?as?well?as? invasive?properties,?while?
we?were?not?able?to?detect?cancer?stemness?or?a?specific?function?of?N?cadherin?during?EMT.?
Thus,?gaining?more?and?better?insights?into?the?molecular?function?of?Foxf2?may?provide?new?
strategies?for?anti?cancer?treatments.?
Table?of?contents?
?
iii?
?
Table?of?contents?
1? Introduction? _____________________________________________________? 1?
1.1? Hallmarks?of?cancer?______________________________________________________________?1?
1.2? Cancer?gene?signatures? ___________________________________________________________?3?
1.2.1? Breast?cancer?signatures? __________________________________________________________?3?
1.3? Cancer?cell?migration?and?metastasis?formation?________________________________________?4?
1.3.1? Single?cell?invasion?_______________________________________________________________?5?
1.3.1.1? Fibroblastoid?migration?________________________________________________________?5?
1.3.1.2? Amoeboid?migration?__________________________________________________________?6?
1.3.2? Collective?cell?migration?___________________________________________________________?7?
1.3.3? Tumor?dissemination?through?the?vasculature?and?extravasation?__________________________?9?
1.3.4? Extravasation?of?circulating?tumor?cells?and?establishment?at?secondary?sites?________________?9?
1.3.5? Preparing?the?pre?metastatic?niche?_________________________________________________?10?
1.4? EMT?__________________________________________________________________________?11?
1.4.1? Epithelial?cell?cell?adhesion? _______________________________________________________?13?
1.4.2? Mechanisms?of?EMT?activation? ____________________________________________________?14?
1.4.3? Loss?of?E?cadherin?function? _______________________________________________________?15?
1.4.3.1? Genetic?and?epigenetic?control?of?E?cadherin? _____________________________________?16?
1.4.3.2? Transcriptional?control?of?E?cadherin?silencing?_____________________________________?17?
1.4.3.3? Post?translational?control?of?E?cadherin?__________________________________________?17?
1.4.4? The?cadherin?switch?_____________________________________________________________?18?
1.4.5? The?role?of?integrins?in?invasion?and?EMT?____________________________________________?19?
1.4.6? EMT?in?cancer?metastasis?_________________________________________________________?20?
1.4.7? EMT?in?cancer?resistance?to?cell?death?_______________________________________________?21?
1.4.8? EMT?induces?resistance?to?chemotherapy?and?immunosuppression?_______________________?21?
1.5? TGF??and?its?role?in?cancer?________________________________________________________?22?
1.5.1? TGF??signaling? _________________________________________________________________?23?
1.5.2? Canonical?TGF??signaling?_________________________________________________________?23?
1.5.3? Non?canonical?TGF??signaling? _____________________________________________________?25?
1.5.3.1? TGF??signaling?through?MAPK?pathways? _________________________________________?25?
1.5.3.2? TGF??induced?PI3K?activation?__________________________________________________?25?
Table?of?contents?
?
iv?
?
1.5.4? TGF??mediated?apoptosis? ________________________________________________________?26?
1.5.5? TGF??mediates?EGFR?signaling?_____________________________________________________?26?
1.5.6? The?dual?role?of?TGF??____________________________________________________________?27?
1.6? Cancer?stem?cells?_______________________________________________________________?28?
1.6.1? Cancer?stem?cell?markers?_________________________________________________________?30?
1.6.2? EMT?and?cancer?stem?cells?________________________________________________________?31?
1.7? Forkhead?box?transcription?factors?_________________________________________________?33?
1.7.1? Foxf2?_________________________________________________________________________?34?
2? Aim?of?the?study?_________________________________________________? 36?
3? Materials?and?methods?____________________________________________? 37?
4? Foxf2???a?protagonist?acting?on?two?parts?in?EMT? _______________________? 45?
4.1? Results? _______________________________________________________________________?45?
4.1.1? Foxf2?expression?increases?during?EMT?______________________________________________?45?
4.1.2? Upregulation?of?Foxf2?is?essential?for?complete?EMT?___________________________________?46?
4.1.3? Foxf2?regulates?the?expression?of?E?cadherin?modulators? _______________________________?52?
4.1.4? Downregulation?of?Foxf2?leads?to?reduced?cell?motility?_________________________________?53?
4.1.5? Foxf2?is?involved?in?TGF??induced?apoptosis?__________________________________________?56?
4.1.6? Foxf2?affects?apoptosis?by?regulating?the?expression?of?Noxa? ____________________________?59?
4.1.7? Foxf2?is?involved?in?TGF??induced?growth?inhibition?via?EGFR?inhibition?____________________?61?
4.1.8? Inhibition?of?EGFR?induces?apoptosis?in?Foxf2?depleted?NMuMG?cells?______________________?63?
4.1.9? Depletion?of?Betacellulin?reduces?cell?growth?in?Foxf2?knockdown?cells?____________________?64?
4.1.10? Combined?ablation?of?Betacellulin,?Epiregulin?and?Amphiregulin?expression?inhibits?EGFR?mediated?
survival?signaling? _______________________________________________________________?65?
4.1.11? High?expression?levels?of?Foxf2?correlates?with?poor?prognosis?for?ER?negative?tumors?________?67?
4.1.12? Correlation?of?Foxf2?expression?with?metastasis?free?survival?depends?on?LN?status? __________?69?
4.2? Discussion?_____________________________________________________________________?71?
5? N?cadherin???a?marker?without?function??______________________________? 75?
5.1? Results? _______________________________________________________________________?75?
5.1.1? Ablation?of?N?cadherin?expression?does?not?prevent?TGF??induced?EMT?in?NMuMG?cells?______?75?
5.1.2? Downregulation?of?N?cadherin?does?not?affect?the?cytoskeletal?composition?________________?77?
5.1.3? N?cadherin?depletion?in?mesenchymal?cells?has?no?impact?on?cell?motility?__________________?80?
Table?of?contents?
?
v?
?
5.1.4? N?cadherin?depletion?does?not?affect?neurite?formation?in??T2?pancreatic?cells?______________?81?
5.2? Discussion?_____________________________________________________________________?84?
6? Cancer?stem?cells???a?potential?outcome?of?EMT??_______________________? 86?
6.1? Results? _______________________________________________________________________?86?
6.1.1? Mesenchymal?cells?show?increased?sphere?formation?capacity?___________________________?86?
6.1.2? TGF??mediated?EMT?increases?the?resistance?against?anoikis? ____________________________?88?
6.2? Cancer?stem?cell?surface?marker?expression?__________________________________________?91?
6.2.1? Hyaluronate?receptor?(CD44)?is?not?an?applicable?murine?cancer?stem?cell?marker? ___________?91?
6.2.2? CD24?surface?expression?varies?between?different?EMT?cell?systems?_______________________?92?
6.2.3? CD29?shows?uniformly?high?surface?expression?in?EMT?cell?systems? _______________________?95?
6.2.4? CD49f?is?not?expressed?in?all?EMT?systems? ___________________________________________?98?
6.3? Discussion?____________________________________________________________________?100?
7? References?_____________________________________________________? 102?
8? Curriculum?vitae?________________________________________________? 112?
9? Acknowledgments?_______________________________________________? 114?

Introduction?
?
1?
?
?
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1.1 Hallmarks?of?cancer?
The?term?cancer?describes?in?a?simplified?manner?a?complicated?disease?in?which?cells?
divide?without? control,? leading? to? the?destruction?of?healthy? tissue?and? spread? into?other?
organs?by?gaining? invasive?properties.?There?are?different?factors,?which?are?able?to? induce?
cancer?and?range?from?extrinsic?factors?like?UV?light,?infections?or?tobacco?smoke?to?intrinsic?
factors? like?reactive?oxygen?species.?They?can?cause?DNA?damage,? leading?to?alterations? in?
gene? expression? resulting? in? silencing? of? tumor?suppressors? and/or? the? activation? of?
oncogenes.?Even?though?there?are?various?causative?factors,?resulting?in?more?than?hundred?
different?types?of?cancer,?eleven?years?ago?Hanahan?and?Weinberg?were?able?to?pinpoint?six?
hallmarks?of?cancer? that?are?essential? for?a?cell? to?acquire?on? its?way? to? form?a?malignant?
tumor?(1,?2):?
Sustained?proliferative?signaling?
Normal?tissue?homeostasis?includes?a?careful?control?of?the?production?and?release?of?
growth?promoting?factors?to?assure?cell?growth?and?proliferation.?Cancer?cells?can?overcome?
this?regulation?by?the?use?of?different?mechanisms.?They?may?produce?growth?factors? in?an?
autocrine? manner? or? send? signals? to? activate? tumor?associated? stroma? cells? to? release?
growth?factors?(3,?4).?Alternatively,?tumor?cells?elevate?the?levels?of?growth?factor?receptors?
on? the? cell? surface? to? become? hyperresponsive? to? the? limiting? amounts? of? growth? factor?
ligands?(5).??
Evading?growth?suppressors?
Tumor?cells?not?only?need?to?induce?growth?stimulation?but?also?need?to?circumvent?
the? negative? regulation? of? cell? proliferation.? This? is? achieved? by? inactivating? cell?cycle?
inhibiting?pathways?blocking?bona?fide?tumor?suppressors? like?retinoblastoma?(Rb)?and?p53?
or? by? overexpressing? mitogenic? proteins? such? as? c?Myc? (6).? Within? normal? tissue,? cell?
proliferation? is? also? controlled?by? contact? inhibition? to? ensure? tissue?homeostasis.?Cancer?
Introduction?
?
2?
?
cells?were?found?to?evade?this?growth?control?via?contact? inhibition?by?downregulating?the?
expression?of?Merlin?or?LKB1?(7,?8).?
Resisting?cell?death?
Physiological? stresses? actuated? by? extrinsic? factors? (e.g.? Fas? ligand/Fas? receptor,?
hypoxia)?or?intrinsic?factors?(e.g.?genetic?instability?or?signaling?imbalances)?induce?apoptosis?
in?cancer?cells.?This?could?be?achieved?by?overexpressing?members?of?the?anti?apoptotic?Bcl?
2?family?or?silencing?tumor?suppressors?like?p53?(9?11).?Another?important?cell?physiological?
response,? usually? triggered? by? nutrient? deficiency,? is? autophagy? (12,? 13).? As? a? result? of?
uncontrolled? and? fast? proliferation?many? cancer? cells? are? forced? to? survive? in? a? nutrient?
limited?environment.?Interestingly?autophagy?is?also?a?strategy?for?tumor?cells?to?circumvent?
metabolic?stress?by?regulation?of?signaling?pathways?such?as?PI3K?and/or?silencing?members?
of?the?BH3?only?subfamily?(e.g.?Beclin?1)?to?restrict?necrosis?(14,?15).??
Inducing?angiogenesis?
Like? untransformed? cells,? cancer? cells? require? oxygen? and? nutrients,? the? supply? of?
which? is? a? limiting? factor? in? fast? growing? tumors.?During?progression? tumors? change? their?
nutrient?needs?and?adjust?the?steady?state?from?an?anti?angiogenic?state?towards?an?excess?
in? pro?angiogenic? factors,? activating? the? sprouting? and? growth? of? the? normally? quiescent?
vasculature?(16).?
Enabling?replicative?immortality?
Untransformed? cells? are? mostly? limited? in? their? cell? growth? and? the? number? of?
division? cycles,? leading? either? to? an? irreversible? non?proliferative? but? viable? state? of?
senescence?or? to?cell?death.?This? limitation? is?due? to? the?shortening?of? the? telomeric?DNA?
(17).?The?expression?of? the? telomere?extending?enzyme? telomerase? leads? to? spontaneous?
immortalization?of?tumor?cells?(18).?
Activating?invasion?and?metastasis?
Solid?benign?tumors?form?tight?junctions?with?neighboring?cells?and?adjacent?tissues.?
By? breaking? down? these? adherens? contacts,? tumor? cells? gain? invasive? capabilities? and?
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progress?to?higher?pathological?grades?of?malignancies?resulting? in?metastasis? formation? in?
distant?organs?(19).?For?more?details?see?Chapter?1.3?Cancer?cell?migration.?
1.2 Cancer?gene?signatures?
Work? on? organ?specific? metastasis? provides? an? indication? for? the? existence? of?
metastasis?promoting?genes.?Therefore? cancer?associated?gene?expression?profiling? serves?
as?a?good?tool?to?classify?tumor?subtypes,?discriminate?disease?etiology,?predict?the?relapse?
risk,?identify?genes?that?mediate?disease?progression?and?select?ideal?therapeutic?options?to?
avoid?resistance.?Among?solid?tumor?types,?breast?cancer?has?been?a?prominent?target?in?this?
kind?of?analyses?(20).??
1.2.1 Breast?cancer?signatures?
Breast?cancer?is?the?top?cancer?in?women?both?in?the?developed?and?the?developing?
world.? This? cancer? shows? heterogeneous? characteristics?with? a? high? variability? in? patient?
survival? rates,?depending?on? the?disease? subtype.?The?availability?of? clinical? samples? from?
large?patient?cohorts?and?the?existence?of?different?therapeutic?options?made?breast?cancer?
a?convenient?subject?for?prognostic?gene?expression?signature?research?(20).?Breast?cancers?
can? be? classified? according? to? several? signatures,? such? as? the? intrinsic? subtype? signature,?
obtained?by?unsupervised?clustering?of?breast? tumors?depending?on? their?gene?expression?
profile?(21)?By?this?they?are?classified?in?the?most?frequent?luminal?subtype,?which?is?divided?
into? two? subclasses? (A? and? B)? that? express? oestrogen? receptor? (ER)? and/or? progesteron?
receptor?(PgR).?Subclass?A?is?usually?HER2?negative?while?subclass?B?is?more?likely?to?be?HER2?
positive.?The?more?aggressive?basal?subtype?is?hormone?receptor?negative?and?in?many?cases?
Brca1?deficient?and/or?HER2?negative?(triple?negative?tumors)?(22,?23).?The?fast?proliferating?
triple?negative?tumors?are? lacking?the?receptors?and?are?therefore?resistant?to?the?existing?
ER,?PgR?and?HER2?targeted?therapies?(24).?Although?widely?used,?the?term?basal?like?breast?
cancer? led? to?some?confusion?due? to? the?unclear?definition?of? their?cytokeratin?expression?
status?to?discriminate?these?tumors?from?luminal?cancers?and?is?therefore?debated?(25).?The?
fourth? subtype?overexpresses? the?human?epidermal? growth? factor?2? (HER2?or? ErbB2)? and?
these? tumors?are?prone? to?early?and? frequent? relapse?and? to?distant?metastasis? (26).?The?
normal?breast?like?subtype?are?the?tumors?that?do?not?fall? into?any?of?the?other?categories?
and? usually? have? a? good? prognosis? (27).? Each? subtype? is? characterized? by? a? distinct?
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histopatology?and?survival?rate?(28).?Other?signatures?were?obtained?from?groups?of?tumors?
with?known?clinical?outcome,?like?for?example?the?76?gene?poor?prognosis?signature?(29)?or?
signatures? derived? from? functions? that? are? associated? with? tumor? progression,? like? the?
hypoxia? signature? (30).? A? more? recently? identified? molecular? subtype? of? triple?negative?
breast? cancer? is? the? claudin?low? subtype,? which? is? characterized? by? the? expression? of?
mesenchymal?and? stem? cell?associated?markers?and?which? correlates?with?poor?prognosis?
(31).?Classification?of? tumors?according? to? these?different?gene?signatures?offers?additional?
predictive?values?for?the?therapeutic?assessment.?
1.3 Cancer?cell?migration?and?metastasis?formation?
Cancer? cell?metastasis? rather? than? the?primary? tumor? itself? is? the? leading? cause?of?
death?of?cancer?patients?worldwide.?The?spread?of?cancer?cells?from?the?primary?tumor?to?a?
secondary? site? within? the? body? is? a? persisting? challenge? in? battling? this? life?threatening?
disease.?Malignant? cells? must? accomplish? different? steps? to? metastasize.? These? are? the?
dissociation? of? tumor? cells? from? the? primary? tumor,? invasion? in? the? adjacent? tissue,?
intravastion? into? lymphatic? or? blood? vessels,? dissemination? through? the? vasculature? and?
finally? the?extravasation?and?nesting? in?distant?organs? (Figure?1)? (32).?Each?of? these? steps?
requires? particular? attributes? and? molecular? programs? to? adapt? to? the? different?
environments? and? conditions.? To? leave? the? solid? primary? tumor? cancer? cells? need? to?
abrogate? the? tight?cell?cell?compound?and? remodel? the?cell?matrix?adhesion? to? invade? the?
adjacent?tissue.?These?initial?steps?involve?cellular?strategies,?which?can?be?divided?based?on?
histological?criteria? in? two? fundamentally?different?patterns?of? invasion? (i)? single?migrating?
cells?and?(ii)?collective?cell?invasion.?
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Figure?1:?Metastasis?formation.?Acquisition?of?unlimited?proliferation?potential?and?resisting?cell?death?predates?
benign? tumor? formation.?Formation?of?new?blood?vessels?provides?the?growing? tumor?with?nutrients?and?oxygen.?During?
progression?to?the?malignant?stage,?tumor?cells?acquire?migratory?and? invasive?properties?and? invade?the?adjacent?tissue.?
Angiogenesis?and?lymphangiogenesis?provide?a?route?for?tumor?cells?to?enter?the?circulation?and?colonize?distant?organs.?
?
1.3.1 Single?cell?invasion?
Single? cell?migration? is? characterized? in? histology? by? the? existence? of? isolated? and?
scattered? tumor? cells? in? the? surrounding? tissue.? Cancer? cells? can? follow? two? distinct?
strategies?to?migrate?as?single?cells:?a?fibroblastoid?(mesenchymal)?or?an?amoeboid?pattern?
(Figure?2A,B).?
1.3.1.1 Fibroblastoid?migration?
It?has?been? shown? that? single? cells? leaving?a? tumor?at? its?periphery? in?many? cases?
migrate?with?a?mechanism?that? involves?the? loss?of?epithelial?polarity?and?the?achievement?
of? mesenchymal? morphology? during? Epithelial? to? Mesenchymal? Transition? (EMT)? (33).?
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Essential? characteristics? of? EMT? are? the? disruption? of? the? tight? cell?cell? contacts,? the?
acquisition?of?a? fibroblastoid? spindle?shape?morphology,? the?gain?of? invasiveness?and? cell?
stroma?interaction?as?well?as?a?slow?division?rate,?resulting?in?the?release?of?single?cells?from?
the? solid?epithelial? tumor? (34).?Mesenchymal? cell?migration? is?not?only?exerted?by? cancer?
cells? but? also? by? normal? untransformed? cells,? such? as? fibroblasts,? endothelial? cells? and?
smooth?muscle?cells,?and?is?based?on?cellular?movements?driven?by?a?leading?edge?with?Rac?
induced?cell?protrusions?and?formation?of?a?focalized?actin?cytoskeleton?with?the?formation?
of? so? called? stress? fibers.? These? spindle?like? shaped? cells? remodel? the? extracellular?matrix?
structure? by? proteolytic? reorganization? and? exhibit? a? slow? turnover? of? integrin?mediated?
focal?adhesions?resulting?in?a?rather?slow?cell?migration?with?velocities?ranging?from?0.1?to?1?
μm/min?(35,?36).?The?EMT?phenomenon?was?first?discovered? in?cell?cultures?and?the?actual?
occurrence? of? EMT? and? its? role? in? the? progression? of? epithelial? cancers? (carcinomas)? in?
patients?is?still?highly?debated.?In?most?cancers?in?fact,?full?EMT,?which?means?the?complete?
loss?of?epithelial?markers?and?the?acquisition?of?mesenchymal?markers,?is?rarely?seen?(37).?As?
these? evading? cells? acquire? more? mesenchymal? traits? it? becomes?more? difficult? for? the?
pathologist? to?distinguish? these? cells? from? the?mesenchymal? cells? surrounding? the? tumor.?
Nevertheless,?there?is?more?and?more?evidence?that?EMT?at?least?to?some?extent?plays?a?role?
in?cancer?cell?metastasis?even? though?most?cancer?cells?were?seen? to?only?undergo?partial?
EMT,? retaining?epithelial?cytokeratin?expression?but?gaining?mesenchymal?markers?such?as?
Vimentin? (38).? In? fact,? the? expression? of? Vimentin? in? epithelial? cells? of? breast? tumors?
correlates?with?a? shorter?post?operative? survival?of?patients? (39).? Furthermore,?nuclear? ??
catenin???another?characteristics?of?EMT???is?found?in?colorectal?cancer?distributed?along?the?
invasive?front?but?not?in?the?tumor?center?(40).?The?highly?invasive?metaplastic?breast?cancer?
(MBC)?and?the?claudin?low?tumors,?have?both?been?observed?to?display?EMT?attributes?such?
as? an? attenuated? E?cadherin? expression? as? well? as? elevated? levels? of? the? EMT? inducing?
transcription? factors? Twist? and? Slug? (31).? These? data? suggest? that? EMT? is? an? important?
process?to?dissect?in?order?to?decode?the?mechanistics?behind?cancer?cell?migration.?
1.3.1.2 Amoeboid?migration??
Some? cell? types,? such? as? circulating? stem? cells,? leukocytes? and? tumor? cells? of?
haematopoietic?origin?show?a?more?diffuse?structure?of?the?actin?cytoskeleton?and?use?more?
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short?lived? and? less? adhesive? cell?matrix? interactions? (41).? This? fast?gliding? manner? of?
migration? is? independent?of? integrins?and?proteolytic?activity,? focal?contact? formation?and?
stress?fibers.?The?movement?is?mainly?driven?by?RhoA/ROCK?mediated?bleb?like?protrusions?
with?active?myosin?actin?contractions,?and?the?cells?squeeze?through?gaps? in?the?ECM.?The?
low?adhesion?attachment?to?the?substrate?allows?the?cells?to?translocate?much?faster?in?the?
3D? environment? (35).? Amoeboid? and? mesenchymal? migration? are? two? modes? that? are?
mutually?interchangeable.?Suppression?or?increase?of?the?activity?of?the?molecular?pathways?
underlying? either? of? the?modes? can? cause? a? switch? to? the? other? type? of?migration.? This?
change? is? called? amoeboid?mesenchymal? transition? (AMT)? or? mesenchymal?amoeboid?
transition?(MAT).?MAT/AMT?is?triggered?by?rapid?alterations?in?the?migratory?mode?that?arise?
as?a?reply?to?the?current?prerequisites?of?the?environment.?The?transition?may?play?a?role?in?
different?stages?of?the?metastatic?process,?when?a?specific?environment?requires?adaption?of?
the?tumor?cells?(42).?
1.3.2 Collective?cell?migration?
In?contrast?to?individual?cell?migration,?collectively?migrating?cells?retain?their?cell?cell?
junctions? by? the? continuous? expression? of? adhesion? molecules? and? migrate? in? sheets,?
strands,? tubes?or? clusters,?either? remaining? connected? to? the?primary? tumor? (coordinated?
invasion)?or?as?detached?cell?groups?or?clusters?(cohort?migration)?(Figure?2?C/D).?This?type?of?
migration? is?mainly? observed? in? basal? cell,? oral? squamous? cell? and? some? other? epithelial?
carcinomas? (43?45).? Similar? to? single? invasive? cells,? collectively? migrating? cells? form?
membrane? protrusions? like? ruffles? and? pseudopodes? and? form? integrin?mediated? focal?
adhesions? connected? to? the? actin? cytoskeleton.? They? apply? pericellular? proteolysis? to?
generate? a? path? through? the? extracellular? matrix? scaffold? and? they? use? actin?myosin?
contraction? for? cell?movement? (46).?Collective?migrating? cells?do?not? retract? their? cellular?
tails?but?rather?exert?mechanical?forces? like?pulling?on?adjacent?cells?that?are?connected?by?
adhesion? junctions? (35).? The? clustered? cohort?like? cancer? cell? dissemination? seems? to? be?
highly?efficient? in?embolizing? lymphatic?or?blood?vessels?and? in? surviving? in? the?circulation?
(47).? This? coordinated? type? of? invasion? is? typically? seen? in? squamous? cell? carcinomas,?
melanoma? and? breast? and? colon? carcinomas.? To? penetrate? the? extracellular?matrix,? the?
leading?cells?generate?an? invasion?path?by? the?use?of??1?integrin?mediated? focal?adhesions?
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and? local? expression? of?MMP14? at? their? leading? edges? to? cleave? the? collagen? fibers? and?
orient? them? in? tube? like?structures? in?which? the? following?cell?mass? is?able? to?migrate? (48,?
49).? Studies? in? our? laboratory? have? also? detected? the? expression? of? Podoplanin,? a?
transmembrane?glycoprotein,?implicated?in?the?remodeling?of?the?actin?cytoskeleton,?on?the?
cell?surface?of?collectively?migrating?cells?(50).?Podoplanin?expression?is?mainly?found?in?the?
outer? layer?of? the? invading? front? and? forced?expression?of?Podoplanin? in?epithelial?breast?
cancer?cells?and? in?human?keratinocytes? induces?cell?migration?and? invasion?with? filopodia?
formation?without? the?downregulation?of?E?cadherin?and?a? significant?decrease?of? cellular?
stress? fibers.?These? findings? indicated? that?Podoplanin? is?able? to? shift? the? invasion?pattern?
from?an?EMT?driven?single?cell?invasion?to?collective?invasion?in?the?absence?of?EMT.?
?
Figure?2:?Different?strategies?of?tumor?cell?invasion.?(A)?Individual?cancer?cells?detach?at?the?invading?front?from?
the?primary?tumor?by?undergoing?an?epithelial?to?mesenchymal?transition?(EMT)?to?break?down?the?tight?cell?cell?contacts?
and?gain?a?spindle?like?morphology.?The?extracellular?matrix?(ECM)?structure?is?remodeled?by?proteolytic?reorganization.?(B)?
The? amoeboid? invasion? is? characterized? by? weak? interactions? with? the? ECM? and? the? independency? of? proteases? and?
calpains.?The? invading?cancer?cells?are?able?to?switch?between?the?amoeboid?and?the?mesenchymal? invasion?(MAT/AMT),?
depending? on? the? prerequisites? of? the?microenvironment? they?meet.? (C)? The? cohort?migration? is? characterized? by? the?
collective?detachment?of?a?migrating?cell?nest?from?the?primary?tumor?invading?the?ECM?by?proteolytic?degradation.?(D)?In?
the? coordinated? collective? cell? invasion? type? cancer? cells? invade? the? surrounding? tissue?by? remaining? their? tight? cell?cell?
contacts?to?the?neighbor?cells?as?well?as?to?the?primary?tumor.?
?
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1.3.3 Tumor?dissemination?through?the?vasculature?and?extravasation?
Although? the? rate? of? disseminating? tumor? cells? increases?with? primary? tumor? size,?
shedding?of?malignant? cells? can?already?occur? in? the?early?onset?of? the? tumor? (20).Tumor?
cells?exhibit?a?high?plasticity? in?adapting?their?type?of? invasion? in?order?to?progress?through?
the?various?stages?of?the?metastatic?process.?Collectively?migrating?cells?need?to?break?away?
from? their?neighbors? to?be?able? to?enter? the?bloodstream.?Therefore,? tumor? cells?have? to?
undergo? adaptive? switches? by? activating? different? programs? like? EMT,? depending? on? the?
different?environments.?Migratory?cancer?cells?that?undergo?EMT?acquire?specific?properties?
like?the?expression?of?VE?cadherin,?which?allow?them?to? interact?with?endothelial?cells?and?
enhance? the? capacity? of? transendothelial? migration? (51,? 52).? Furthermore,? the? widely?
observed? increase? in?microvessel?density?as?well?as? the? leakiness?of? the? tumor?vasculature?
facilitates? the? entry? of? cancer? cells? into? the? circulation.? Surviving? in? the? bloodstream?
necessitates?acquisition?of?qualities,?such?as?the?evasion?of?detachment?triggered?cell?death?
(anoikis)?as?well?as?surviving? the?shear? forces?and?evade?attacks? from? the? immune?system?
(53).? To? be? protected? from? immunological? assault,? some? tumor? cells? induce? platelet?
aggregation,? which? has? also? been? reported? to? facilitate? tumor? cell? cluster? arrest? in? the?
microvasculature?(54).?One?of?the? factors? identified?to? induce?platelet?aggregation? in?some?
human?cancers,?is?the?transmembrane?protein?Podoplanin?(55),?which?was?already?identified?
to?play?an?important?role?in?collective?cell?migration.?
1.3.4 Extravasation?of?circulating?tumor?cells?and?establishment?at?secondary?sites?
Gains? of? invasive? characteristics? as?well? as? angiogenesis? are? important? events? for?
metastasis? albeit? they? are? not? sufficient? themselves.?Outgrowth? of?metastases? in? distant?
organs?depends?on?whether?some?circulating?tumor?cells???generally?only?a?small?minority?of?
them???manage?to?enter?the?parenchyma?of?a?target?organ?(20).?To?do?so,?cancer?cells?need?
to?extravasate?from?the?blood?stream?by?first?adhering?to?the?vascular?endothelium?and?then?
transmigrate?through?the?endothelial?cells?to?invade?the?surrounding?tissue.?The?mechanisms?
underlying?this?extravasation?process?is?still?poorly?understood.?Nevertheless,?recent?studies?
have?identified?a?lung?metastasis?gene?signature?in?breast?cancer,?whereof?the?combinatorial?
expression?of?four?genes,?namely?the?EGFR? ligand?Epiregulin,?the?cyclooxygenase?COX2?and?
the?matrix?metalloproteinases?MMP1?and?2,?were?found?to?not?only?facilitate?the?formation?
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of?new?tumor?blood?vessels?and?the?entry? into?the?circulation?but?also?to?advance?the?exit?
from? the? bloodstream? at? the? lung? capillaries? (56,? 57).? Furthermore? VEGF,? an? angiogenic?
factor,? which? is? expressed? by? most? cancer? cells,? increases? the? permeability? of? the?
endothelium? by? uncoupling? endothelial? cell?cell? junctions? and? thereby? potentiating? tumor?
cell?extravasation?(58).?The?dissemination?of?tumor?cells?has?characteristic?patterns?of?organ?
tropism?depending?on?the?cancer?type.?The?precise?mechanism?of?this?homing?process?still?
needs?to?be?established,?although?a?number?of?chemokines?have?been? implicated?to?play?a?
crucial? role? in? organ?specific? metastasis.? Breast? cancer? is? characterized? by? a? distinct?
metastatic?pattern,?involving?regional?lymph?nodes,?bone?marrow,?lung?and?liver.?It?has?been?
shown? that? in? malignant? breast? cancer,? the? chemokine?receptors? CXCR4? and? CCR7? are?
expressed?at?high?levels?in?the?primary?tumor?as?well?as?in?the?metastases.?Their?respective?
ligands?SDF1??and?CCL21?are?abundant? in?organs? representing? the? first? target? location? for?
breast? cancer?metastasis? (59).? This? finding? implicates? that? specific? expression? of? a? set? of?
genes?may?guide?circulating?tumor?cells?to?distinct?secondary?sites.?
1.3.5 Preparing?the?pre?metastatic?niche?
Another? interesting? hypothesis? to? explain? the? tissue?specific? pattern? of?metastatic?
progression? in? cancer,? is? the? formation? of? a? permissive?microenvironment? for? incoming?
tumor? cells,? by? bone? marrow?derived? cells? (pre?metastatic? niche)? (60).? Labeled? bone?
marrow?derived?cells?have?been?observed?to?specifically?home?and?form?clusters?at?common?
sites? of? metastasis? before? the? arrival? of? tumor? cells.? These? bone? marrow?derived? cells?
(BMDCs)? express?VEGFR?1? and? other? hematopoietic?markers? to?maintain? their? progenitor?
status?and?preferentially? localize?at?Fibronectin?rich?areas.? Interestingly,?the?preparation?of?
the?pre?metastatic?niche?is?regulated?by?the?primary?tumor.?Expression?of?high?levels?of?VEGF?
mobilizes?and?recruits?VEGFR?1?expressing?hematopoietic?progenitor?cells?(HPC)?resulting?in?
increased?HPC?clustering?and? formation?of?metastasis?at?multiple? sites? (61).?Moreover? the?
secretion? of? tumor? specific? growth? factors? like? VEGF?A,? TNF?? and? TGF?? induces? the?
expression?of? inflammatory?chemoattractants,?which? in?turn?attract?myeloid?cells?at?distant?
pre?metastatic?sites?(62).?By?this?a?tumor?specific?chemokine?profile?can?prime?and?direct?the?
location?of? future?metastatic? tumor? growth.?More? recently,? the? ECM? crosslinking? enzyme?
LOX?was?identified?as?an?important?factor?in?the?formation?of?the?pre?metastatic?niche.?The?
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secretion?of?the?enzyme? into?the?circulation?by?the?hypoxic?environment?of?primary?breast?
tumors? leads? to? a? co?localization? of? LOX?with? Fibronectin? at? future?metastatic? sites? and?
crosslinking?of?ECM?components? like?collagen? IV.?Thereby?attracted?myeloid?cells? initiate?a?
positive? feedback? loop?by? further?cleavage?of?collagen? IV?and?a?recruitment?of?BMDCs?and?
metastasizing? tumor? cells? (63).? These? findings? indicate? that? the? initial? deposition? of?
Fibronectin? and? LOX? in? the? pre?metastatic? niche? contribute? to? the? formation? of? an?
appropriate?ECM? that? facilitates? the? recruitment?of?BMD? and?other?mesenchymal? cells? to?
prepare? the? suitable? environment? for? future?metastasis? (64).? Targeting? the? factors? that?
initiate? the?pre?metastatic?niche?could?be?a?novel?approach? to?effectively? treat?cancer?cell?
metastases?and?therefore?improve?patient?survival.?
1.4 EMT?
The? expression? Epithelial? to? Mesenchymal? Transition? (EMT)? describes? a? complex?
molecular? and? cellular? program? by? which? epithelial? cells? abandon? their? differentiated?
features,?such?as?cell?cell?adhesion,?planar?and?apical?basal?polarity?and?low?cell?motility?and?
acquire? mesenchymal? characteristics,? including? motility,? invasiveness? and? increased?
resistance?to?apoptosis?(Figure?3)?(65).?EMT? is? implicated? in?several?physiological?as?well?as?
pathological? processes,? as? a? critical? mechanism? for? embryonic? development? and? is? re?
engaged? in? adults? during? wound? healing,? tissue? regeneration,? organ? fibrosis? and? cancer?
progression?and?metastasis?(66).?The?biological?need?for?EMT?is?to?produce?cells?with?distinct?
morphology?and? functions? to?acquire?motile?and? locally? invasive?capabilities?and? to?enable?
genetically? unstable? tumor? cells? to? disseminate.? EMT? can? be? classified? into? three? types,?
depending?on?the?biological?context?in?which?they?proceed?(67).??
Type?1?EMT? is? the?subtype?associated?with? implantation,?embryogenesis?and?organ?
development?and?is?the?only?subtype,?which?is?independent?of?inflammatory?processes.?Type?
1?EMT?does?not?result?in?systemic?spread?of?mesenchymal?cells?via?the?circulation?but?rather?
generates?mesenchymal?cells,?which?have?the?potential?to?subsequently?undergo?the?reverse?
process?(MET)?to?redifferentiate?and?form?secondary?epithelia.??
The? second? type? of? EMT? is? a? repair?associated? incident? provoking?wound? healing,?
tissue? regeneration?and?organ? fibrosis.?This? type?2? is? clearly? inflammation?dependent?and?
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ends?when? the? inflammatory? process? diminishes.?Ongoing? inflammation? causes? persisting?
EMT,?which?can?result?in?organ?destruction.?
The? EMT? associated?with? cancer?progression? and?metastasis? is? classified? as? type?3?
EMT.?This?subtype?occurs? in?neoplastic?cells?and?may?go?on?to?variable?extents,?resulting? in?
groups?of?cells?retaining?epithelial?characteristics?while?gaining?some?mesenchymal?ones?and?
other?cells?undergoing?full?EMT.?The?specific?signals?inducing?EMT?in?cancer?cells?still?need?to?
be?elucidated?but?the?genetic?and?epigenetic?alterations?occurring?during?cancer?progression?
result?in?a?high?responsiveness?to?EMT?inducing?signals,?which?are?contributed?by?the?tumor?
stroma.?
The?actual?occurrence?of?EMT? in? the?process?of?metastasis? in?patients? is?still?highly?
debated,?however?recent?studies?implicate?that?primary?tumors?displaying?an?EMT?like?gene?
expression?profile?are?more? likely? to?be?associated?with?distant?metastases? formation?and?
worse? prognosis? for? overall? survival? (68?70).? In? contradiction? to? these? findings? are? the?
frequent? observations? that? distant? metastases? from? carcinomas? are? formed? by? cells?
displaying?an?epithelial?phenotype?highly?similar?to?the?cancer?cells?of?the?primary?tumor?(68,?
69).?This?discrepancy?can?be?explained?by? the?highly?dynamic?nature?of? the?EMT?program.?
The? disseminated? mesenchymal? cancer? cells? undergo? the? reverse? process? (MET)? after?
metastatic?spread?and?colonization,? to? revert? to?a?more?differentiated,?epithelial?cell?state?
enabling?them?to?establish?in?the?distant?location?(71).?There?is?increasing?evidence?that?EMT?
and? its?reverse?process?MET?are?pivotal?regulators?of?cell?plasticity? in?carcinomas?and?play?
important?roles?in?drug?resistance,?relapse?and?metastatic?progression?(72).?
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Figure?3:?The?transition?from?the?epithelial?to?the?mesenchymal?state?is?accompanied?by?specific?morphological?
changes.? EMT? occurs?when? epithelial? cells? break? down? their? cell?cell? junctions? and? lose? their? apical?basal? polarity? and?
acquire?mesenchymal?characteristics? such?as? focal?adhesions,?actin? skeletal? reorganization? to? stress? fibers?and? increased?
invasiveness.?
?
1.4.1 Epithelial?cell?cell?adhesion??
Epithelial?cells?naturally?form?stable?sheets?containing?of?apical?basal?polarized?cells?
with? tight?cell?cell?contacts? formed?by? tight? junctions? (TJ)?and?adherens? junctions? (AJ)?and?
desmosomes? (73).? Tight? junctions? are? located? at? the? apical? side,? forming? an? intercellular?
sealing?to?avoid?paracellular?diffusion.?Among?the?main?components?building?the?TJ?are?the?
transmembrane?proteins?Occludin?and?Claudins?as?well?as?the?cytoplasmic?molecules?Zonula?
Occludens?(ZO)?1,2,3?and?p120.?The?cytosolic?part?of?ZO?proteins?contribute?to?the?strength?
and?integrity?of?the?TJ?by?attaching?to?the?actin?filaments?(74).?Located?adjacent?to?the?tight?
junctions?are?the?adherens?junctions,?forming?a?belt?like?structure?at?the?lateral?interface?of?
epithelial? cells.? The? single?span? transmembrane? glycoprotein? E?cadherin? is? the? prototype?
member?of? the? adherens?proteins.? E?cadherin? interacts?with?neighboring? cells?by? forming?
calcium?dependent?homodimers?with?their?cadherin?repeats.?The?cytoplasmatic?domains?of?
E?cadherin?are?anchored?to?the?cytoskeleton?by?binding?directly?to???catenin,?which?is?linked?
to?the?actin?filaments?via???catenin?(75).?Thus,?the?formation?of?cadherin?mediated?cell?cell?
interaction? not? only? functions? to? establish? tight? cell?cell? adhesion? but? also? to? define? the?
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adhesive? specificity? of? the? cell? and? to?modulate? the? organization? of? its? cytoskeleton.? The?
juxtamembrane? domain? of? E?cadherin? is? bound? to? another? catenin,? namely? p120,?which?
assures?surface?tracking,?the?proper?membrane? localization?of?E?cadherin?and? its? lysosomal?
degradation? (76?78).? Moreover,? p120? is? involved? in? the? stability? of? epithelial? cell?cell?
adhesion?via?the?repression?of?RhoA?GTPase?activity?and?activation?of?the?GTPases?Rac?and?
Cdc42.?These?key?regulators?of?actin?assembly?play?a?major? role? in? the?stability?of?cell?cell?
adhesion?by? fortifying? actin? stress? fibers? (RhoA)? and? activate? the? formation?of?membrane?
protrusions? like? lamellipodia? and? filopodia? (Rac? and? Cdc42)? (79,? 80).? In? addition? to? its?
adhesive? function,? E?cadherin? comprises? also? signaling? capacities,? transduced? by? the?
intracellular? domain? or? its? interacting? proteins,? such? as? ??catenin? or? it? forms?multimeric?
complexes? with? receptors? such? as? c?Met,? IGF1R? or? integrins? (81).? Notably,? proteolytic?
cleavage? of? the? intracellular? domain? of? E?cadherin? by? ??secretase? produces? a? C?terminal?
cytoplasmic? fragment? (Ecad/CTF2).? This? Ecad/CTF2? is? imported? into? the? nucleus,?where? it?
modulates? the? interaction? between? the? suppressive? complex? of? p120?catenin? and? the?
transcriptional? repressor? Kaiso,? which? is? involved? in? the? regulation? of? the?Wnt? signaling?
pathway?(82).?The?nuclear?localization?of?Ecad/CTF2?is?specifically?enhanced?by?p120?catenin,?
where? it? forms?a? trimeric?complex?with?p120?and?Kaiso,? implicating?a?role?of?Ecad/CTF2? in?
the? regulation?of? gene? transcription? (83).? These? findings?expand? the? field?of? activity?of? E?
cadherin?beyond?its?adhesive?functions?and?punctuate?the?critical?capacity?of?E?cadherin?as?a?
regulator?of?signaling?complexes.?
1.4.2 Mechanisms?of?EMT?activation??
The? process? of? EMT? can? be? triggered? by? diverse? intrinsic? signals,? such? as? gene?
mutations,?as?well?as?extrinsic?stimuli?including?growth?factor?signaling,?extracellular?stroma?
interaction? and? hypoxia.? The? downstream? intracellular? signaling? of? EMT? includes?
transcriptional? reprogramming?and?various?positive? feed?back? loops? (84).?Among? the?EMT?
inducing?growth?factors,?the?members?of?the?transforming?growth?factor???(TGF?)?family?are?
the?best?characterized? inducers.?They?are? involved? in?EMT?during?embryonic?development,?
wound? healing? and? cancer? progression? (65,? 85).? Receptor?mediated? signaling? can? also? be?
activated? by? various? other? factors,? such? as? the? hepatocyte? growth? factor? (HGF)? (86),?
members?of?the?epidermal?growth?factor?(EGF)?(87)?and?of?the?fibroblast?growth?factor?(FGF)?
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family.? In?detail,?hepatocyte? growth? factor? (HGF)? and? its? cognate? receptor? c?Met? are?well?
known? inducers? of? cell? scattering,? migration,? invasion? and? EMT? and? were? found? to? be?
mutated? in? a? variety?of?human? cancers? (88).?The? cooperation?of? c?Met?with? the? v6?splice?
variant?of?the?hyaluronan?receptor?CD44,?which?is?frequently?upregulated?in?cancer?and?was?
implicated? in? tumor?metastasis,? seems? to? be? required? for?HGF?induced? c?Met? stimulation?
with? subsequent?MEK?and?MAPK?activation? (89,?90).?All? the?above?mentioned? inducers?of?
EMT? activate? the? disassembly? of? junctional? complexes? and? changes? in? cytoskeletal?
organization? as? well? as? the? activation? of? transcriptional? regulators? accompanying? this?
process.?A?central?target?of?these?changes? in?gene?expression?patterns? is?E?cadherin,?which?
has?a?direct?relevance? in? the?onset?and?continuation?of?EMT.?E?cadherin?expression? is?also?
targeted?by?genetic?or?epigenetic? changes?occurring?during?or?activating?EMT,? resulting? in?
heritable?effects? and? a? stable?mesenchymal?phenotype.?An? important? activator?of? EMT? is?
hypoxia,?which? is? often? associated?with? fast? growing? tumors.? Low? O2? levels? activate? the?
various?hypoxic?programs? including?hypoxia?induced?factor?1??(HIF1?),?HGF,?Notch?or?NF?B?
pathway?activation,?resulting?in?the?induction?of?the?EMT?inducing?transcription?factor?SNAI1?
(91,?92).?With?increasing?interest?in?non?coding?RNAs,?miR?200?family?(miR?200a,?miR?200b,?
miR?200c,?miR?141?and?miR?429)?and?miR?205?have?been?identified?as?regulators?of?EMT?and?
metastasis.?The?regulation?of?EMT?by?non?coding?RNAs?has?been?found?to?be?coupled?to?the?
repression?of?E?cadherin?expression?by? targeting? the? transcription? factors?ZEB1? (?EF1)?and?
ZEB2? (Sip1)? (93,? 94).? Another? recently? found? potential? EMT?inducing? mechanism? is?
alternative? splicing,? which? can? generate? isoforms? of? the? same? gene? with? antagonistic?
functions.? Two? RNA? binding? proteins,? the? epithelial? splicing? regulatory? proteins? 1? and? 2?
(ESRP1? and? ESRP2)? were? recently? identified? to? control? the? splicing? of? epithelial?specific?
isoforms? of? EMT?associated? genes,? such? as? FGFR2,? CD44? and? p120?catenin? (95,? 96).? This?
complexity? of? factors? and? pathways? involved? in? the? induction? and? continuation? of? EMT?
explains?why?EMT? is?not?a?simple?change? in?cell?shape?or?adhesive?capabilities?but?rather?a?
modification?of?all?fundamental?cell?programs?in?a?highly?dynamic?manner.??
1.4.3 Loss?of?E?cadherin?function?
An? early? event? during? EMT? is? the? disassembly? of? tight? junctions? resulting? in? the?
disruption?of?the?polarity?complex?and?initiation?of?cytoskeleton?reorganization?(97,?98).?Loss?
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of? adhesive? function? of? E?cadherin? is? frequently? observed? in? clinical? and? experimental?
studies,?occurring? in?most?human?epithelial?cancers?and? is?therefore?a?clinical? indicator? for?
poor?prognosis? (19,? 99).?Given? that? E?cadherin? is? an? important? regulator?of? epithelial? cell?
shape? and? tissue? homeostasis,? its? expression? is? accurately? controlled? and? its? loss? can? be?
caused? by? a? variety? of? genetic? as? well? as? post?translational?modifications? during? tumor?
progression.?
1.4.3.1 Genetic?and?epigenetic?control?of?E?cadherin?
Stable? alterations? of? gene? expression? occurring? during? cancer? progression? include?
gene?mutations?and?deletions,?copy?number?aberrations?or?chromosomal?rearrangement?as?
well? as? epigenetic? changes,? like? covalent? modification? of? the? DNA? (72).? Although? the?
suppression?of?CDH1,?the?gene?encoding?E?cadherin,?is?usually?achieved?by?post?translational?
or?epigenetic?modifications,?inactivating?mutations?have?been?identified?in?hereditary?gastric?
cancer? (100).? Furthermore,? lobular? breast? carcinomas? frequently? show? somatic? genetic?
inactivation?of?the?CDH1?gene?with?an?indication?that?this?is?as?an?early?event?during?sporadic?
tumor? development? (101).?Another? important? repressing?mechanism? of? E?cadherin? is? the?
hypermethylation? of? its? promoter? CpG? islands,? which? can? act? as? a? second? hit? for?
transcriptional?repression?(102).?This?modification?is?associated?with?the?recruiting?of?methyl?
DNA? binding? proteins? (MBDs)? as? well? as? histone? deacetylase? activity? (HDACs),? which? in?
conjunction?result?in?the?compaction?of?the?promoter?region?and,?thus,?to?the?inactivation?of?
the?gene? (103).?Epigenetic?silencing?of?tumor?suppressor?genes? is?also?achieved?by?histone?
modifications? such? as? acetylation,? phosphorylation,? ubiquitination,? sumoylation? and?
methylation,? each? of? these?with? specific? consequences? for? chromatin? function,? of?which?
lysine?methylation?has?been?shown?to?play?a?crucial?role? in?the?control?of?gene?expression?
(104,?105).?The?well?described?E?cadherin?repressor?Snail1?has?been?found?to?associate?with?
the? polycomb? repressor? complex? 2? (PRC2)?members? Suz12? and? Ezh2? and? to? recruit? this?
complex? to? the? CDH1? promoter? region,? thus? promoting? the? repression? of? E?cadherin? by?
trimethylation?of?lysine?27?in?histone?3?(H3K27?me3).?These?epigenetic?changes?appear?to?be?
dynamic? during? tumor? progression,? as? hypermethylation? of? the? CDH1? gene? is? frequently?
found? in? invasive? and?metastatic? tumors.? Yet,? it?has?been? shown? that? re?expression?of? E?
cadherin?at?secondary?sites?promotes?survival?of?the?cancer?cells?(106,?107).?
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1.4.3.2 Transcriptional?control?of?E?cadherin?silencing?
Besides? the? regulation? of? the? CDH1? promoter? via? hypermethylation,? direct?
transcriptional? control?by? a? list?of? transcription? factors,? such? as? Snail1,? Slug? (Snail2),? ZEB1?
(?EF1),?ZEB2?(Sip1),?E47?and?Twist?have?emerged?as? important?regulatory?mechanism?of?E?
cadherin? expression? (108).? The? expression? of? these? repressors? is? controlled? by? diverse?
signaling?such?as?the?activation?of?the?TGF?,?HGF,?EGF?and?Notch?pathways?and?furthermore,?
they?show?mutual?regulation?via?positive?and?negative?feedback?loops.?The?above?mentioned?
transcriptional? repressor? Snail1?was? also? found? to? bind? directly? to? the? E2?boxes? in? the? E?
cadherin? promoter? to? regulate? its? expression? (109).? Furthermore,? Snail1? induces? the?
expression? of? the? zinc? finger? transcription? factor? ZEB1,?which? interacts?with? the?CtBP? co?
repressor? to? suppress?E?cadherin? (110,?111).?ZEB2,?another?member?of? the?homeodomain?
and? zinc? finger? family,?was? also? found? to?be? coexpressed?with? Snail1.? In? contrast? to? Snail?
proteins,?ZEB1?and?ZEB2?are?able?to?interact?with?transcriptional?co?activators?such?as?p300?
and? pCAF,? indicating? a? fundamental? different?mechanism? of? Snail? and? ZEB? transcription?
factors? to? activate? mesenchymal? markers? (112).? A? more? indirect? mechanism? of?
transcriptional?regulation?is?observed?for?the?members?of?the?inhibitor?of?differentiation?(Id)?
protein?family.?These?proteins?were?found?to?function?as?negative?regulators?of?E?protein?or?
basic?helix?loop?helix? (bHLH)?transcription? factors?by?the? formation?of?active?heterodimers,?
since?they?are?lacking?an?own?DNA?binding?domain?(113).?These?data?indicate?that?different?
repressors?participate?in?E?cadherin?silencing?using?diverse?mechanism?depending?on?cancer?
type?or?the?stage?of?tumor?progression?(103).??
1.4.3.3 Post?translational?control?of?E?cadherin?
A?more?dynamic?way?of?E?cadherin?control?happens?on? the?post?translational? level?
such?as?O?glycosylation?of?the?freshly?synthesized?E?cadherin?to?prevent?protein?transport?to?
the?membrane?(114)?as?well?as?the?degradation?of?mature?membrane?bound?E?cadherin?by?
proteolytic? cleavage? or? endocytosis? (115,? 116).? As? described? in? chapter? 1.4.1,? proteolytic?
cleavage? of? E?cadherin? by? ??secretase? can? result? in? the? release? of? the? active? fragment?
Ecad/CTF2,? which? is? subsequently? transported? to? the? nucleus? to? interfere? with? the?
transcriptional?repressor?complex?p120?and?Kaiso,?affecting?survival? (83).?Furthermore,?the?
E?cadherin? adhesion? complex? is? a? target? of? receptor? tyrosine? kinase? or? Src?mediated?
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phosphorylation,? leading? to?ubiquitylation?by? the?H3? ligase?Hakai? followed?by?degradation?
(117).?The?downregulation?of?E?cadherin?not?only?entails? the?disassembly?of? the?adherens?
junctions?but?also?releases?cytoplasmic?members?of?the?adhesion?complex,?such?as???catenin?
and? p120?catenin,? to? administrate? ambivalent? functions? controlled? by? their? subcellular?
localization? (32).? This? complexity? and? diversity? of? E?cadherin? regulation? indicates? that? the?
cells?need?to?have?dynamic?range?of?E?cadherin?expression,?depending?on?the?environmental?
and?competence?requirements.?
1.4.4 The?cadherin?switch?
E?cadherin,? the? prototype? family?member? of? epithelial? Cadherins,? is? important? for?
epithelial? structure? maintenance,? whereas? the? mesenchymal? N?cadherin? is? expressed? in?
nervous? tissue,?connective? tissue?and?migratory?cells.?The?cadherin?switch? is?a?hallmark?of?
EMT?resulting?in?alterations?of?adhesive?properties,?acquiring?affinity?for?mesenchymal?cells,?
such?as?fibroblasts?or?vascular?endothelial?cells?and?enhancement?of?migratory?and?invasive?
capabilities? (118,? 119).? Change? from? E?cadherin? to? N?cadherin? expression? occurs? during?
development?in?mesoderm?formation,?but?it?is?also?suspected?to?support?the?transition?from?
benign?to?invasive?malignant?tumors?(120).?In?most,?if?not?all,?epithelial?cell?derived?tumors,?
loss? of? E?cadherin?mediated? cell?cell? adhesion? is? associated? with? increasing? malignancy,?
achieving? the? prerequisites? for? dissociation? and? invasion? of? cancer? cells? (121).? Indeed? in?
some? human? tumors,? a? de? novo? expression? of? N?cadherin? or? Cadherin?11? is? observed?
subsequent? to? E?cadherin? silencing? and? correlates? with? poor? prognosis? (119,? 122?124).?
Although? N?cadherin? has? been? shown? to? promote?motility? and?migration,? the? functional?
implication?of? this? switch? could?be?more?diverse? than? first?expected? in? tumor?progression?
and?play?a?role? in? the?process?of?new?homing?and?altered?affinity? to?neighboring?cells? (98,?
125,?126).?The?regulation?of?N?cadherin?expression?still?needs?to?be?elucidated?in?detail,?yet?
recent? studies? showed?an?activation?of?N?cadherin?via?collagen? I?as?well?as? transcriptional?
upregulation?of?the?mesenchymal?protein?by?the?transcription?factor?Twist,? in?a??1?integrin?
dependent? manner? (127,? 128).? Like? its? epithelial? counterpart? E?cadherin,? N?cadherin? is?
coupled?to?the?cytoskeleton?via???catenin?and???catenin,?displaying?cell?adhesion?properties?
by? the? formation?of? transcellular?homodimers?as?well?as? signaling? functions?by? interacting?
with? signal? transduction?molecules,? such? as? the? PDGFR,?which? is? known? to? induce? actin?
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reorganization,?proliferation?and?differentiation,?playing?an?important?role?in?EMT?(129?131).?
Furthermore,? our? laboratory? has? shown? a? physical? association? of? N?cadherin? with? the?
fibroblast?growth?factor?receptor?(FGFR)?forming?a?complex?together?with?the?cell?adhesion?
molecule?NCAM?(132,?133).?This?functional?cooperation?stabilizes?the?receptor?by?preventing?
its? internalization? and? therefore? results? in? sustained?MAPK? activity,? increased? cell?motility?
and?MMP?secretion,?promoting? invasiveness?(134,?135).?Additionally,?proteolytic?processing?
of?N?cadherin?by?ADAM10?and???secretase?initiates?the?shedding?of?extracellular?domain?and?
release? of? the? cytoplasmic? fragment? (Ncad/CTF2)? acting? as? a? transcriptional? repressor.?
Binding?of?the?Ncad/CTF2?to?CBP?leads?to?the?induction?of?its?proteosomal?degradation?and?
by? this? interferes?with? the? CBP/CREB? transcription? complex? and? the? expression? of? genes,?
which?are? important?for?proliferation?and?differentiation,?such?as?c?Fos?(136).? Interestingly,?
N?cad/CTF2? conveys? also? pro? invasive? ??catenin/Tcf? signaling? by? diverse? contributions,? as?
there? is?the? inhibition?of???catenin?phosphorylation,?upregulation?of???catenin?transcription?
and? reduced? sequestration? of? ??catenin? at? the? cell?cell? junctions? as? a? result? of? reduced?
protein?levels?of?full?length?N?cadherin?(137).?Faced?by?this?pleiotropic?functions,?N?cadherin?
plays? a? critical? role? in? the? regulation? of? EMT? and? invasiveness.? Besides? executing? cell?
adhesion?functions?and?determination?of?mesenchymal?cell?affinity,? it? is? involved? in?distinct?
signaling? pathways,? altering? the?migratory? capability? of? the? cell? by?modulation? of? growth?
factor?signaling?and?actin?cytoskeleton?remodeling.?
1.4.5 The?role?of?integrins?in?invasion?and?EMT??
The?extracellular?matrix?(ECM)? is?a?highly?dynamic?structure,?formed?by?a?variety?of?
proteins? and? proteoglycans,? involved? in? cellular? processes? such? as? proliferation,? survival,?
differentiation? and? migration.? The? control? of? these? processes? is? mainly? mediated? by?
interactions? of? the? cellular? adhesive? adaptors,? integrins? and? the? ECM.? Integrins? are?
heterodimeric?transmembrane?receptors,?formed?by????and???subunits,?executing?similar?to?
the? cadherins?mechanical?adhesion?as?well?as? signaling? functions.?The? inactive,? low? ligand?
affinity? confirmation? can? be? activated? by? binding? of? intracellular? proteins? like? talin? or? by?
MMP?mediated?proteolytic?cleavage?(138,?139).?Integrins?are?linked?to?the?actin?cytoskeleton?
via?Parvin?or?a?Paxillin/Vinculin/Parvin?complex,?triggering?the?activation?of?diverse?signaling?
cascades? and? their? effector? proteins,? such? as?MAPK,?NF?B,? Jun,? ??catenin? and? others,? via?
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direct?targets? like?FAK,?Src?family?kinases?and?PKB? (140,?141).?During?EMT? integrins?display?
distinct? functions? including? the? initiation? and? enforcement? of? EMT? and? invasion.? In?
pancreatic? cancer? integrin? ?1?1? as?well? as? ?2?1?were? found? to? induce? loss? of? E?cadherin?
mediated? cell?cell? contacts? and? activation? of? the? ??catenin/TCF? pathway? by? binding? to?
Collagen? I? (142).?Furthermore,?as?described? in?chapter?1.4.4,?activation?of??2?1?integrin?by?
Collagen?I?together?with?the?collagen?receptor?discoidin?domain?receptor?(DDR1)?leads?to?the?
upregulation?of?N?cadherin?expression?(127).?This? induction?of?the?cadherin?switch?plays?an?
important? role? in? the? initiation? and? progression? of? EMT.?Moreover,? Snail,? a?well? known?
inducer?of?EMT,?is?able?to?activate?the?expression?of?the?pro?invasive??v?3?integrin,?which?is?
mainly? located?at? the? invading?cancer? front? (143,?144).?Other? studies? showed? that? the?co?
localization?and?cooperation?of??1?integrin?and?membrane?type?matrix?metalloproteinase?1?
(MT1?MMP)?is?essential?for?tumor?cell?invasion?into?a?collagen?matrix?and?that?both?proteins?
are? implicated? to?have? important? roles? in?EMT? (145?147).? Furthermore,? the? interaction?of?
MT1?MMP? and? ?v?8?integrin? leads? to? the? activation? of? TGF?,? one? of? the? most? potent?
inducers?of?EMT?(84),? indicating?diverse?contributions?of?the? integrin?family?to?this?complex?
process?.?
1.4.6 EMT?in?cancer?metastasis?
The? EMT? transdifferentiation? program? was? first? delineated? as? a? cell? culture?
phenomenon?and? the? relevance?of?EMT? in?physiological?processes?and?cancer?progression?
has? remained? a?matter? of? debate? until? very? recently? (72).? The? long? believed? theory? of?
metastasis?as?a? late?event?during?tumor?progression? is?refuted?by?the?finding?of?a?systemic?
spread?of?tumor?cells?from?early?lesion?in?HER?2?transgenic?mice?as?well?as?in?human?ductal?
carcinomas?(148).?In?clinical?samples,?EMT?may?be?a?focal?event?that?is?easily?overseen?as?it?is?
highly? dynamic.?Moreover? the? individual? tumor?derived?mesenchymal? cells? invading? the?
surrounding? tissue? are? delicate? to? distinguish? from? stromal? cells? or? tumor? associated?
fibroblast?(149).?Nevertheless,?there?is?morphological?evidence?of?EMT?at?the?invasive?tumor?
fronts?of?many?human?tumors,?like?in?colon?carcinoma,?where?single?migratory?cells?show?an?
EMT?phenotype,?with? loss?of?E?cadherin,?deregulation?of? the?Wnt?pathway?and?a?selective?
loss?of?the?basement?membrane?(150).?This?phenomenon?is?also?found?in?other?solid?tumors?
like? breast? carcinomas,? where? EMT? is? associated? with? histological? grades,? the? basal?like?
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phenotype?and?the?metaplastic?subtype,?correlating?with?a?decrease?in?relapse?free?survival?
(149,? 151?154).? Although? EMT? is? observed? at? the? invading? front? of? epithelial? cell?derived?
cancers,?there?is?only?few?data?demonstrating?the?presence?of?EMT?in?circulating?tumor?cells?
(CTCs).? Recent? studies? in? human? non? small? cell? lung? cancers? (NSCLC)? uncovered? a? dual?
epithelial? and? mesenchymal? phenotype? of? CTCs? in? the? peripheral? blood? of? metastatic?
carcinoma?patients,?still?expressing?epithelial?markers?such?as?cytokeratins?but?showing?also?
expression? of? mesenchymal? markers? like? Vimentin? and? the? loss? of? E?cadherin? (155).?
Furthermore,? the? majority? of? clusters? of? circulating? tumor? cells,? circulating? tumor?
microemboli? (CTMs),?show?a?higher? fraction?of?Vimentin?expressing?cells?and?also?a?higher?
resistance?to?apoptosis?than?isolated?CTCs?(156).?The?expression?of?these?EMT?markers?were?
observed? with? high? intra?? and? inter?patient? heterogeneity,? and? the? phenomenon? of? this?
partial?or?incomplete?EMT?in?CTCs/CTM?and?their?metastatic?potential?needs?further?detailed?
analysis.??
1.4.7 EMT?in?cancer?resistance?to?cell?death?
Although?the?involvement?of?EMT?in?metastasis?is?of?great?interest,?its?contribution?to?
other? incidences?of?tumor?progression?may?also?be?relevant.?Different?cell? lines?have?been?
found? to?escape?apoptosis?while?undergoing?EMT?using? this?dedifferentiation?process?as?a?
survival?mechanism.? For? example? in? activated?Ras?expressing?mammary? epithelial? cells? as?
well?as? in?hepatocytes,? treatment?with?TGF?? leads? to? inhibited?apoptosis?and? induction?of?
EMT? (157).? TGF?? as? a? potent? promoter? of? tumor? progression? and? invasion? is? further?
discussed? in? chapter? 1.5.? Twist,? another? EMT? inducer,?was? found? to? activate? survival? by?
suppressing? the?Myc?mediated? proapoptotic? effect? in? neuroblastoma? (158).? Furthermore,?
Twist1?and?Twist2?can?also?prevent?oncogene?induced?senescence?via?p16/ink4?and?p21/cip?
inhibition? (159).?These?data? indicate,? that?EMT? is?not?only?an?approach? for? tumor? cells? to?
maintain? a? mesenchymal? invasive? phenotype? but? also? to? ensure? the? survival? of?
micrometastatic?cells?by?circumventing?premature?senescence?and?apoptosis,?two?safeguard?
mechanisms?against?cancer.?
1.4.8 EMT?induces?resistance?to?chemotherapy?and?immunosuppression?
Several? in? vitro? studies? indicate? coherence? between? EMT? and? resistance? against?
chemotherapeutic?therapies.?For?example,?epithelial?cell?lines?derived?from?colon?carcinoma?
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or?ovarian?carcinoma,?which?are?resistant?to?oxaliplatin?or?paclitaxel?were?shown?to?associate?
with? the? loss? of? epithelial? markers? and? gain? of? mesenchymal? morphology? (160,? 161).?
Moreover,?depletion?of?Twist?in?breast?cancer?cells?can?partially?reverse?multidrug?resistance?
(162).?Consistent?with?these?results,?forced?expression?of?the?EMT?suppressing?miR?200c?was?
able? to? restore? sensitivity? to?microtubule?targeting? chemotherapeutic?agents?via? its? target?
gene?class?III???tubulin?(TUBB3)?(163).?Another?drawback?that?cancer?cells?need?to?overcome?
is? immune? surveillance,? and? EMT? is? an? effective? approach? to? escape? this? safeguard?
mechanism,?as? shown? in?Neu?driven? tumor?mice,?where? tumor? cells? that?have?undergone?
immunoediting?and? lost?antigen?expression,?upregulated?genes?associated?with?EMT? (164).?
Moreover,?after?transgene?deactivation? in?a?Neu/ErBb2?inducible?transgenic?mouse?model,?
tumor?relapse?from?residual?foci?resulted?in?more?aggressive?new?tumors?of?a?mesenchymal?
phenotype,? indicating? that? EMT? offers? a?way? to? escape? dependence? on? initial? oncogenic?
pathways? as?well? as? resistance? to? targeted? therapies? (165).? Interestingly,? recent? findings?
identified? Snail? as? an? activator? of? immunosuppressive? cytokines,? cytotoxic? T? lymphocyte?
resistance?and?the?generation?of?impaired?dendritic?cells?(166).?This?impairment?of?multiple?
immunosuppression? and? immunoresistance?mechanisms? leads? to? an? altered? response? of?
host? versus? tumor,? thus? therapies? targeting? EMT? inducers?might? not? only? interfere?with?
metastasis?but?also?retain?immunocompetence?in?patients?(149).?
1.5 TGF??and?its?role?in?cancer?
The? transforming?growth? factor? (TGF?)? signaling?pathway?plays?a?dominant? role? in?
development,?repair?and?homeostasis?of?most?tissues?in?metazoan?organisms.?It?belongs?to?a?
superfamily? of? growth? factors? consisting? of? more? than? 35? structurally? related? secreted?
proteins? including? also? activins? and? bone? morphogenic? proteins? (BMPs).? These? proteins?
regulate? tissue? differentiation? by? diverse? cellular? activities,? such? as? proliferation,?
differentiation,?migration,?adhesion,?ECM?deposition?and?cell?death?(167).?Because?of?these?
pleiotropic? functions? of? TGF?,? a? misregulation? of? this? regulatory? cytokine? pathway? is?
implicated? in? pathological? conditions? and? can? result? in? tumor? development? as? discussed?
further?in?this?chapter.?
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1.5.1 TGF??signaling?
The?cytokine?TGF?? is?a?secreted?protein,?existing? in? three?variant? forms? (TGF?1,? ?2?
and??3).?The?inactive?precursor?form?is?bound?in?the?extracellular?matrix?by?the?latent?TGF??
binding?proteins? (LTBPs)?and?activated?by?proteolytic?cleavage? from? the? latent?complex?by?
convertase? enzymes,? such? as? furins? (168).? Bioactive? TGF?? signals? by? forming? a? hetero?
tetrameric? receptor? complex?with? two?pairs?of? receptor? serine/threonine? kinases,?namely?
TGF?RI? and? TGF?RII.? Upon? ligand? binding,? the? type? II? receptors? activate? the? TGF?RI? by?
specific? phosphorylation? of? serine? and? threonine? residues? in? the? juxtamembrane? region,?
leading?to?subsequent?conformational?changes?of?the?catalytic?domain.?The?activated?type?I?
receptor?then?propagates?the?signal?by?phosphorylating?associated?effector?proteins,?such?as?
the?receptor?associated?Smad?proteins?(R?Smads).?Once?activated,?the?R?Smads?interact?with?
the? common?mediator? Smad4? and? shuttle? to? the? nucleus? to? control? the? transcription? of?
various? genes? (169).? Besides? this? well? characterized? canonical? signaling? pathway,? TGF??
signals? also? via? non?canonical? Smad?independent? signaling? branches? by? interaction? with?
various? partners,? such? as? receptor? tyrosine? kinases? (RTKs)? and? diverse? adaptor? proteins.?
These? two? signaling? branches,? the? canonical? and? the? non?canonical? pathways,? can? act?
independently? from? each? other,? but? in?most? cases? cooperate? during? TGF?? signaling.? This?
complexity? and? flexibility? of? the? TGF??induced? signaling? enables? the? comprehensive?
regulation?of?diverse?cellular?processes.?
1.5.2 Canonical?TGF??signaling?
The? canonical? TGF?? signaling? activates? Smad? proteins? to? submit? signals? from? the?
heteromeric? receptor? complex? to? the? nucleus? (Figure? 4).? The? eight? members? of? the?
mammalian?Smad?family?can?be?divided?in?three?groups?according?to?their?function:?receptor?
activated?Smads?(R?Smads),?consisting?of?Smad1,?2,?3,?5?and?8,?the?common?mediator?Smad?
(Co?Smad)?is?Smad4,?and?both?Smad6?and?7?belong?to?the?inhibitory?Smad?group?(I?Smads).?
The?R?Smads?are?ligand?specific?signal?mediators,?of?which?Smad1,?5,?and?8?are?activated?by?
BMP,?whereas?Smad2?and?Smad3?mediate?signals?downstream?of?TGF??and?activins.?Once?
activated,? these?R?Smads? associate?with? each?other,? forming? a? trimeric? complex?with? the?
common?mediator? Smad4? via? their?MH2?domains,? to? traffic? into? the?nucleus? and? interact?
with?various?transcriptional?regulators?and?co?activators?like?the?CREB?binding?protein?(CBP)?
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or?p300?(170?172).?While?the?R?Smads?and?Smad4?are?ubiquitously?expressed,?the?regulation?
of? the? canonical? TGF?? signal? transduction? pathway? is? controlled? by? an? intrinsic? negative?
feedback?loop,?exerted?by?three?types?of?proteins,?namely?the?inhibitory?Smads,?E3?ubiquitin?
ligases? of? the? Smurf? family? and? phosphatases? like? the? SH2? domain?containing? inositol? 5?
phosphatase? (SHIP).? After? ligand? stimulation,? the? inhibitory? Smads? translocate? from? the?
nucleus? to? the? cytoplasm,? where? they? suppress? R?Smad? activation? by? competitively?
interacting?with? type? I?TGF?R? to? inhibit?R?Smad?phosphorylation?and? recruit?phosphatases?
like? SHIP,? which? dephosphorylate? and? inactivate? the? TGF??receptor? complex? (173).?
Moreover,?Smad7?can?bind?and?activate?the?ubiquitin?ligases?Smurf1?and?Smurf2?and?recruit?
them? to? the? TGF??receptor? complex,? thus? leading? to? its? endocytosis? and? lysosomal?
degradation?by?ubiquitinylation?(174).?
?
Figure?4:? Intracellular?signal?transduction?of?TGF??signaling.?TGF??signaling? is?transduced?via?the?canonical?and?
non?canonical?pathways.?TGF??binds?to?its?receptors?leading?to?a?transactivation?of?TGF?RI?and?subsequent?phosphorylation?
of?R?Smads?(Smad2?and?Smad3),?which?bind?the?common?Smad,?Smad4,?and?then?translocate?to?the?nucleus?by?forming?a?
Smad? complex.? By? interacting?with? co?activators? and? co?repressors? and? other? transcritpion? factors,? the? Smad? complex?
regulates? the? transcription?of?TGF?? target?genes.?TGF?? stimulation?also?activates? Smad? independent? signaling? cascades,?
such?as?Ras?Erk,?p38,?JNK,?PI3K?PKB,?and?small?GTPases?like?RhoA.?
?
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1.5.3 Non?canonical?TGF??signaling?
Besides? Smad,? the? TGF??receptor? complex? interacts?with?proteins?of? various?other?
signaling?branches?(Figure?4),?including?the?small?GTPase?Ras,?the?mitogen?activated?protein?
kinases? (MAPKs)? Erks,? p38? and? c?Jun?N?terminal? kinases? (JNKs)? (175,? 176).? Each? of? these?
interaction?partners?can?be?activated?by?TGF??and?deploy?signaling?cascades,?which?can?act?
independently?from?or?interfere?with?the?canonical?Smad?dependent?signaling.?
1.5.3.1 TGF??signaling?through?MAPK?pathways?
Multicellular? organisms? possess? three? well?characterized? subfamilies? of? MAPKs,?
involved? in? the?control?of?various?physiological?processes.?Among? the?MAPKs?activated?by?
TGF?,?are?the?extracellular?signal?regulated?kinases?Erk1?and?Erk2,?JNK1?and?2?and?the?four?
isoforms?of?p38? (p38???).?Activation?of?the?TGF??receptor?complex?by?binding?to? its? ligand?
leads?to?the?trans??and?autophosphorylation?of?the?type?I?and?II?receptors?on?multiple?sites.?
These?phosphorylation?sites?can? then?be?recognized?by?adaptor?proteins,? including?growth?
factor?receptor?binding?protein?2?(Grb2)?and?the?Src?homology?domain?2?(Shc2).?Subsequent?
single?or?contiguous?activation?of?these?adaptor?proteins?leads?to?the?activation?of?Ras?with?
ensuing? activation? of? the?MAPKs? Erk1/2,?which? has? been? shown? to? be? important? for? the?
disruption?of? cells?adherens? junctions,?ECM?modulation?and? to?accompany?with? increased?
motility?and?endocytosis?(85).?Furthermore,?Erk1/2?can?phosphorylate?Smad2?and?Smad3?in?
their? linker? region? and? Erk1/2? cooperation? with? Smad3? has? been? found? to? induce? the?
expression? of? connective? tissue? factor? (CTGF),?which? is? involved? in?metastases? formation?
(177).?Conversely,?activated?Erk1/2?can?also?negatively? regulate?Smad2?and?3?by? inhibiting?
nuclear? accumulation? and? reducing? Smad?dependent? transcription? (178).? Another?
interaction? partner? of? the? activated? TGF??receptor? complex? is? the? interleukin?1? receptor?
effector? module,? called? IL1R?TRAF6?TAK1,? which? is? activated? by? subsequent?
polyubiquitination,? leading? to? the? activation? of? the?MAPKs? JNK? and? p38? via?MKK4? and?
MKK3/6? (179).? This? TRAF6?TAK1?JNK/p38? activation? is? known? to? cooperate? with? the?
canonical?TGF??pathway?to?induce?apoptosis?or?EMT?(180).?
1.5.3.2 TGF??induced?PI3K?activation?
Another? pathway,? which? can? be? activated? by? TGF?? is? the? phosphatidylinositol?3?
kinase? (PI3K),?as? indicated?by? the?phosphorylation?of? its?downstream?effector?protein?PKB?
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(181).? This? can? be? direct? via? the? TGF?RII?associated? regulatory? subunit? p85,? but? can? also?
result? from? cross?activation? of? the? EGF? receptor? (182).? PKB? phosphorylation? leads? to? the?
subsequent?activation?of?mammalian?target?of?rapamycin?(mTOR),?and?via?phosphorylation?
of? its?target?proteins?S6K?and?4E?BP1? it? is?a?key?regulator?of?protein?synthesis,?shown?to?be?
important? in?TGF??induced?EMT.?Furthermore,?activated?PKB?can?regulate?the?sensitivity?to?
TGF??induced?apoptosis?by?direct?interaction?with?Smad3?and?inhibition?of?the?pro?apoptotic?
transcription?factor?FoxO?(183,?184).?
1.5.4 TGF??mediated?apoptosis??
TGF??is?able?to?limit?cancer?formation?by?inducing?a?vast?number?of?proteins,?involved?
in?apoptotis.?Among?the?well?characterized?downstream?targets?for?pro?apoptotic?functions?
of?TGF??are? the?growth?arrest?and?DNA?damage?inducible?protein? ?? (GADD45?),?BH3?only?
factors,?such?as?Bim,?and?the?death?associated?protein?kinase?(DAPK),?which?all?converge? in?
the?mitochondrial?pathway?with?subsequent?cytochrome?C?release?and?Caspase?dependent?
apoptosis? (185?187).? In?breast? cancer? cell? lines,?Bim?was? found? to?be? strongly? induced?by?
TGF?? in?a?FoxC1?dependent?manner?(188).?In?hepatocyte?cells? lines?a?conjoint?upregulation?
of? the? two?BH3?only?proteins?Bmf?and?Bim?by?TGF?? is?essential? to? induce?apoptosis? (189).?
The? expression? of? Noxa,? another? BH3?only? protein,? has? been? shown? to? be? strongly?
upregulated?by?Notch?signaling,?which? is?known? to?synergistically? regulate?with?TGF?? their?
common?target?genes?via?Smad3? in?many?cell?types? (190).?These? findings?suggest,?that?the?
BH3?only?protein?family?members?play?at?least?partially?redundant?roles?in?the?regulation?of?
TGF??induced?cell?death.?Different?mechanisms?to?promote?cell?death?are?used?by?activating?
the? lipid?phosphatase? SHIP,?which?promotes? apoptosis?by? inhibiting?PI3K? activity,? thereby?
blocking? its?survival?promoting?signaling? (191).?Furthermore,? interaction?of?Smad?with?PKB?
and?TGF?R?interactions?with?the?p38?activator?DAXX?have?also?been?proposed?as?mediators?
of?apoptosis?(168).?
1.5.5 TGF??mediates?EGFR?signaling?
Focusing?on?the?anti?apoptotic?role?of?TGF??in?later?stages?of?tumorigenesis?opens?a?
complex? interplay? of? cellular? signaling.? In? hepatocytes? TGF?? has? been? shown? to? activate?
epidermal? growth? factor? receptor? (EGFR)? and? phosphorylate? c?Src.? Blocking? of? EGFR?
amplifies?the?apoptotic?response?to?TGF?1?without?blocking?the?EMT?process,? indicating?an?
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essential? role?of?EGFR? signaling? in? impairing?TGF??mediated?apoptosis? (192).?Furthermore,?
activation? of? EGFR? is? involved? in? the? neoplastic? transformation? of? solid? tumors? and? its?
overexpression?correlates?with?poor?prognosis?(193).?It?has?been?actually?demonstrated?that?
various?epithelial?tumors?cells?are?significantly?more?sensitive?to?EGFR?inhibition?than?tumor?
cells?which?have?acquired?mesenchymal?phenotypes,? including?NSCLC,?colorectal,?head?and?
neck?and?breast?carcinomas?(194?196).?This?data?indicate,?that?the?EMT?status?of?a?tumor?can?
be?a?broadly?applicable?indicator?of?sensitivity?to?EGFR?inhibitor?therapies?in?patients.?
1.5.6 The?dual?role?of?TGF??
Perturbations?of?TGF??signaling?are?frequently?involved?in?tumor?initiation?and?tumor?
progression?through?their?effects?on?cellular?processes.?The?growth?inhibitory?effect?of?TGF??
signaling? in?epithelial? cells? as?well? as? the? absence?or?decrease?of? the?downstream? Smad4?
expression? in? various? cancer? types,? including? pancreatic,? colorectal? and? head? and? neck?
cancers,? establishes? the? role? of? TGF?? as? a? tumor? suppressor? (197,? 198).?However,? during?
tumor?progression,?malignantly? transformed?cells? frequently? lose? the? responsiveness? to?or?
even?distort?the?tumor?suppressive?effects?of?TGF?.?The?evasion?of?cancer?cells?from?the?anti?
proliferative?effect?of?TGF??was?found?to?be?more?than?just?breaking?the?signaling?circuitry.?
By?activating?the?cellular?EMT?program?late?stage?tumors?are?able?to?redirect?TGF??to?act?as?
an? autocrine? tumor?promoting? factor? by? elevating? tumor? growth,? evasion? of? immune?
surveillance? and? cancer? cell? dissemination? and?metastasis? (168,? 199).? These? two? faces? of?
TGF??signaling?can?be?observed? in?various?transformed?cell?systems,?namely?Ras?expressing?
mammary?epithelial? cells?were? found? to?preferentially?undergo?EMT?and? inhibit?apoptosis?
when?treated?with?TGF??(157).?In?addition,?the?untransformed?murine?mammary?gland?cells?
(NMuMG)? exhibit? upon? longterm? TGF?? treatment? a? sustained? EMT? with? resistance? to?
apoptosis?reflecting?the?long?term?effect?of?chronic?TGF??exposure?in?epithelial?tissues?during?
fibrosis?and?in?cancer?cells?(200).?The?mechanism?behind?this?dual?function?of?the?cytokine?is?
based?on? the?disruption?of? the? signaling?and? the? context,? in?which? this?disruption?occurs.?
Malignant? cells? can? bypass? the? suppressive? effects? of? TGF?? either? by? inactivation? of? core?
components?of? the? signaling?pathway,? such?as?TGF?R? through?mutation? concomitant?with?
loss? of? heterocygosity? (197).? The? alternative? path? comprises? selective? alterations? of? the?
tumor?suppressive? arm? of? the? pathway,?which? then? also? allows? the? cancer? cells? to? freely?
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adopt? the? remaining? TGF?? regulatory? functions? to? their? advantage? for? pro?tumorigenic?
purposes?(168).?In?both?cases,?cancer?cells?can?make?use?of?the?TGF??mediated?modulations?
of? the? microenvironment? by? enforcing? immune? tolerance,? shielding? cancer? cells? from?
immune?surveillance.?Moreover,?malfunction?of?TGF??signaling? in? immune?cells?can? induce?
chronic?inflammation,?leading?to?a?tumor?friendly?environment?(201,?202).?Secretion?of?TGF??
by?the?tumor?itself?attracts?stromal?cells,?such?as?myofibroblasts,?which?have?been?shown?to?
facilitate?tumor?development?and? invasion?by?producing?MMPs?and?pro?angiogenic?factors,?
such?as?CTGF?and?VEGF?(203,?204).?Upregulation?of?angiopoietin?like?4?(ANGPTL4),?a?vascular?
remodeling? gene? and? downstream? target? of? TGF?,? helps? to? disrupt? endothelial? cell?cell?
junctions?and?by?this,?facilitates?transendothelial?extravasation?of?cancer?cells?at?secondary?
sites? (205).? Also? in? distant? organs,? TGF?? exerts? an? important? function? in? enhancing?
colonization?and?metastasis?outgrowth?shown?by?positive?phospho?Smad2?stains?of?multiple?
bone,? lung,? liver?and?brain?metastases?of?breast?cancer?patients?(206).?These?highly?diverse?
functions?of?TGF??and?its?dual?role?as?tumor?suppressor?and?tumor?promoter?make?it?obvious?
that? therapeutic? targeting? of? the? TGF?? pathway? should? reconstitute? balanced? intact?
signaling,?as?a?distortion?of?the?concinnity?could?lead?to?the?transformation?of?normal?cells?to?
cancer?cells.?
1.6 Cancer?stem?cells?
Due? to? hyperproliferation? combined?with? genetic? instability,? advanced? tumors? are?
usually? showing? a? high? grade? of? heterogeneity,? containing? regions?with? distinct? stages? of?
differentiation,? proliferation,? inflammation? and? invasiveness.? Although? still? debated,?
evidence?emerged?in?the?last?few?years?for?the?existence?of?a?new?subclass?of?neoplastic?cells?
within?tumors,?namely?cancer?stem?cells?(CSCs)?or?alternatively?cancer?initiating?cells?(CICs).?
This? CSCs? are? defined? by? their? self?renewing? capacity? and? the? ability? to? newly? generate?
tumors?when?transplanted?into?host?mice.?They?are?often?accompanied?by?the?expression?of?
cell?surface?stem?cell?markers,?also?expressed?by?normal?stem?cells?of?the?tissue,?which?gave?
rise? to? the? tumor? (207,? 208).? Cancer? stem? cells? were? first? identified? in? hematopoietic?
malignancies,? and? later? they?were?also? found? to?be? implicated? in? solid? tumors? like?breast?
carcinomas,? glioblastomas,? pancreas? carcinomas? and? neuroectodermal? tumors? (207,? 209?
212).? The? origin? of? CSCs? within? solid? tumors? is? still? unclear? and?might? be? variable? and?
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dependent?on?the?type?of?tumor.?Cancer?stem?cells?can?either?develop? from?normal?tissue?
stem? cells? by? oncogenic? transformation? triggered? by? the? tumor? microenvironment? or?
alternatively? from? partially? differentiated? tumor? cells? that? have? adopted?more? stem?like?
properties.? The? latter? theory? is? supported? by? the? finding? that? forced? expression? of? the?
transcription? factor? Oct4,? a? master? regulator? and? gatekeeper? of? self?renewal? and?
pluripotency,?in?normal?breast?cells?leads?to?the?generation?of?stem?like?cells?with?increased?
tumor? initiation? capacity? (213).? Additionally,? there? is? an? increasing? number? of? data?
suggesting? that? cells,?which?undergo? EMT,? acquire? stem? cell? like?properties? (214)? (further?
discussed? in?chapter?1.6.2).?Several?parallels?have?been?drawn?between?normal?and?cancer?
stem?cells?to?have?a?better?understanding?of?the? innate?biology?of?cancer?stem?cells.?While?
the?relative?quiescence?of?normal?stem?cells? is? in?discrepancy?to?the?uncontrolled?and?high?
proliferation?of?cancer?stem?cells,?the?two?cell?types?share?several?essential?characteristics,?
such?as? self?renewal? capacity,?expression?of?high? levels?of?ABC? transporters,?high?mobility?
and?resistance?to?anoikis?(215).?A?number?of?studies?have?shown?that?Integrin?expression?is?
required?for?tumor?initiation?and?hyperproliferation?in?various?types?of?epithelial?cell?derived?
cancers?and?it?has?also?been?demonstrated?that?this?protein?family?plays?an?important?role?in?
migration?and? invasion?during?cancer?progression? (216,?217).??1?Integrin? (CD29)?as?well?as?
?6?Integrin?(CD49f)?have?been?shown?to?be?highly?expressed?in?stem?cells?of?various?organs?
and? to? regulate? their? homeostasis? and? self?renewal? capacity? in? brain,? skin? and?mammary?
gland?(218?220).?Following?the?theory?that?similar?signaling?pathways?are?at?work?in?normal?
and?cancer?stem?cells?lead?to?the?identification?of?several?cancer?cell?populations?with?stem?
cell?properties?and?high?expression?of? Integrins? (further?discussed? in?1.6.1).?Recent?studies?
revealed? the? high? resistance? of? leukemic? stem? cells? towards? cytotoxic? treatments? and?
moreover,?glioblastoma?stem?cells?are?less?sensitive?to?radiation?than?their?non?tumorigenic?
counterparts? indicating? an? important? role? of? this? subpopulation? in? drug? and? radiation?
resistance?and?concomitant?cancer?recurrence?(221,?222).?Based?on?this?evidence?targeting?
CSCs?will? be? one? of? the? future? clinical? focus? to? fight? therapy? resistant? cancer? and? tumor?
relapse?in?patients.??
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1.6.1 Cancer?stem?cell?markers?
One?major? concern? in? assessing? a? therapeutic? anti?cancer? strategy? is? indeed? the?
damage?or?eradication?of?normal?stem?cells?when?targeting?cancer?stem?cells?by?using?shared?
markers.?However,? if?the?CSC? is?a?transformed?cell?of?normal?progenitor?origin,?the?surface?
markers? should? also? contain? progenitor? specific? surface? proteins.? This? would? allow? to?
specifically? identify? and? target? CSCs.? Indeed? extensive? studies? on? specific? CSC? surface?
markers? as?prognostic?or?drugable? targets? are? currently?ongoing.? Several? combinations?of?
surface?markers?have?been?published?up?to?date?to?identify?cancer?stem?cell?subpopulations,?
and?the?expression? levels?and?combination?of?these?markers?have?been?shown?to?be?tissue?
and? species?specific.? Among? the? proposed? markers? are? the? hyaluronate? receptor? CD44,?
CD24,?CD133,? aldehyde?dehydrogenase? (ALDH),?CD90,?members?of? the?ABC? family,? Sca?1,?
Lgr5,?CD29?and?CD49f,?some?of?them?being?more?specific?than?others,?but?none?of?them? is?
sufficient? by? itself? to? identify? CSCs? with? adequate? sensitivity? and? specificity.? The? most?
prominent?marker?combination?was?defined?by?the? isolation?of?CSCs?from?pleural?effusions?
with? advanced? stages? of? breast? cancer? by? sorting? for? the? CD44+/CD24?/low? subpopulation,?
proving? that? these? cells? have? increased? tumor? initiation? capacity? in? limiting? dilution?
experiments? (207).?This? surface?marker?combination?was?also? found? in? several? in?vitro?cell?
systems?of?human?breast? cancer? to?be?enriched? for? cancer? stem? cells,? showing? increased?
tumor?forming?capacity,?increased?invasive?properties?and?resistance?to?radiation?(223?225).?
However,?there?is?increasing?evidence?that?the?appearance?of?this?marker?combination?is?not?
shared?by?different?species?and?that?there?can?be?differences?in?the?marker?expression?levels?
between?human?and?mouse?models.?Recent?data?suggest?that? in?mouse?tumors?and?tumor?
cell?lines,?the?CSC?subpopulation?can?rather?be?defined?by?high?expression?of?CD24?combined?
with? the? expression? of? other?markers,? such? as? ?1?integrin? (CD29)? or? ?6?integrin? (CD49f).?
Stingl?et?al.?and?Shackleton?et?al.?have?shown?that?mouse?mammary?gland?cells?with?colony?
formation? capabilities? (MaCFC)? are? CD24high/CD49flow? and? more? differentiated? than? the?
CD24highCD49fhigh?mammary? gland? repopulating? units? (MRUs)? and? found? a? CD24+/CD29high?
subpopulation? to? be? enriched? in?mammary? stem? cells? (226,? 227).? Similar? findings? were?
reported? for?the?combination?of?CD24high?and?Prominin?1?? (CD133),?which?showed?a?higher?
colony? forming? capacity? compared? to? CD24high/CD133+? or? CD24low/CD133?? (228).? These?
markers,?which?have?been?shown?to?be?specific?for?mouse?mammary?stem?cells?could?also?be?
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used? to? identify? tumor? subpopulations?enriched? for?cancer? stem?cells.?For?example?Brca1?
mutant? mouse? cancer? cell? lines? contain? a? CD24+/CD29+? as? well? as? CD24+/CD49f+?
subpopulation?showing? increased?proliferation?and?colony?formation? in?vitro?and?enhanced?
tumor? initiation? capacity? in? vivo? (229).? Moreover,? isolated? cells? from? p53?null? mouse?
mammary? gland? tumors? showed? a? CD24high/CD29high? subpopulation? with? increased?
mammosphere? formation? and? tumor? initiation? ability,? and? in? Brca1/p53?mediated? breast?
tumors? the? CD24med/CD29high? population? exhibited? increased? tumorigenicity? and? cisplatin?
resistance? (230,? 231).? Furthermore,? the? above?mentioned? Prominin?1,? a? cell?membrane?
glycoprotein? hitherto? used? for? the? identification? of? endothelial? progenitor? cells,? has? been?
established?as?a?reliable?marker?for?the?identification?of?stem?like?tumor?cells?in?glioblastoma?
with?distinct? specificity?depending?on? the?glycosylation? status? (211,?232).?Additionally,? the?
concomitant? expression? of? CD133? and? ALDH? correlated? with? reduced? disease?free? and?
overall? survival? in?ovarian? cancer?patients?and? isolation?of?a?CD133+/ALDH+? subpopulation?
from?ovarian?cancer?cell?lines?resulted?in?a?CSC?enriched?cell?population?with?highly?increased?
tumor? forming?capacity? (233).?A?detailed? study? for? the?expression? for?diverse?cancer? stem?
cell?markers?in?breast?cancers?according?to?tumor?subtype?and?histological?stages?in?human,?
revealed?a?large?discrepancy?among?the?histological?groups.?For?example?ALDH1+?cells?were?
present? to? a? greater? excess? in?basal?like? and?HER2+? tumors? than? in? luminal?ones? and? the?
before?described?CD44+/CD24??population?had?a?much?higher?incidence?in?basal?like?than?in?
HER2+? tumors? (234).? This? variety? of? markers? depending? on? tumor? type,? subtype? and?
histological?stage?and? the?absence?of?conservation?between?different?species?manifest? the?
need?of?more?detailed?investigations?to?utilize?these?markers?as?effective?therapeutic?targets?
for?sustained?cancer?cure?and?prohibition?of?tumor?relapse.?Nevertheless,?there?is?a?hint?that?
the? quite? conserved? expression? of?members? of? the? integrin? family? in? cancers? and? their?
implication? in? tumor? onset? and? progression?makes? them? definitely? an? interesting? target?
candidate,?which?warrants?further?investigations.?
1.6.2 EMT?and?cancer?stem?cells?
There?is?substantial?evidence?suggesting?an?association?of?CSCs?with?a?specific?state?of?
differentiation.?Hence,?EMT?has?been?studied?as?a?process?to?produce?cancer?stem?cells?due?
to?its?ability?to?convert?cells?from?one?state?of?differentiation?to?another.?Normal?stem?cells?
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and?cancer?stem?cells?may?share?a?mesenchymal?phenotype,?which?increases?their?capability?
to?preserve?stemness?and?retain?migratory?properties.?This?is?the?case?with?embryonic?stem?
cells? grown?on?matrigel,?which?have?been? shown? to? adopt? a?mesenchymal?phenotype?by?
performing? the? cadherin? switch? and? expression? of? Snail? factors,? Vimentin? and?
Metalloproteinases?but? retaining? their?pluripotency?by? the?expression?of?Oct?4?and?Nanog?
(235).? Furthermore,? it? has? been? demonstrated? that? overexpression? of? the? EMT?inducing?
transcription? factor? Snail? in? trophoblast? stem? cells? induces? a? metastable? phenotype? by?
epigenetic? changes? resulting? in? the? loss? of? epithelial?maintenance? while? preserving? self?
renewal? and?multipotency? (236).? Indeed,? the? induction? of? EMT? in? transformed?mammary?
epithelial? cells? has? been? shown? to? generate? populations?with? enriched? CSC? subsets?with?
increased? tumorigenicity,? mammosphere? formation? capacity? and? cell? surface? marker?
expression? (214,?237).?Furthermore,? it?has?been? shown? that?exposure? to?TGF??and? tumor?
necrosis? factor? ?? (TNF?)? induces? EMT? in? breast? tumor? cells? and? generates? cells? with?
increased?self?renewal?capacity,?greatly?increased?tumor?seeding?and?increased?resistance?to?
chemotherapeutics,? which? are? all? hallmarks? of? breast? cancer? stem? cells? (BCSC)? (238).?
Conversely,? fractionation?of?naturally?occurring?normal?and?neoplastic?mammary?epithelial?
cells?with? CSC? surface?markers? showed? attributes? of?mesenchymal? transdifferentiation? as?
well?as?expression?of?mesenchymal?markers?such?as?Vimentin?and?Fibronectin?(214).?Another?
example?linking?EMT?and?cancer?stem?cell?formation?was?found?in?pancreatic?cancer?cells?by?
the?overexpression?of?FoxM1,?which?lead?to?a?bona?fide?EMT?by?the?activation?of?ZEB1,?ZEB2?
and?Slug?concomitant?with?the?expression?of?the?CSC?surface?markers?CD44?and?EpCAM?and?
increased?sphere?forming?capacity?(239).?Moreover,? induction?of?the?EMT?activator?ZEB1? in?
pancreatic? and? colorectal? cancer? not? only? promotes? tumor? cell? dissemination,? but? also?
represses? expression? of? the? stemness?inhibiting? miR?203? and? members? of? the? miR?200?
family,?which?target?stem?cell?factors,?such?as?Sox2?and?Klf4.?Thus?indicating,?that?ZEB1?links?
EMT?induction? and? stemness?maintenance? by? suppressing? stemness?inhibiting?microRNAs?
(240).?Above?all,?the?coherence?between?EMT?and?cancer?stem?cells?was?also?demonstrated?
in?a?more? clinical? related?background?by? the? finding? that? treatment?of?breast? cancer? cells?
with? TGF?? and? TNF?? generates?mesenchymal? cells?with? BCSC? phenotype? associated?with?
downregulation?of? claudins,? indicating? a? shift? to? the? claudin?low?molecular? subtype? (238).?
The? claudin?low? breast? cancer? subtype? has? been? characterized? by? the? low? to? absent?
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expression?of? luminal?differentiation?markers,?high?enrichment? in?EMT?phenotype? to?most?
closely?resemble?the?mammary?epithelial?stem?cell? (241).?Taken?together,?EMT?and?cancer?
stem?cells?appear?to?be?closely?networked?and?are?responsible?to?a?great?extend?for?therapy?
resistance?and?tumor?relapse?constituting?a?stepping?stone? in?cancer?treatments,?for?which?
better?understanding?may?lead?to?new?therapeutic?platforms.?
1.7 Forkhead?box?transcription?factors?
The? family? of? Forkhead? box? (Fox)? genes? are? defined? by? a? conserved?DNA? binding?
domain?of?a?winged?helix?structure?acting?as?transcription?factors,?which?have?been?found?to?
serve?as?key?regulators?in?embryogenesis,?signal?transduction,?maintenance?of?differentiated?
cell?states?and?tumorigenesis?(242).?There?are?three?families?of?Fox?genes,?namely?the?Foxc,?
Foxf?and?Foxl1,? that?are?extensively?expressed? in?mesodermal? tissue?and? form?paralogous?
clusters? in?the?genome?(243,?244).?One?of?the?best?characterized?members?of?this?family? is?
Foxc2,?which?has?been?implicated?in?the?regulation?of?EMT?by?interacting?with?Smad?proteins?
and? to? be? a? key? player? in?metastasis? (152,? 245).?Moreover,? Foxc1? and? Foxc2? have? been?
shown?to?be?highly?expressed? in?the?claudin?low?metaplastic?breast?cancer?subtypes,?which?
is? associated? with? EMT? and? cancer? stemness? and? high? expression? correlates? with? poor?
survival?of?breast?cancer?patients?(246,?247).?Furthermore,?the?overexpression?of?Foxm1? in?
pancreatic?cancer?cells?lead?to?the?acquisition?of?an?EMT?phenotype?via?upregulation?of?ZEB1?
and? ZEB2? as?well? as? stem? cell?like? characteristics? (239).? Another? famous?member? of? the?
forkhead?family?is?the?Foxo?transcription?factor,?which?acts?as?a?tumor?suppressor?in?various?
cancer? types.? Foxo? actively? promotes? apoptosis? in? a? mitochondria?independent? and?
dependent?manner?by?inducing?the?expression?of?death?receptor?ligands?such?as?FasL,?as?well?
as?Bcl?2?family?members?such?as?Bim?and?Bcl?XL?(248).?This?data?indicate?a?key?regulatory?role?
of? the? Forkhead? protein? family? in? the? regulation? of? EMT? and? tumor? progression.? In? this?
context,? a? less? established? forkhead? protein? came? into? our? interest,?which? is? Foxf2? (also?
known? as? Freac?2? or? Fkhl6),? a? widly? expressed? protein? in? various?mesenchymal? tissues,?
adjacent?to?the?epithelium,? including?the?alimentary,?respiratory?and?urinary?tracts,?central?
nervous?system?and?organs?of?special?sense?and?limb?buds?(249).??
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1.7.1 Foxf2?
Foxf2?was?first?identified?as?a?transcriptional?activator,?containing?a?forkhead?domain?
for? nuclear? localization? and? two? independent? C?terminal? activation? domains.? Foxf2? was?
found?to?interact?with?TBP?and?TFIIB,?two?components?of?the?general?transcription?complex?
binding?a? specific?motif? (Figure?5)? (250,?251).? In?a?prostate?cell? line,?Foxf2?expression?was?
shown? to? be? epigenetically? controlled? via? histone? trimethylation? by? EZH2? (252).? During?
mouse? development? of? the? palatal?mesenchyme,? expression? of? several? Fox? family? genes,?
including? Foxf1?and? Foxf2,?were? found? to?be? specifically? regulated?by? the? sonic?hedgehog?
(Shh)?and?its?binding?partner?Smo,?which?are?also?implicated?in?EMT?induction?and?crosstalk?
with?Notch,?EGF/FGF?and?TGF??signaling?(253,?254).?Indeed,?TGF??induced?EMT?is?one?of?the?
mechanisms? strongly? involved? in? regulating? fusion? of? the? palatal? cleft,? and? Foxf2? is?
upregulated? in? the?mesenchyme? of? the? secondary? palate? (255,? 256).?Moreover,? Foxf2?/?
mutant?mice?die?shortly?after?birth?due?to?cleft?palate?and?abnormal?tongue?development,?
indicating? an? essential? role? of? Foxf2? in? this? EMT?associated? developmental? process? (257).?
Furthermore,? Foxf2? expression? was? detected? in? the? mesenchyme? of? the? lung? and? gut?
indicated?to?regulate?the?activation?of?canonical?Wnt?pathway?and?secretion?of?ECM?proteins?
and? Bmp4,? which? inhibits? the? production? of?Wnt5a? in? the? mesenchymal? cells,? thereby?
maintaining? the? epithelial?mesenchymal? structure.? Epithelial? cells? of? Foxf2?/?? mice? show?
typical? signs? of? depolarization,? and? the? subcellular? localization? of? adherens? junctions,?
normally?confined?to?lateral?membranes,?expand?into?the?basal?and?apical?membranes.?Even?
though?in?some?cells?a?complete?depolarization?was?observed,?they?fail?to?undergo?apoptosis?
(258,?259).?More?recently,?Foxf2?has?been?shown?to?be?one?of?the?direct?targets?of?miR?301,?
which? promotes? breast? cancer? proliferation,? invasion? and? tumor? growth? (260).? This? data?
indicates?an? important?role?of?Foxf2? in?maintaining?tissue?homeostasis?and?preservation?of?
the?mesenchymal?phenotype.?A?better?understanding?of? the?FoxF2?protein?and? its?biology?
may? thus? provide? new? opportunities? for? developing? effective? therapeutic? approaches? to?
treat?cancer.?
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Figure?5:?Weight?matrix?of?the?Foxf2?transcription?factor?binding?motif.?(kindly?provided?by?Erik?van?Nimwegen)?
?
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2 Aim?of?the?study?
Epithelial? to?mesenchymal? transition? (EMT)? is?a?complex?process? involved? in?cancer?
initiation?and?progression?by?modulating?cell?migration,?cell?differentiation?and?metastasis.?
Thus,?identifying?prognostic?markers?and/or?therapeutic?targets?to?block?EMT?driven?cancer?
cell? invasion?and? circumvent?drug? resistance? is?essential? for? future? cancer?diagnostics?and?
relapse?free?therapy.??
To?gain?new?and?more?detailed? insights? into? the?molecular?mechanism?of?EMT,?we?
established? different? in? vitro? EMT? model? systems? and? analyzed? changes? in? the? gene?
expression?profile?to:?
i. identify?globally?important?regulators?of?EMT??
ii. get? insights? into? their? biological? function? and? their? implication? on? EMT?
associated? acquirements? such? as? increased? resistance? to? apoptosis? and?
enhanced?cell?migration?and?invasion.?
iii. dissect? the? importance?of? EMT? on? the? generation? of? cancer? stem? cells? and?
characterize?the?stem?cell?properties?of?epithelial?and?mesenchymal?cells?
?
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3 Materials?and?methods?
Reagents?and?Antibodies?
Recombinant?human?TGF??(#240?B,?R&D?Systems),?Small?hairpin?and?silencing?RNAs:?
shRNAs?and?siRNAs?were?purchased?from?Sigma?Aldrich,?Control?shRNA?(shCtrl,?Mission?Non?
Target?shRNA?control?vector,?#SHC002),?murine?Foxf2?shRNAs? ? (MISSION®?shRNA?bacterial?
glycerol? stock,? shFoxf2? 703? #TRCN0000084958,? shFoxf2? 704? #TRCN0000084960),?murine?
Betacellulin? siRNA? (MISSION®? siRNA,? siBtc,? #SASI_Mm02_00311942),? murine? Epiregulin?
siRNA? (MISSION®? siRNA,? siEreg,? #SASI_Mm01_00072956),? murine? Amphiregulin? siRNA?
(MISSION®? siRNA,? siAreg,? #SASI_Mm02_00316835),?murine?Noxa? siRNA? (MISSION®? siRNA,?
siNoxa1,3? #SASI_Mm01_00077286,8),? murine? N?cadherin? siRNA? were? purchased? from?
Invitrogen? (Stealth™? RNAi,? siNcad4? #MSS202874,? siNcad5? #MSS202875,? siNcad6?
#MSS202876).? Antibodies:? E?cadherin? for? immunofluorescence? (#13?1900,? Zymed),? for?
western? blot? (#610182,? Transduction? Laboratories),? N?cadherin? for? immunofluorescence?
(#610921,? Transduction? Laboratories),? for? western? blot? (#M142,? Takara),? NCAM? (OB11,?
#9672,? Sigma?Aldrich),?Vimentin? (#V2258,? Sigma?Aldrich),? ZO?1? (#617300,? Zymed),? Paxillin?
(#P13520,?Transduction?Laboratories),?Fibronnectin? (#F?3648,?Sigma?Aldrich),?PARP? (#9542,?
Cell?Signaling),?EGFR?(#2232,?Cell?Signaling),?pEGFR?(Y1173)?(#sc?12351,?Santa?Cruz),?cleaved?
Caspase?3? (#9664,?Cell?Signaling),?Tubulin? (#T?9026,?Sigma?Aldrich),?Actin? (#sc?1616,?Santa?
Cruz),?GAPDH?(#G8795,?Sigma?Aldrich),?HA?tag?for?ChIP?(#ab9110,?Abcam).? Inhibitors:?EGFR?
inhibitor?AG1478?(#ALX?270?036,?Alexis?Biochemicals).?
Cell?culture?and?cell?lines?
All? reagents? used? for? cell? culture? were? obtained? from? Sigma/Fluka? (Basel,?
Switzerland)? if?not?otherwise?mentioned.?All? cells?were? cultured?at?37? °C?with?5?%?CO2? in?
DMEM?medium?supplemented?with?glutamine?[2?mM],?penicillin?(100?U),?streptomycin?[0.2?
mg/L]?and?10%?FBS.?The?subclone?NMuMG/E9?(hereafter?NMuMG)?is?expressing?E?cadherin?
and? has? previously? been? described? (261).? MTdeltaEcad? and? MCF7?shEcad? have? been?
described? (262).?NMuMG?shSmad4? and?NMuMG?shCont?were? obtained? from? P.? ten?Dijke?
(Leiden?University?Medical?Center,?The?Netherlands;?(263).?NMuMG?cells?were?treated?with?
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TGF?? [2?ng/ml]?without?serum?deprivation?and?TGF??was? replenished?every?2?days.?SiRNA?
transfections?with? LipofectAMINE?RNAiMAX? (Invitrogen)?were?performed?according? to? the?
manufacturer’s?protocol?24h?before? treatment?with?TGF?.?The?established? cell? line? ?T2? is?
derived?from?Rip1Tag2? induced?pancreatic???cell?tumors?and?has?previously?been?described?
(133).?The?established?cell?line?Py2T?is?derived?from?MMTV?PyMT?(264)?mammary?tumors?(L.?
Waldmeier,?unpublished?data)?
Generation?of?lentivirus?
A?cDNA?encoding?Foxf2?(kindly?provided?by?Leif?Lundh,?Goteborg?University,?Sweden)?
(265)?was?tagged?N?terminally?with?HA?tag?and?cloned? into?the? lentiviral?expression?vector?
pLenti?CMV?Puro? (kindly? provided? by? Matthias? Kaeser,? Bern).? Lentiviral? particles? were?
produced?by?transfecting?HEK293T?cells?with?the?lentiviral?expression?vectors?in?combination?
with?the?packaging?vector?pR8.91?and?the?envelope?encoding?vector?pVSV?using?Fugene?HD?
(Roche).?After? two?days? the?virus?containing?HEK293T? supernatant?was?harvested,? filtered?
(0.45? μm),? supplemented? with? polybrene? (8? ng/ml)? and? used? for? target? cell? infection.?
Infections?were?performed?twice?a?day?for?two?consecutive?days.?
Growth?Curves?
One?day?before? t0?1.6? x?104?NMuMG? cells?were? seeded? in? triplicates?onto?24?well?
plates?and?transfected?with?the?indicated?siRNA.?After?24h?the?cells?were?treated?with?TGF??
and?cell?numbers?were?determined?by?use?of?a?Neubauer?counting?chamber.??
Migration?assay?
NMuMG?cells?(2?x?104?/well)?pretreated?for?18?days?with?TGF??were?seeded?in?DMEM,?
2?%?FBS?and?TGF??into?the?upper?chamber?of?a?cell?culture?insert,?pore?size?8?μm?(Falcon?BD,?
Franklin?Lakes,?NJ).?The?lower?chamber?was?filled?with?DMEM?20%?FBS?and?TGF?.?After?16h?
incubation?at?37?°C?and?5?%?CO2?the?cells?that?had?traversed?the?membrane?were?fixed?in?4?%?
paraformaldehyde?/?PBS?(15?min?at?room?temperature),?stained?with?DAPI?[0.5?μg/ml]?and?
counted?by?use?of?a?fluorescence?microscope.?
? ?
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Quantitative?RT?PCR?
Total?RNA?was?prepared?using?Tri?Reagent?(Sigma?Aldrich),?reverse?transcribed?with?
ImProm?II?Reverse?Transcriptase?(Promega)?and?transcription? levels?were?quantified?by?use?
of? SYBR?green? PCR?Mastermix? (Eurogentec)? in? a? real? time? PCR? system? (Step? One? Plus,?
Applied?Biosystems).?Human?or?mouse?riboprotein?L19?primers?were?used?for?normalization.?
PCR? assays?were? performed? in? duplicates? and? the? fold? induction?was? calculated? against?
control?treated?cells?using?the?comparative?Ct?method?(???Ct).?Following?primers?were?used:??
murine?RPL19?
fwd:?5’?CTCGTTGCCGGAAAAACA?3’,??? rev:?5’?TCATCCAGGTCACCTTCTCA?3’?
human?RPL19?
fwd:?5’?GATGCCGGAAAAACACCTTG?3’,?? rev:?5’?CAGGGCAGTGATCTCCTTCTG?3’?
murine?Foxf2?
fwd:?5’?AGCAGAGCTACTTGCACCAGA?3’,? ?rev:?5’?GCAGTCCGACTGAGAGATCCT?3’?
human?Foxf2?
fwd:?5’?AGCAGAGCTACTTGCACCAGA?3’,?? rev:?5’?GCAGTCCCACTGAGAGGTCCT?3’?
murine?E?cadherin?
fwd:?5’?CGACCCTGCCTCTGAATCC?3’,?? rev:?5’?TACACGCTGGGAAACATGAGC?3’?
murine?ZEB1?
fwd:?5’?GCCAGCAGTCATGATGAAAA?3’,?? rev:?5’?TATCACAATACGGGCAGGTG?3’?
murine?ZEB2?
fwd:?5’?GGAGGAAAAACGTGGTGAACTAT?3’,??rev:?5’?GCAATGTGAAGCTTGTCCTCTT?3’?
murine?Id2?
fwd:?5’?ACTATCGTCAGCCTGCATCA?3’,?? rev:?5’?AGCTCAGAAGGGAATTCAGATG?3’?
murine?Noxa?
fwd:?5’?CAGATGCCTGGGAAGTCG?3’,?? rev:?5’?TGAGCACACTCGTCCTTCAA?3’?
? ?
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murine?Btc?
fwd:?5’?ACCAATGGCTCTCTTTGTGG?3’,?? rev:?5’?CCGAGAGAAGTGGGTTTTCA?3’?
murine?Ereg?
fwd:?5’?TTGACGCTGCTTTGTCTAGG?3’,?? rev:?5’?GGATCACGGTTGTGCTGAT?3’?
murine?Areg?
fwd:?5’?AAGAAAACGGGACTGTGCAT?3’,?? rev:?5’?GGCTTGGCAATGATTCAACT?3’?
Immunoblotting?
Cells?were? lysed?for?20?min?on? ice? in?Ripa?buffer?(150?mM?NaCl,?2?mM?MgCl,?2?mM?
CaCl2,?0.5?%?NaDOC,?1?%?NP40,?0.1?%?SDS,?10?%?Glycerol,?50?mM?Tris?pH?8.0,?2?mM?Na3VO4,?
10? mM? NaF,? 1? mM? DTT,? and? a? 1:200? dilution? of? stock? protease? inhibitor? cocktail? for?
mammalian?cells? (Roche).?Protein?concentration?was?determined?using?DC™?Protein?Assay?
(BioRad?Laboratories).?Equal?amounts?of?protein?were?diluted?in?SDS?PAGE?loading?buffer?(10?
%?glycerol,?2?%?SDS,?65?mM?Tris,?1?mg/100?ml?Bromphenolblue,?1?%?betamercaptoethanol)?
and?resolved?by?SDS?PAGE.?SDS?PAGE?gels?were?transferred?to?polyvinylidene?fluoride?(PVDF)?
membranes? (Millipore)? by? semi?dry? transfer,? blocked?with? 5?%? skim?milk? powder? in? Tris?
buffered?saline?with?0.05?%?Tween?20? (TBST)?and? incubated?with?the? indicated?antibodies.?
HRP? conjugated? antibodies? were? detected? using? enhanced? chemiluminescence.? In? some?
cases?immunoblots?were?also?quantified?using?the?Odyssey?Imager?(Li?Cor?Biotechnology)?or?
ImageJ?1.4.3.67?(Broken?Symmetry?Software).?
Immunofluorescence?Experiments?
shCtrl?or?shFoxf2?NMuMG?cells?were?plated?on?glass?coverslips?and? treated? for? the?
indicated?times?with?TGF??[2?ng/ml].?Cells?were?fixed?using?4?%?paraformaldehyde?/PBS?for?
10?min?and?permeabilized?with?0.2?%?Triton?X? for?2?min?at? room? temperature.?Then? cells?
were?blocked?using?3?%?BSA,?0.01?%?Triton? in?PBS? for?1?h?at? room? temperature.?The?cells?
were?incubated?with?the?indicated?primary?antibody?for?1?h?followed?by?incubation?with?the?
fluorochrome?labelled? secondary? antibody? (Alexa? Fluor®,? Invitrogen)? for? 1? h? at? room?
temperature.?Nuclei?were?stained?with?6?diamidino?2?phenylindole?[1?μg/ml]?(Sigma?Aldrich)?
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for? 10? min.? The? coverslips? were? mounted? (Fluorescent? mounting? medium,? Dako)? on?
microscope?slides?and?imaged?by?using?a?confocal?microscope?(Leica?SP5).?
Apoptosis?assay?
Cells?were?washed? twice? in? ice? cold?PBS?and? resuspended? in?1x?Annexin?V?binding?
buffer? (0.01?M?HEPES,? pH? 7.4,? 0.14?M?NaCl,? 2.5?mM? CaCl2,)? at? a? concentration? of? 1x106?
cells/ml.?5?μl?of?Cy5?Annexin?V?was?added?to?1x?105?cells?and?incubated?for?15?min?on?ice?in?
the?dark.?Stained?cells?were?filtered?through?a?40?μm?mesh?and?analyzed?on?a?FACSCanto?II?
using? DIVA? Software? (Becton? Dickinson).? Cell? debris? and? duplets? were? excluded? by? a?
combination?of?light?scatter?and?forward?scatter?plus?width.?
Flow?cytometric?analysis?
Cells?were?washed?twice?in?PBS?supplemented?with?5%?FBS?and?stained?with?directly?
fluorochrome?labeled?or?biotin?conjugated?monoclonal?atibodies?against?CD44?PE?(#553143,?
BD?Pharmingen),?CD24?Biotin? (#553260,?BD?Pharmingen),?CD29?Alexa647? (#MCA2298A647,?
Serotec),?CD49f?Biotin? (#MCA699BT,?Serotec),? followed?by?an? incubation?with?streptavidin?
fluorochrome? secondary? molecules,? streptavidin? FITC? (#11?4317?87,? eBioscience),?
streptavidin? APC? (#17?4317?82,? eBioscience),? streptavidin? PE? (#12?4317?87,? eBioscience).?
Stained?cells?were?analyzed?on?a?FACSCanto?II?using?DIVA?software?(Becton?Dickinson).?Dead?
cells?were?excluded?by?a?combination?of?PI?fluorescence?and?light?scatter.??
Proliferation?assay?(BrdU?incorporation)?
Cells?were?incubated?with?10?μM?BrdU?for?2?h?at?37?°C?and?5?%?CO2.?Then?cells?were?
fixed?in?70?%?ice?cold?Ethanol?and?lysed?by?incubating?first?with?2?N?HCl,?0.5?%?Triton?X?100?
for?30?min?and?secondly?in?0.1?M?Na2B4O7,?pH?8.5?for?2?min?at?room?temperature.?The?Nuclei?
were?washed?with?0.5?%?Tween?20,?1?%?BSA/PBS?and?incubated?with?FITC?labeled?anti?BrdU?
antibody?(#347583,?Beckton?Dickinson)?for?30?min?at?room?temperature.?Nuclei?were?stained?
for?DNA?content?by?incubating?with?5?μg/ml?PI?for?a?minimum?of?1?h?at?room?temperature.?
Stained?cells?were?filtered?through?a?40?μm?mesh?and?analyzed?on?a?FACSCanto?II?using?DIVA?
Software?(Becton?Dickinson).?
? ?
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Chromatin?immunoprecipitation?
Chromatin? immunoprecipitation? (ChIP)? experiments?were? performed? as? previously?
described? (266).? In? brief,? crosslinked? chromatin? was? sonicated? to? receive? an? average?
fragment?size?of?500?bp.?Starting?with?100?μg?of?Chromatin?and?5?μg?of?HA?tag?antibody,?1μl?
of?ChIP?material?or?1?μl?of? input?material?were?used? for?quantitative?RT?PCR,?usinf?specific?
primers?covering?the?noxa?gene?promoter?region?from?basepair??696?to??499,?the?betacellulin?
gene?promoter?region?from?basepair??450?to??253,?the?epiregulin?gene?promoter?region?from?
basepair??851?to??654,?the?amphiregulin?gene?region?in?exon?2?from?basepair?+1086?to?1210,?
and? primers? covering? an? intergenic? region? as? control.? The? amplification? efficiencies?were?
normalized?between?the?primer?pairs.?
Microarray?processing?and?data?analysis?
RNA?was?isolated?using?Tri?Reagent?(Sigma?Aldrich)?from?NMuMG?cells?infected?with?
control?shRNA?or?shRNA?specific?for?Foxf2?treated?with?TGF??for?0,?1,?4,?7?and?10?days.?RNA?
quality?and?quantity?was?evaluated?using?an?Agilent?2100?Bioanalyzer?(Agilent?Technologies).?
The? manufacturer’s? protocols? for? the? GeneChip? platform? by? Affimetrix? were? followed.?
Methods? included? synthesis?of? the? first??and? second?strand?cDNA? followed?by? synthesis?of?
cRNA?by?in?vitro?transcription,?subsequent?synthesis?of?single?stranded?cDNA,?biotin?labeling?
and?fragmentation?of?cDNA?and?hybridization?with?the?microarray?slide?(GeneChip®?Mouse?
Gene?1.0?ST?array),?posthybridization?washings?and?detection?of?the?hybridized?cDNAs?using?
a?streptavidin?coupled?fluorescent?dye.?Hybridized?Affimetrix?GeneChips?were?scanned?using?
an? Affimetrix? GeneChip? 3000? scanner.? Image? generation? and? feature? extraction? were?
performed? using? Affimetrix? GCOS? Software,? and? quality? control? was? performed? using?
Affimetrix?Expression?Console?Software.?Raw?microarray?data?were?normalized?with?Robust?
Multi?Array?(RMA)?and?analyzed?using?Partek®?Genomics?Suite?Software?(Partek? Inc.).?One?
way?analysis?of?variance?(ANOVA)?and?asymptotic?analysis?were?used?to?identify?significantly?
differentially?expressed? genes.?The? gene?ontology? (GO)? tool? from?Partek®?Genomics? Suite?
Software?as?well?as?the?Ingenuity?Pathway?Analysis?Software?(IPA®,?Ingenuity?Systems,?Inc.)?
were?used?for?further?analysis.?
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Mammosphere?formation?
Mammosphere?formation? experiments?were?performed? as?previously?described?by?
Dontu?et?al.?with?minor?modifications? (267,?268).? In?brief,? cells?were?used?as?a? single? cell?
suspension? at? a? starting? concentration? of? 1x105? cells/ml? in? DMEM/F12? medium?
supplemented?with?B27?(Invitrogen),?glutamine?[2?mM],?penicillin?(100?U),?streptomycin?[0.2?
mg/L],? heparin? [1? U/ml],? hEGF? [20? ng/ml]? and? bFGF? [20? ng/ml],? seeded? on? ultra? low?
attachment?(ULA)?plates?(Corning).?Cells?were? incubated?at?37?°C?and?5?%?CO2?and?medium?
was?replenished?by?25?%?every?second?day?of?culture.?Mammospheres?were?passaged?after?7?
days?of?culturing?by?3?4?rounds?of?Trypsin?incubation?in?turns?with?pipetting?up?and?down?to?
reach?a?single?cell?suspension.?Single?cells?were?reseeded?for?M2?or?M3?at?a?concentration?of?
5x104?cells/ml?and/or?used?for?FACS?analyses.?
Survival?and?metastasis?correlation?analysis?
Analyses? of? Foxf2? expression? correlation? with? breast? cancer? patient? survival? or?
metastasis?formation?were?performed?using?two?distinct?datasets?of?the?Netherlands?Cancer?
Institute? (NKI295)? (269)? and? of? the?Memorial? Sloan?Kettering? Cancer? Center? (MSKCC)?NY,?
described? in? detail? in? (57).? The?NKI295? database? contained? of? 288? tumors? of? early?stage?
breast?cancer?(stageI?and?stageII)?with?information?on?Foxf2?expression,?overall?survival?(10y)?
and? time? to? metastasis.? Tumors? were? divided? into? two? groups? based? on? the? relative?
expression?of?Foxf2?to?the?tumor?pools?(logFC?=?0)?and?further?stratified?by?ER?status?(N=68?
ER?,? N=220? ER+).? The? Minn? database? consisted? of? microarray? expression? data? from? 82?
patients,?with?more?advanced?(T2?T4)?mammary?carcinomas?analyzed?for?overall?metastasis?
free? survival,? also? subdivided? into? lung? and? bone?metastasis? free? survival.? Tumors?were?
divided? into?two?groups?based?on?the?median?expression?of?Foxf2?and?further?stratified?by?
LN? status? (N=54? LN+,? N=28? LN?).? Overall? and? metastasis?free? survival? was? estimated? by?
applying?Kaplan?Meier? survival?analysis?and?Cox?proportional?hazards? regression?modeling?
with?the?R?survival?package?2.36?5?and?R?version?2.11.1?(www.r?project.org).?The?p?value?of?
the?likelihood?ratio?test?was?used?to?assess?the?statistical?significance?between?the?different?
patient?groups.?
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Statistical?analysis?
Statistical? analysis? and? graphs?were? generated?using? the?GraphPad?Prism? software?
(GraphPAd?Software?Inc,?San?Diego?CA).?All?statistical?analyses?were?performed?as?indicated?
by?paired?or?unpaired?two?sided?t?test.?
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4 Foxf2???a?protagonist?acting?on?two?parts?in?EMT?
4.1 Results?
4.1.1 Foxf2?expression?increases?during?EMT?
To? identify?genes,?which?are? critical?key?players? in? the?onset?and? regulation?of? the?
EMT?process,?a?gene?expression?profiling?of?three? independent? in?vitro?EMT?model?systems?
before?and?after?EMT?was?performed? in?our? laboratory? (270).?The? three?EMT?cell? systems?
used?were?(i)?MTflEcad?cells,?an?MMTV?neu?(271)?mammary?tumor?derived?cell?line,?in?which?
both? E?cadherin? alleles? were? flanked? by? LoxP? recombination? sites? (272).? The? complete?
ablation?of?E?cadherin?was?achieved?by?expression?of?Cre?recombinase?(MT?Ecad)?(262).?(ii)?
In? the? human? breast? cancer? cell? line?MCF7,? EMT? was? induced? by? downregulation? of? E?
cadherin?using?stable?expression?of?shRNA?(262).?(iii)?The?third?system?used?was?the?murine?
mammary?epithelial?cell?line?NMuMG,?in?which?EMT?was?induced?upon?treatment?with?TGF??
(273)?(Figure?6A).?Screening?for?genes?that?are?commonly?regulated?in?all?three?EMT?systems,?
we?identified?the?forkhead?transcription?factor?Foxf2?as?a?commonly?upregulated?gene.?The?
transcriptional? up?? regulation?was? verified? by? quantitative? RT?PCR? (MT?Ecad? 70x,?MCF7?
shEcad?28x,?NMuMG?+TGF??5x).?In?NMuMG?cells,?Foxf2?is?up?regulated?already?after?1?day?of?
treatment?and?remains?high?in?expression?with?consecutive?TGF??application?(Figure?6B).?To?
assess?whether?Foxf2?is?a?target?of?canonical?or?non?canonical?TGF??signaling,?we?monitored?
Foxf2?expression? in? stable? Smad4? knockdown? cells? (NMuMG?shSmad4)? (263)? treated?with?
TGF?.? Foxf2?mRNA?expression? levels?were? significantly? reduced? in? TGF??treated?NMuMG?
shSmad4?compared?to?control?cells,? indicating?that?Foxf2? is?regulated?via?canonical?Smad4?
dependent?TGF??signaling?(Figure?6C).?
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Figure?6:?Foxf2?expression?is?upregulated?during?EMT?via?the?canonical?Smad?pathway.?(A)?MTflEcad,?MCF7?and?
NMuMG? cells?undergo?EMT?upon?deletion?of? the?E?cadherin?gene?by?expression?of?Cre?recombinase? (MT?Ecad),? shRNA?
expression? against? E?cadherin? (MCF7?shEcad)?or? treatment?with? TGF?? (NMuMG/E9+TGF?)? respectively.? (B)? Foxf2?mRNA?
levels? were? determined? by? quantitative? RT?PCR? in?MTflEcad/MT?Ecad,?MCF7?shCont/MCF7?shEcad,? and? NMuMG? cells?
treated?with?TGF?? for? the? indicated? times.?Values?were?normalized? to?endogenous?murine?RPL19.? (C)?Foxf2?mRNA? levels?
were?quantified?by?quantitative?RT?PCR?in?stable?Smad4?knockdown?(shSmad4)?and?control?(shCont)?NMuMG?cells?treated?
with?TGF??for?the?indicated?times.?Values?were?normalized?to?endogenous?murine?RPL19.?Data?are?shown?as?mean?of?two?
independent? experiments.? Statistical? values? were? calculated? by? using? a? paired? two?tailed? t?test.? P?values? ?? 0.05? are?
indicated?with?(*),?p?values???0.01?are?indicated?with?(**),?p?values???0.001?are?indicated?with?(***).?
?
4.1.2 Upregulation?of?Foxf2?is?essential?for?complete?EMT?
To?assess?whether?the?expression?of?Foxf2?is?able?to?induce?EMT,?NMuMG?cells?were?
stably? infected? with? lentiviral? particles? encoding? HA?tagged? human? Foxf2.? Although? the?
stable? expression? of? Foxf2? in? the? nucleus? of? the? cells? could? be? demonstrated? by?
immunofluorescence? staining? with? anti?HA? antibody,? the? cells? did? not? gain? an? EMT?like?
phenotype? (data?not?shown).?To? investigate?whether? the?upregulation?of?Foxf2? is?required?
for? EMT?we? stably? infected?NMuMG? cells?with? two? different? lentiviral? particles? encoding?
shRNA?against?murine?Foxf2?(shFoxf2?703,?shFoxf2?704).?NMuMG?shFoxf2?cells?treated?with?
TGF??show?a?clear?change? in?morphology:? they?gain?a?spindle?like?structure? like? the?shCtrl?
cells.?Yet,? the?NMuMG? cells?expressing? shFoxf2?are?not?breaking?down? their? tight? cell?cell?
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contacts,? which? is? a? key? step? during? EMT? (Figure? 7A).? The? knockdown? efficiency? of? the?
shRNAs?was?determined?by?quantitative?RT?PCR,? showing? a? remaining?upregulation?when?
the?cells?were?treated?with?TGF??(Figure?7B),?indicating?that?there?could?even?be?a?stronger?
effect?with?complete?abrogation?of?Foxf2?expression.?To? investigate?whether?the?reduction?
of?Foxf2?derogates?the?loss?of?epithelial?markers?and?the?gain?of?mesenchymal?markers,?we?
analyzed? the? expression? of? epithelial?markers? E?cadherin? and? ZO?1? and? the?mesenchymal?
markers?N?cadherin,?NCAM?and?Fibronectin.?Western?blot?analysis?displayed?a?sustained?E?
cadherin? expression? in? Foxf2? knockdown? cells? even? after? 10? d? of? treatment? with? TGF?,?
accompanied?with?a?stabilization?of?ZO?1?expression.?These?results?showed?that?the?shFoxf2?
cells?did?not?show?a?bona?fide?EMT?upon?treatment?with?TGF?,?whereas?Fibronectin,?NCAM?
and? N?cadherin? expression? remained? unchanged? (Figure? 7C).? By? determining? the?mRNA?
expression?levels?of?E?cadherin?in?Foxf2?knockdown?and?control?cells?we?were?able?to?show?
that? E?cadherin? expression? is? regulated? at? the? transcriptional? level? by? Foxf2? (Figure? 7D).?
However,?the?mRNA?expression?levels?of?the?mesenchymal?markers?NCAM?and?N?cadherin?in?
shFoxf2?cells?were?comparable?to?the?NMuMG?control?cells?(data?not?shown).?
?
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Figure?7:?Downregulation?of?Foxf2?attenuates?TGF??induced?EMT.? (A)?Phase?contrast?micrographs?of?NMuMG?
cells?stably?expressing?a?control?shRNA?(shCtrl)?or?a?Foxf2?specific?shRNA?(shFoxf2?703,?shFoxf2?704)?treated?with?TGF??for?
the? indicated? times.? (B)?Knockdown?efficiency?was?determined?by?quantitative?RT?PCR? for? Foxf2? in?NMuMG? cells? stably?
infected? with? shCtrl,? shFoxf2? 703? or? shFoxf2? 704,? treated? with? TGF?? for? times? indicated.? Values? were? normalized? to?
endogenous? murine? RPL19.? (C)? Knocking? down? Foxf2? leads? to? a? sustained? expression? of? cell? junction? components.?
Immunoblotting?analyses? for? the?epithelial?markers?E?cadherin?and?ZO?1?as?well?as? the?mesenchymal?markers?NCAM,?N?
cadherin?and?Fibronectin?in?shFoxf2?knockdown?and?control?NMuMG?cells?treated?with?TGF??for?the?time?indicated.?Actin?
was?used?as?a?loading?control.?(D)?E?cadherin?downregulation?during?TGF??induced?EMT?is?regulated?at?the?transcriptional?
level?by?Foxf2.?E?cadherin?mRNA?levels?in?shFoxf2?knockdown?and?control?NMuMG?cells?were?determined?by?quantitative?
RT?PCR.?Values?were?normalized?to?endogenous?murine?RPL19.?Data?are?shown?as?mean?of?three?independent?experiments.?
Statistical? values?were? calculated?by?using?a?paired? two?tailed? t?test.?P?values? ??0.05? indicated?with? (*),?p?values? ??0.01?
indicated?with?(**),?p?values???0.001?indicated?with?(***).?
?
To?investigate?whether?a?downregulation?of?Foxf2?during?EMT?causes?a?difference?in?
EMT?associated?changes?in?cell?adhesion,?cell?junctions?and/or?cytoskeletal?composition,?we?
performed? an? immunofluorescence? staining? for? the? cell? adhesion? proteins? E?cadherin,?N?
cadherin? and?NCAM,? the? tight? junction? protein? ZO?1,? the? focal? adhesion? protein? Paxillin,?
Actin? stress? fibers? (phalloidin)? and? the? intermediate? filament? Vimentin.? NMuMG? shFoxf2?
cells? did? not? show? a? classical? cadherin? switch? when? treated? with? TGF?.? A? normal?
upregulation? of? the?mesenchymal?marker? N?cadherin? was? observed? but? E?cadherin? was?
maintained?at? the?cell?membrane? in?contrast? to? the?control?cells,?which? show?a?bona? fide?
EMT?(Figure?8).?
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Figure? 8:? Foxf2? is? required? for? TGF??induced?disruption?of? adherens? junctions.?Representative? confocal? laser?
scanning?microscopy?analysis?of?E?cadherin?(red)?and?N?cadherin?(green)? in?shFoxf2?knockdown?and?control?NMuMG?cells?
treated?with?TGF??for?the?indicated?times.?The?nuclei?are?visualized?by?staining?with?DAPI?(blue).?
?
Furthermore?we?could?also?show?that?the?stabilization?of?the?cell?adhesion?protein?E?
cadherin?is?accompanied?by?a?sustained?localization?of?the?tight?junction?component?ZO?1?at?
the?membrane,? indicating? that? Foxf2? upregulation? is? required? for? cell? junction? disruption?
during?TGF??induced?EMT?(Figure?9).? 
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Figure?9:?Reduced?levels?of?Foxf2?expression?results?in?a?stabilization?of?tight?junctions.?Representative?confocal?
laser?scanning?microscopy?analysis?of?ZO?1?(red)?and?NCAM?(green)?in?shFoxf2?knockdown?and?control?NMuMG?cells?treated?
with?TGF??for?the?indicated?times.?The?nuclei?are?visualized?by?staining?with?DAPI?(blue).?
?
Additionally,?we?observed?that?the?upregulation?of?Foxf2?during?EMT?is?not?required?
for? the?EMT?associated?cytoskeletal? reorganization? including? the? rearrangement?of?cortical?
Actin?to?stress?fibers?and?the?upregulation?of?filamentous?Vimentin.?Compared?to?the?control?
cells,? shFoxf2?knockdown? cells? showed?a? likewise?upregulation?of?NCAM?expression?and?a?
similar?formation?of?focal?adhesions?shown?by?Paxillin?staining?(Figure?9,Figure?10Figure?11).?
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Figure?10:?Foxf2?knockdown?does?not?affect?cytoskeletal?rearrangement?and?focal?adhesion?formation?of?TGF??
induced?EMT.?Representative?confocal?laser?scanning?microscopy?analysis?of?filamentous?actin?(red)?and?paxillin?(green)?in?
shFoxf2? knockdown? and? control?NMuMG? cells? treated?with? TGF?? for? the? indicated? times.? The? nuclei? are? visualized? by?
staining?with?DAPI?(blue).?
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Figure?11:? Foxf2?knockdown? cells? show?EMT?associated?upregulation?of?Vimentin? to?a? similar?extend?as? the?
NMuMG? control? cells.? Representative? confocal? laser? scanning? microscopy? analysis? of? Vimentin? (green)? in? shFoxf2?
knockdown?and?control?NMuMG?cells?treated?with?TGF??for?the?indicated?times.?The?nuclei?are?visualized?by?staining?with?
DAPI?(blue).?
?
4.1.3 Foxf2?regulates?the?expression?of?E?cadherin?modulators??
Although?several?genetic?and?epigenetic?mechanisms?have?been?identified,?loss?of?E?
cadherin? is? often? attributed? to? transcriptional? dysregulation.? Several? transcription? factors?
were? discovered? as? repressors? of? E?cadherin? transcription.? Among? them? the? zinc?finger?
homeodomain? transcription? factors? ZEB1? and? ZEB2? were? found? to? interact? in? a? ligand?
dependent?fashion?with?receptor?activated?Smads?involved?in?mediating?TGF??signaling?(274)?
and? to?downregulate?E?cadherin? transcription?by?binding? to? the?conserved?E2?boxes? in? the?
cdh1?promoter?(275).?By?quantitative?RT?PCR?we?have?demonstrated?that?a?downregulation?
of? Foxf2? in? TGF??treated? NMuMG? cells? clearly? attenuated? the? upregulation? of? the? two?
transcription? factors? ZEB1? and? ZEB2? (Figure? 12A,B).? These? findings? suspected? that? the?
regulation?of?E?cadherin?by?Foxf2? is?at? least?partly?mediated?by? the? regulation?of? the?ZEB?
proteins.? Furthermore,? levels?of? Id2?proteins?were? found? to?be?dramatically?decreased?by?
TGF?.? Generally? the? Inhibitors? of? Differentiation? (Ids)? were? found? to? act? as? positive?
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regulators?of?proliferation?and?as?negative?regulators?of?differentiation.?The?Id?proteins?lack?a?
DNA?binding?motif?and?inhibit?bHLH?transcription?factors,?like?HEB,?E2?2?and?E2A?by?binding?
with?their?HLH?dimerization?motif?(276).?By?this?mechanism,?Id2?antagonizes?E2A?dependent?
suppression?of?the?E?cadherin?promoter?(277).?Attenuation?of?Foxf2?in?TGF??treated?NMuMG?
cells?showed?a?significantly?higher?maintenance?of? Id2?expression?compared?to?the?control?
NMuMG? cells? (Figure? 12C),?which? is? consistent?with? the? sustained? expression? levels? of? E?
cadherin.?
?
Figure?12:?Foxf2?regulates?the?expression?of?E?cadherin?modulators?and?transcriptional?repressors.?(A/B/C)?ZEB1?
mRNA? levels,?ZEB2?mRNA? levels?and? Id2?mRNA? levels,? respectively,?were?determined?by?quantitative?RT?PCR? in? shFoxf2?
knockdown?and?control?NMuMG?cells.?Values?were?normalized?to?endogenous?murine?RPL19.?Data?are?shown?as?mean?of?
three? independent? experiments.? Statistical? values?were? calculated? by? using? a? paired? two?tailed? t?test.? P?values? ?? 0.05?
indicated?with?(*),?p?values???0.01?indicated?with?(**),?p?values???0.001?indicated?with?(***).?
?
4.1.4 Downregulation?of?Foxf2?leads?to?reduced?cell?motility?
An? important? initial? step?of? fibroblast?like? single? cell?migration? is? the?disruption?of?
intercellular? contacts? to? leave? the? cell? compound.? This? is? accompanied? by? the? loss? of? E?
cadherin?and?acquisition?of?mesenchymal?characteristics?such?as?a?spindle?shape,?fibroblast?
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like?morphology,?which? enables? the? cells? to? disseminate? from? their? neighboring? cells? and?
facilitates? their? ability? to?migrate? individually? and? invade? (34).?We? have? shown? that? the?
upregulation? of? Foxf2? is? essential? for? the? loss? of? E?cadherin? and? the? disruption? of? cell?
junctions?and?therefore?wanted?to?investigate?whether?cells?deficient?for?Foxf2?were?able?to?
emigrate?from?the?adjacent?cells.?We?performed?a?migration?assay?comparing?the?migratory?
capability? of? TGF??treated,? stable? Foxf2? knockdown? cells? to? the? mesenchymal? control?
NMuMG?cells? infected?with?control?shRNA?and?found?a?decrease? in?motility?for?cells?stably?
expressing?a?specific?shRNA?against?murine?Foxf2?(Figure?13A).?Concomitant?determination?
of? the?E?cadherin?mRNA?and?protein?expression? levels? revealed? that? the?Foxf2?knockdown?
cells?after?19?days?of?TGF??treatment?still?express?E?cadherin?to?a?comparable?extend?of?non?
treated?epithelial?NMuMG? (Figure?13B,E).?Although?elongated,? the?cells?deficient? for?Foxf2?
show? epithelial?like? cell? adherence?when? treated?with? TGF?? for? 20?days? contrary? to? their?
foxf2?expressing?counterparts? (Figure?13C).?We?were?able? to? show? that? this?effect? is?dose?
dependent,?as?there?was?a?clear?correlation?between?the?efficiency?of?the?Foxf2?knockdown?
and? the? expression? levels? of? E?cadherin? and? the? migratory? capability? (Figure? 13D).? In?
summary,? the?upregulation?of? Foxf2? in?NMuMG? cells?undergoing? EMT? is?essential? for? the?
transcriptional?repression?of?E?cadherin?and?concomitant?the?disruption?of?the?cell?adhesions?
and?the?ability?to?migrate.?
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Figure? 13:? Depletion? of? Foxf2? expression? reduces? cell?motility.? (A)? Depletion? of? Foxf2? leads? to? reduced? cell?
migration?of?TGF??treated?NMuMG?cells?through?transwell?filters?compared?to?control?cells?(shCtrl).?Data?is?shown?as?mean?
±SEM?of?three?independent?experiments.?Statistical?values?were?calculated?by?using?an?unpaired?two?tailed?t?test.?P?value???
0.05? indicated?with? (*).? (B)?Knocking?down?Foxf2? leads? to? sustained?E?cadherin?expression?after?19d?of?TGF?? treatment?
shown?by? immunoblotting?analysis? in?shFoxf2?and?shCtrl?NMuMG?cells.?Tubulin?was?used?as?a? loading?control.? (C)?Phase?
contrast?micrographs?of?NMuMG?cells?stably?expressing?a?control?shRNA? (shCtrl)?or?a?Foxf2?specific?shRNA? (shFoxf2?703,?
704?respectively).?(D/E)?Foxf2?mRNA? levels?and?E?cadherin?mRNA? levels?respectively?were?determined?by?quantitative?RT?
PCR? in? shFoxf2?and? shCtrl?NMuMG?cells? treated? for?19?d?with?TGF?.?Values?were?normalized? to?endogenous?RPL19?and?
shown? as? fold? induction? to? untreated? shCtrl? NMuMG? cells.? Data? are? shown? as? mean? ±SEM? of? three? independent?
experiments?performed?in?parallel?with?the?migration?assay.?Statistical?values?were?calculated?by?using?a?paired?two?tailed?t?
test.?P?values???0.05?indicated?with?(*),?p?values???0.01?indicated?with?(**).?
? ?
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4.1.5 Foxf2?is?involved?in?TGF??induced?apoptosis?
We?next? investigated?whether?the?depletion?of?Foxf2?has?an? impact?on?proliferation?
and/or?cell?death?of?NMuMG?cells?undergoing?EMT.?NMuMG?cells?stably?expressing?shRNA?
specific? for? Foxf2? showed? TGF??mediated? growth? inhibition? to? a?minor? extent? than? the?
control? cells? (Figure? 14A).? To? assess? whether? this? is? due? to? increased? proliferation? or?
decreased?cell?death,?we?compared?the?rates?of?apoptosis?(Annexin?V?staining)?and?the?rates?
of? proliferation? (BrdU? incorporation? and? PI? staining)? of? Foxf2? knockdown? and? control?
NMuMG?cells?treated?with?TGF?.?The?depletion?of?Foxf2?significantly?reduced?the? levels?of?
apoptosis?when? compared? to? the?control? cells?and?only? showed?a?minor?difference? in? the?
number? of? cycling? cells,? indicating? that? the? increased? cell? numbers? observed? can? be?
attributed? to? an? attenuation?of?TGF??induced?apoptosis? (Figure?14B,?D,?G).?To? investigate?
whether?Foxf2? influences? the?Caspase?dependent?programmed?cell?death?we?analyzed? the?
activation?of?the?zymogen?Caspase?3?and? its?downstream?cleavage?target?Poly?(ADP?ribose)?
polymerase?(PARP)?by?western?blot?analysis.?Downregulation?of?Foxf2?shows?an?impairment?
of?Caspase?3?and?PARP?cleavage?in?TGF??treated?NMuMG?cells?(Figure?14C).?In?summary,?we?
were?able?to?show?that?the?increase?of?Foxf2?is?required?for?TGF??induced?cell?death.?
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Figure? 14:? Depletion? of? Foxf2? attenuates? TGF??induced? apoptosis.? (A)? Downregulation? of? Foxf2? promotes?
accelerated?cell?growth.?shFoxf2?expressing?and?control?NMuMG?cells?were?treated?with?TGF??for?the?indicated?times?and?
counted? using? a? Neubauer? chamber.? Representative? result? of? three? independent? experiments.? (B)? Foxf2? depletion?
decreases?the?level?of?apoptosis?during?TGF??induced?EMT.?shFoxf2?expressing?and?control?NMuMG?cells?were?treated?with?
TGF??for?the?indicated?times?and?apoptosis?was?detected?by?Annexin?V?staining?and?FACS?analysis.?Data?are?means?of?three?
independent? experiments.? Statistical? values? were? calculated? by? using? an? unpaired? two?tailed? t?test.? P?values? ?? 0.05?
indicated?with? (*),?p?values? ??0.01? indicated?with? (**),?p?values? ??0.001? indicated?with? (***).? (C)?TGF?? induces? classical?
caspase?dependent?apoptosis,?and?is?regulated?by?the?upregulation?of?Foxf2.?Immunoblotting?analyses?for?cleaved?caspase?
3?and?PARP? in?shFoxf2?and?control?NMuMG?cells? treated?with?TGF?? for? the?times? indicated.?Actin?was?used?as?a? loading?
control.?(D)?Foxf2?downregulation? leads?to?a?minor? increase? in?proliferation.?shFoxf2?cells?and?control?NMuMG?cells?were?
treated?with?TGF?? for? the? times? indicated?and?proliferation?was?assessed?by?BrdU? incorporation?and?PI?staining?by?FACS?
analysis.?(E)?shFoxf2?expressing?and?control?NMuMG?cells?were?treated?with?TGF??for?the?indicated?times?and?apoptosis?was?
detected? by? Annexin? V? staining? and? FACS? analysis.? Data? shown? are? representative? results? out? of? three? independent?
experiments,?qualified?in?panel?B.?
? ?
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4.1.6 Foxf2?affects?apoptosis?by?regulating?the?expression?of?Noxa?
TGF??has?been?shown?to?act?as?a?tumor?suppressor? in?early?stages?of?tumorigenesis?
by? inducing? cell? cycle? arrest? and? apoptosis? (278).? Canonical? TGF?? signaling? results? in? the?
regulation?of?various?apoptotic?factors.?To?investigate?which?genes?involved?in?apoptosis?are?
regulated? by? Foxf2?we? performed? a? gene? expression? profiling? using?GeneChip?microarray?
(Affimetrix)? on? shFoxf2? and? shCtrl? NMuMG? cells.? Data? analysis? for? differently? expressed?
genes?upon?Foxf2?depletion?during?EMT?using?Partek?Software?revealed?a?regulation?of?Noxa?
by? Foxf2.? This? expressional? regulation? could? be? confirmed? by? quantitative? RT?PCR? (Figure?
15A).? As? the? upregulation? of? Foxf2? is? necessary? for? the? increase? in?Noxa? expression,?we?
wanted? to? assess?whether? loss?of?Noxa? is? sufficient? to?prevent? apoptosis? in? TGF??treated?
NMuMG?cells.?To?address?this?question?we?knocked?down?Noxa?by?the?use?of?two?different?
siRNAs?(siNoxa1,?siNoxa3)?to?analyze?apoptosis?and?cell?growth.?Consequently,?following?the?
reduction?of?Noxa?mRNA? levels?(Figure?15B),?apoptosis?was?attenuated?significantly?(Figure?
15C)?and?cell?growth? inhibition?was?compensated?(Figure?15D),? indicating?that?depletion?of?
Noxa? is? sufficient? to? preserve? NMuMG? cells? from? TGF?? induced? apoptosis.? Chromatin?
immunoprecipitation? (ChIP)? experiments? with? NMuMG? cells? expressing? HA?tagged? Foxf2?
treated? for? 2? days?with? TGF?? demonstrated? a? direct? binding? of? Foxf2? to? the? noxa? gene?
promoter?(Figure?15F).?
Together? these? data? indicate? that? Foxf2? is? involved? in? TGF?? apoptosis? by? direct?
transcriptional?activation?of?the?pro?apoptotic?protein?Noxa.??
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Figure? 15:? Noxa? depletion? prevents? NMuMG? cells? from? TGF?? induced? apoptosis.? (A)? Knockdown? of? Foxf2?
attenuates?the?upregulation?of?Noxa?expression.?Noxa?mRNA?levels?in?shFoxf2?and?control?NMuMG?cells?treated?with?TGF??
for?the?number?of?days?indicated,?were?determined?by?quantitative?RT?PCR.?Values?were?normalized?to?endogenous?murine?
RPL19.?Data?presented?as?mean?±SEM?of?three?independent?experiments.?Statistical?values?were?calculated?using?a?paired?
two?tailed? t?test.?P?values? ??0.05? indicated?with? (*),?p?values? ??0.01? indicated?with? (**),?p?values? ??0.001? indicated?with?
(***).?(B?E)?shFoxf2?and?control?NMuMG?cells?were?transfected?with?control?siRNA?(siCtrl)?and?two?different?siRNAs?specific?
for? murine? Noxa? (siNoxa1,? siNoxa3)? and? incubated? with? TGF?? for? the? indicated? times.? (B)? Noxa? mRNA? levels? were?
determined? by? quantitative? RT?PCR? and? values?were? normalized? to? endogenous? RPL19.? (C)?Noxa? depletion? significantly?
decreases?TGF??induced?apoptosis.?Apoptosis?was?detected?by?Annexin?V?staining?and?FACS?analysis.?Results?presented?as?
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mean?±?SEM?of?three? independent?experiments.?Statistical?values?were?calculated?by?using?an?unpaired?two?tailed?t?test.???
P?values? ?? 0.05? indicated?with? (*),? p?values? ?? 0.01? indicated?with? (**),? p?values? ?? 0.001? indicated?with? (***).? (D)? The?
impairment?of?Noxa?leads?to?accelerated?cell?growth.?Cell?numbers?were?determined?using?a?Neubauer?chamber.?(E)?Phase?
contrast?micrographs?of?shFoxf2?and?control?NMuMG?cells? transfected?with?siCtrl?or?siNoxa1/3.? (F)?Foxf2? regulates?Noxa?
expression?by?direct? transcriptional?activation.?Chromatin? immunoprecipitaiton?of?HA?tag?was?performed?either?on?Foxf2?
expressing?or?control?NMuMG?cells?treated?for?2?days?with?TGF?.?Immunoprecipitated?DNA?fragments?were?quantified?by?
quantitative? PCR? using? primers? covering? basepairs? ?696? to? ?499? of? the? noxa? promoter? region? and? primers? covering? an?
intergenic?region?were?used?as?negative?control.??
?
4.1.7 Foxf2?is?involved?in?TGF??induced?growth?inhibition?via?EGFR?inhibition?
Besides?directly?activating?the?transcription?of?the?noxa?gene?and?inducing?apoptosis?
we?here?demonstrate?that?Foxf2?also?regulates?EGFR?signaling?by?transcriptional?regulation?
of?its?ligands.?EGFR?family?members?are?well?known?to?protect?from?TGF??induced?cell?cycle?
arrest?and?apoptosis?by?activating?the?PI3K?pathway?(192,?279).?We?were?able?to?show?that?
the?survival?signaling?of?activated?EGFR? is? impaired?by?TGF?? in?NMuMG?cells?and? that? this?
effect?is?dependent?on?the?upregulation?of?Foxf2.?Immunoblotting?analyses?revealed?that?the?
levels? of? activated? (phosphorylated? on? Tyrosine? 1173)? forms? of? EGFR?were? higher? in? the?
stable?shFoxf2?cells?compared?to?the?control?NMuMG?cells?when?treated?with?TGF??(Figure?
16A).? To? investigate? how? Foxf2? influences? EGFR? activation,? we? assessed? whether? the?
expression? of?members? of? the? EGF? family? was? regulated.? Gene? expression? analysis? and?
confirmation? by? quantitative? RT?PCR? revealed? that? the? EGFR?ligands? Betacellulin? and?
Amphiregulin? but? not? Epiregulin? show? sustained? expression? upon? knockdown? of? Foxf2?
(Figure?16B?D).?By?use?of?promoter?binding?prediction?programs?a?direct?binding?of?Foxf2?to?
the?betacellulin?promoter?could?be?expected?(data?not?shown).?We?were?able?to?verify?the?
direct?binding?of?the?transcription?factor?Foxf2?not?only?to?the?betacellulin?promoter?region?
but?also?to?the?regulatory?region?in?exon?2?of?the?amphiregulin?gene?and?to?a?smaller?extent?
to? the? epiregulin? promoter? region? by? ChIP? experiments? on? HA?tagged? Foxf2? expressing?
NMuMG?cells?treated?for?two?days?with?TGF??(Figure?16E).?In?addition,?the?MAPK?and?PI3K?
pathways?were?described?to?be?interactively?engaged?upon?TGF??signaling?to?assure?survival?
and? proliferation? (280).? Hence? we? investigated? whether? these? pathways? are? involved? in?
TGF??resistant?growth?of?Foxf2?knockdown?cells.?As?shown,?Erk?phosphorylation? levels?are?
increased? in?the?control?NMuMG?cells?upon?TGF??treatment?whereas?they?remain?constant?
in?the?NMuMG?cells?expressing?shRNA?specific?for?Foxf2,?indicating?that?Foxf2?depleted?cells?
do? not? activate? the? survival? signaling? via? MAPK? activation? (Figure? 16F).? To? investigate?
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whether? PI3K? pathway? is? regulated? by? Foxf2? to? influence? TGF?? resistant? cell? growth?we?
assessed? the? phosphorylation? of? the? downstream? signaling? kinase? PKB.?We? observed? a?
sustained?phosphorylation?on?the?activation?site?serine?473? in?the?Foxf2?depleted?NMuMG?
cells?(Figure?16G)?compared?to?the?control?shRNA?expressing?cells.?
?
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Figure? 16:? Foxf2? represses? EGFR? signaling? via? regulation? of? its? ligands? Betacellulin? and? Amphiregulin.? (A)?
Depletion?of?Foxf2?leads?to?sustained?EGFR?activation.?Representative?immunoblotting?analyses?for?the?phosphorylation?of?
EGFR? and? total? EGFR? protein? levels? in? shFoxf2? knockdown? and? control?NMuMG? cells? treated?with? TGF?? for? the? times?
indicated.?Actin?was?used?as?a?loading?control.?(B/C/D)?Betacellulin,?Epiregulin?and?Amphiregulin?mRNA?levels?respectively?
were?determined?by?quantitative?RT?PCR? in?shFoxf2?and?control?NMuMG?cells?treated?with?TGF??for?the? indicated?times.?
Data?are?shown?as?mean?±SEM?of?three?independent?experiments.?Statistical?values?were?calculated?by?using?a?paired?two?
tailed? t?test.?P?values???0.05? indicated?with? (*),?p?values???0.01? indicated?with? (**).? (E)?Foxf2? regulates? the?expression?of?
EGFR?ligands?by?direct?transcriptional?repression.?Chromatin?immunoprecipitaiton?of?HA?tag?was?performed?either?on?Foxf2?
expressing?or?control?NMuMG?cells?treated?for?2?days?with?TGF?.?Immunoprecipitated?DNA?fragments?were?quantified?by?
quantitative?PCR?using?primers?covering?basepairs??450?to??253?of?the?betacellulin?promoter?region,?basepairs??851?to??654?
of? the?epiregulin?promoter,?and?basepairs?+1086? to?1210?of? the?amphiregulin?exon?2?and?primers?covering?an? intergenic?
region?were? used? as? negative? control.? (F)? Foxf2? knockdown? suppresses? Erk? activation.? Representative? immunoblotting?
analysis?for?the?phosphorylation?of?Erk?and?total?Erk?protein?levels?in?shFoxf2?and?control?NMuMG?cells?treated?with?TGF??
for?the?times?indicated.?Band?intensities?were?quantified?using?the?Odyssey?Imager?(Li?Cor?Biotechnology).?(G)?Depletion?of?
Foxf2? leads? to? sustained?PKB? activation.? Immunoblotting? analysis? for? the?phosphorylation?of?PKB? and? total?PKB?protein?
levels?in?shFoxf2?and?control?NMuMG?cells?treated?with?TGF??for?the?times?indicated.?Signal?intensity?was?quantified?using?
ImageJ?software?(Broken?Symmetry?Software).?
?
4.1.8 Inhibition?of?EGFR?induces?apoptosis?in?Foxf2?depleted?NMuMG?cells?
As?we?were?able? to? show? that?Foxf2?negatively? regulates?EGFR?driven?proliferation?
and? survival?during?TGF??mediated?EMT,?we?next? investigated?whether? inhibition?of?EGFR?
signaling? impairs?the?anti?apoptotic?effect?of?Foxf2?depletion.?For?this?objective?we?treated?
shFoxf2? and? control?NMuMG? cells?with? the? EGFR? inhibitor?AG? 1478,?which? inhibits? EGFR?
activation? (Figure?17D),?and?assessed?cell?growth?and?apoptosis.?Combined?treatment?with?
EGFR? inhibitor? (EGFRi)? and? TGF?? for? four? days? lead? to? a? significantly? reduced? growth? of?
shFoxf2?expressing?NMuMG?cells?compared? to? the? solvent? (DMSO)? treated?control? (Figure?
17B).?In?addition?we?could?show?that?treating?shFoxf2?expressing?NMuMG?cells?with?AG?1478?
increases? the? apoptosis? to? a? similar? extent? as? in? the? control? cells? (Figure? 17C),? which?
correlates?with? the? levels?of?EGFR? inhibition? (Figure?17D).?This? result? indicated? that?TGF??
resistant? growth? of? Foxf2? knockdown? cells? relied? also? on? the? activation? of? EGFR? survival?
signaling.
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Figure?17:?Inhibition?of?EGFR?increases?apoptosis?in?Foxf2?depleted?cells.?(A?D)?NMuMG?cells?expressing?shRNA?
specific? for? Foxf2? or? control? shRNA?were? treated?with? TGF?? and? AG? 1478? (EGFRi)? or? control? solvent? (DMSO)? for? the?
indicated?times.?(A)?Phase?contrast?micrographs?of?NMuMG?cells?expressing?shRNA?specific?for?Foxf2?(shFoxf2)?or?control?
shRNA? (shCtrl)?treated?with?EGFR? inhibitor? (EGFRi)?or?solvent?control? (DMSO).? (B)?The? inhibition?of?EGFR?activity? leads?to?
accelerated?cell?growth.?Cell?numbers?were?determined?using?a?Neubauer?chamber.?Results?presented?as?mean?±SEM?of?
three? independent?experiments.?Statistical?values?were?calculated?by?using?an?unpaired? two?tailed? t?test.?P?values???0.05?
indicated?with?(*),?p?values???0.01?indicated?with?(**),?p?values???0.001?indicated?with?(***)?(C)?EGFR?inhibition?significantly?
increases? apoptosis? in? Foxf2? knockdown? cells.? Data? shown? represent? the?mean? ±SEM? of? 5? independent? experiments.?
Statistical?values?were?calculated?using?an?unpaired?two?tailed?t?test.?P?values???0.001?indicated?with?(***).?(D)?Treatment?
with? AG? 1478? decreases? EGFR? activation? in? shFoxf2? cells? to? a? similar? extend? as? seen? in? TGF?? treated? NMuMG? cells?
expressing?control?shRNA.?Immunoblotting?analysis?for?EGFR?phosphorylation?and?total?EGFR?levels.?Tubulin?was?used?as?a?
loading?control.??
4.1.9 Depletion?of?Betacellulin?reduces?cell?growth?in?Foxf2?knockdown?cells?
To? assess? whether? Betacellulin? was? responsible? for? the? stimulation? of? EGFR? and?
increased? cell? survival? of? the? Foxf2? depleted? cells,? we? transfected? NMuMG? cells? stably?
expressing? Foxf2? specific? or? control? shRNA? with? siRNAs? against? Betacellulin? and? treated?
additionally?with?TGF?.?The?extent?of?Betacellulin?ablation?was?determined?by?quantitative?
RT?PCR? (Figure?18B).?Reduction?of?Betacellulin?mRNA? levels? resulted? in?an?ablation?of? cell?
growth? in?shFoxf2?expressing?cells?when?treated?with?TGF??(Figure?18C)? indicating?that?the?
perpetuation?of?Betacellulin?expression? in?Foxf2?depleted?cells? is?at? least?partly?responsible?
for?the?TGF??resistant?cell?growth.?To?our?surprise,?the?attenuation?of?Betacellulin?resulted?in?
a? reduction?of? apoptosis? in?both,? the? shFoxf2? and? the? control? shRNA?expressing?NMuMG?
cells?(Figure?18D).?
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Figure? 18:? Depletion? of? the? EGFR? ligand? Betacellulin? reduces? cell? growth.? (A?D)? Betacellulin? expression?was?
downregulated?by?the?use?of?siRNA?in?NMuMG?cells?expressing?shRNA?specific?for?Foxf2?or?control?shRNA.?TGF??treatment?
was? started? 24h? after? siRNA? transfection? for? the? time? indicated.? (A)? Phase? contrast?micrographs? of? shFoxf2? of? shCtrl?
NMuMG? cells? transfected? with? siRNA? specific? for? Betacellulin? (siBtc)? or? control? siRNA? (siCtrl).? (B)? Betacellulin? mRNA?
expression? levels? were? determined? by? quantitative? RT?PCR? and? values? were? normalized? to? endogenous? RPL19.? (C)?
Betacellulin? depletion? leads? only? to? a?minor? reduction? in? cell? growth? in? Foxf2? knockdown? cells? treated?with? TGF?.? Cell?
numbers?were?determined?using?a?Neubauer?chamber.?Statistical?values?were?calculated?by?using?an?unpaired?two?tailed?t?
test.?P?values???0.01? indicated?with?(**),?(D)?Transfection?of?NMuMG?cells?with?siRNA?specific?for?Betacellulin?reduces?the?
levels?of?apoptosis.?Apoptosis?was?detected?by?Annexin?V?staining?and?FACS?analysis.?Results?are?presented?as?mean?±SD?of?
two?independent?experiments?(4?days?TGF?)?or?of?a?single?experiment?(7?days?TGF?).?Statistical?values?were?calculated?by?
using?an?unpaired?two?tailed?t?test.?P?values???0.05?indicated?with?(*).?
?
4.1.10 Combined?ablation?of?Betacellulin,?Epiregulin?and?Amphiregulin?expression?inhibits?
EGFR?mediated?survival?signaling?
To? evaluate? whether? a? concomitant? downregulation? of? the? three? EGFR? ligands?
Betacellulin?(Btc),?Epiregulin?(Ereg)?and?Amphiregulin?(Areg)?abrogates?the?protective?effect?
of? the? Foxf2? depletion,?we? transfected? stable? shFoxf2? and? shControl? NMuMG? cells?with?
siRNAs?specific?for?Betacellulin,?Epiregulin?and?Amphiregulin?and? induced?growth? inhibition?
and?apoptosis?by?treating?with?TGF?.?The?extent?of?expression?repression?was?determined?by?
quantitative?RT?PCR?(Figure?19B).?Reduction?of?expression?of?the?three?EGFR?ligands?caused?
an?ablation?of?cell?growth?in?Foxf2?depleted?NMuMG?cells?treated?with?TGF?,?mimicking?the?
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growth?arrest?observed? in?control?NMuMG?cells?(Figure?19C).?Furthermore?we?detected?an?
increase? in?apoptosis?upon? ligand?depletion.?This?result? indicated?that?attenuation?of?EGFR?
activation? by? repression? of? ligand? expression? abrogated? the? survival? benefit? of? Foxf2?
downregulation? (Figure? 19D).? In? summary,? upon? TGF?? treatment? Foxf2? mediated? an?
impairment? of? EGFR? activation? by? transcriptional? repression? of? its? ligands? Betacellulin,?
Epiregulin?and?Amphiregulin,?leading?to?an?ablation?of?survival?signaling.?
?
?
Figure?19:?Concomitant?knock?down?of?Betacellulin,?Epiregulin?and?Apmphiregulin?decreased?cell?growth?and?
enhanced?TGF??mediated?apoptosis.?(A?D)?Combined?depletion?of?Betacellulin?Epiregulin?and?Amphiregulin?was?achieved?
by? the?use?of? siRNA? in?NMuMG? cells?expressing?Foxf2? specific?or? control? shRNA.?TGF?? treatment?was? started?24h?after?
siRNA?transfection?for?the?time? indicated.?(A)?Phase?contrast?micrographs?of?shFoxf2?and?shCtrl?NMuMG?cells?transfected?
either?with?control?siRNA?(siCtrl)?or?a?combination?of?Betacellulin,?Epiregulin?and?Amphiregulin?siRNA?(siB/E/A).?(B)?mRNA?
expression?levels?of?the?three?EGFR?ligands?Betacellulin?(Btc),?Epiregulin?(Ereg)?and?Amphiregulin?(Areg)?were?determined?by?
quantitative?RT?PCR,?normalized?to?endogenous?RPL19.?(C)?Contiguous?depletion?of?Btc,?Ereg?and?Areg?leads?to?reduced?cell?
growth?in?stable?Foxf2?knockdown?cells.?Cell?numbers?were?determined?using?a?Neubauer?chamber.?Statistical?values?were?
calculated?in?relation?to?shFoxf2?siCtrl,?by?using?an?unpaired?two?tailed?t?test.?P?values???0.05?indicated?with?(*),?p?values???
0.01? indicated?with? (**)? (D)?Downregulation?of? the? three?EGFR? ligands? leads? to?an? increase? in?TGF?? induced?apoptosis.?
Apoptosis?was?detected?by?Annexin?V?staining?and?FACS?analysis.?
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4.1.11 High? expression? levels? of? Foxf2? correlates? with? poor? prognosis? for? ER?negative?
tumors?
Cancer?associated?gene?expression?profiling?has?emerged? to?be?an?appropriate? tool?
to? predict? the? relapse? risk? and? to? identify? genes? that? mediate? disease? progression.? To?
investigate?whether?Foxf2? is?predictive? for? tumor?progression?or?metastasis? formation,?we?
analyzed? the? Netherlands? Cancer? Institute? (NKI295)? breast? cancer? database? for? Foxf2?
expression? (269).?The?NKI295?database? consists?of?Microarray?gene?expression?analysis?of?
tumor?samples?from?295?patients?with?early?stage?breast?cancer?(stage?I?or?stage?II?primary?
breast?carcinomas,?determined?by?H&E?staining).?The?expression? levels?of? the? investigated?
genes?are?listed?as?fold?change?induction?normalized?to?the?expression?of?the?pooled?tumors.?
Although? Foxf2? expression?was? not? predictive? for?metastasis? formation? or? survival? in? the?
total?patient?pool,?high?expression?of?Foxf2? in?tumors?with?negative?estrogen?receptor?(ER)?
status?correlated?with?high?significance?with?early?metastasis?onset?as?well?as?poor?overall?
survival?(Figure?20B,C).?This?outcome? indicates?that?high?expression?of?Foxf2? in?ER?negative?
mammary? carcinomas? correlates?with? poor? prognosis? for? tumor? progression? and? patient?
survival.?
?
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Figure?20:?High?Foxf2?expression?correlates?with?faster?metastases?formation?and?worse?overall?survival?in?ER?
negative? tumors.? Statistical? analysis? of? the?Netherlands? Cancer? Institute? (NKI295)? database?was? performed? by?Nathalie?
Meyer?Schaller.? (A)?Tumors?were?divided? into?high?and? low?Foxf2?expressing?groups?based?on? the? relative?expression?of?
Foxf2?to?the?tumor?pools?(logFC?=??0).?(B/C)?Expression?of?Foxf2?was?correlated?with?time?to?metastasis?(B)?or?overall?survival?
(C)?either?in?all?tumors?analyzed?(N=288)?or?specifically?in?ER?negative?tumors?(N=68)?and?ER?positive?tumors?(N=220).?Foxf2?
expression? does? not? correlate? with? tumor? metastasis? of? the? total? tumor? pool? but? Foxf2? expression? is? predictive? for?
metastasis?incidence?in?ER?negative?tumors?were?high?expression?of?Foxf2?correlates?with?an?early?onset?of?metastases?(p?
value?=?6.53e?03).?Consistently?high?Foxf2?expression?levels?correlate?with?shorter?overall?survival?in?ER?negative?tumors?(p?
value?=?0.0154).?
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4.1.12 Correlation?of?Foxf2?expression?with?metastasis?free?survival?depends?on?LN?status?
To?further?substantiate?a?potential?correlation?between?Foxf2?expression?and?patient?
survival,? we? analyzed? a? breast? cancer? database? of? the?Memorial? Sloan?Kettering? Cancer?
Center?(MSKCC),?published?by?Minn?et?al.?(57).?This?"Minn"?database?consists?of?microarray?
gene? expression? analysis? of? tumor? samples? from? 82? patients?with?more? advanced? breast?
cancer? (T2?T4).?The? tumors?were?divided? into? two?groups?according? to? the? log?expression?
levels?relative?to?the?median?expression?of?the?investigated?genes?(Figure?21A).?The?low?and?
high?expressing?groups?were?further?stratified?for?lymph?node?(LN)?status.?Interestingly,?low?
Foxf2? expression? significantly? correlated? with? early? distant? metastasis? formation? in? LN??
tumors,?whereas?the?opposite?tendency?was?found?in?tumors?of?patients,?that?were?positive?
for? lymph?node?metastases?(Figure?21B).?This?tendency? is?even?more?obvious,?although?not?
significant?(probably?due?to? low?sample?number),?when?the?correlation?of?Foxf2?expression?
to?bone?marrow?metastases?formation?was?analyzed?(Figure?21C).?This?outcome?reflects?the?
dual? function?of?Foxf2,? seen? in? the? in?vitro? studies,? ??while?Foxf2?might? function?as? tumor?
suppressor? in? early? cancer? development? by? promoting? apoptosis? ,? hence? showing? a? bad?
prognosis?in?LN??patients?with?low?Foxf2?expression???more?advanced?tumors?with?high?Foxf2?
expression?correlates?with?shorter?metastasis? free?survival,? further?substantiating?a? role?of?
Foxf2?in?cancer?cell?invasion?and?metastases?formation.??
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Figure?21:?Low?Foxf2?expression?correlates?with? faster?metastases? formation? in?LN?negative?tumors,?whereas?
high? Foxf2? expression? correlates? in? tendency? with? bad? prognosis? in? LN?positive? tumors.? Statistical? analysis? of? the?
Memorial? Sloan?Kettering? Cancer? Center? (Minn)? database?was? performed? by?Nathalie?Meyer?Schaller.? (A)? Tumors?were?
divided? into?high?and? low?Foxf2?expressing?groups?based?on? the?median?expresson?of?Foxf2.? (B)?Expression?of?Foxf2?was?
correlated?with? distant?metastasis? free? survival? (mfs)? in? LN?? tumors? (N=28)? or? LN+? tumors? (N=54).? Foxf2? expression? is?
predictive? for?metastasis? incidence? in? LN?negative? tumors,?where? low?Foxf2?expression? correlates?with?early?metastases?
onset? (p?value?=?0.0351).? (C)?Correlation?of?Foxf2?expression?with?bone?marrow? (BM)?metastasis? free? survival? (mfs)?was?
investigated? stratified?by?LN? status.?High?Foxf2?expression?correlates? in? tendency?with?BM?metastasis,?where?high?Foxf2?
levels?are?indicative?for?earlier?metastasis?(p?value?=?0.114).??
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4.2 Discussion?
Overcoming?the?growth?inhibitory?effect?of?TGF??during?tumor?onset?and?early?stages?
of? tumor? development? as? well? as? the? ability? of? advanced? tumors? to? convert? TGF??
responsiveness? in? cancer? cells? to?gain? invasive?properties?are? important? incidences?during?
tumor? growth? and? metastasis? formation? (65,? 84).? Thus,? understanding? the? mechanisms?
behind? this? dual? role? of? TGF?? in? cancer? progression? and? the? strategies? of? cancer? cells? to?
circumvent? TGF??induced? apoptosis? offers? potential? for? new? cancer? therapies.? In? vitro?
studies?of?the?molecular?mechanisms?of?the?EMT?process?in?non?transformed?NMuMG?cells?
facilitate? the? dissection? of? the? individual? processes? during? EMT,? including? resistance? to?
apoptosis?and?acquisition?of?invasive?properties.??
In?the?present?study,?we?generated?an?EMT?gene?signature?by?use?of?different?in?vitro?
EMT?model? systems? to? identify? the? transcription? factor?Foxf2?as?a? commonly?upregulated?
gene? in? cells?undergoing? EMT.?By? studying? TGF??treated?NMuMG? cells? as? a? flexible? EMT?
model?system?and?human?breast?cancer?gene?expression?profiling?databases,?we?depicted?a?
dual?function?of?Foxf2,?acting?as?a?tumor?suppressor?by?promoting?apoptosis?as?well?as?a?pro?
migratory?function?by?inducing?the?disruption?of?cell?cell?adhesion.??
Foxf2? is?upregulated?via?the?canonical?TGF??pathway?and?gain?of?function?studies? in?
NMuMG?cells?revealed?that?its?expression?is?not?sufficient?to?induce?EMT.?Interestingly,?loss?
of?function?studies?showed?that?Foxf2?is?not?required?for?the?gain?of?mesenchymal?markers?
but? its?upregulation? is?essential? for? the?disruption?of?cell? junctions?and?downregulation?of?
epithelial?markers.?Furthermore,?we?found?that?Foxf2?function? is?crucial?for?TGF??mediated?
cell? death? via? upregulation? of? BH3?only?mediated? caspase?dependent? apoptosis? and?
attenuation?of?EGFR?mediated?survival?signaling.??
The?failure?of?Foxf2?depleted?cells?to?disrupt?cell?cell?contacts?by?downregulation?of?
tight??and?adherens?junction?components?displays?its?indispensable?role?in?the?acquisition?of?
an?invasive?single?cell?morphology.?Loss?of?E?cadherin?is?an?early?event?during?EMT?resulting?
in?the?disruption?of?the?polarity?complex,?a?prerequisite?for?the?dissociation?and?invasion?of?
cancer?cells? (98,?121).?Direct?and? indirect? transcriptional? repression?via?mediators,?such?as?
ZEB1,? ZEB2? and? Id2,? have? emerged? as? common? regulatory? mechanisms? of? E?cadherin?
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expression? in?various?cancer?types?(108,?113).?By?mediating?the?TGF??induced?upregulation?
of?the?transcriptional?repressors?ZEB1?and?ZEB2?as?well?as?the?repression?of?Id2,?Foxf2?causes?
the?transcriptional?downregulation?of?E?cadherin?and?consequently?the?disruption?of?cell?cell?
adhesion.? The?mechanism? by?which? Foxf2? regulates? the? expression? of? these? transcription?
factors?remains?elusive.?Interestingly,?recent?findings?identified?the?miR?200?family?as?potent?
EMT?inducing?non?coding?RNAs?targeting?ZEB1?and?ZEB2?transcripts? (93,?94).?The?potential?
role?of?further?non?coding?RNAs?during?EMT?is?under?current?investigation?in?our?laboratory.?
The?failure?of?TGF??to?induce?adherens?junction?breakdown?in?Foxf2?depleted?cells?results?in?
the? preservation? of? tight? cell?cell? contacts? and,? consequently,? in? a? clear? reduction? in? cell?
motility,?suggesting?a?role?for?Foxf2?as?a?pro?metastatic?factor.??
Furthermore,? our? results? show? that? Foxf2? upregulation? is? essential? for? TGF??
mediated? apoptosis.?The? reduction?of?TGF??induced? apoptosis? in? Foxf2?deficient? cells? is?a?
consequence?of?the?loss?of?the?direct?transcriptional?activation?of?Noxa?expression.?The?pro?
apoptotic?protein? is?highly?upregulated?by?TGF?,?activating?classical?mitochondrial?caspase?
dependent?cell?death,?and?we?have?been?able?to?show?that?its?upregulation?is?indispensable?
for?apoptosis?induction?in?NMuMG?cells.?The?BH?3?only?protein?Noxa?has?been?shown?to?be?
crucial? in?fine?tuning?cell?death?decisions?via?degradation?of?the?pro?survival?molecule?Mcl1?
(281).?Although?Noxa?has?been?identified?as?a?primary?p53?response?gene,?oncogenic?stress,?
such?as?irradiation?and?hypoxia,?resulted?in?efficient?induction?of?Noxa?also?in?the?absence?of?
p53? (282,?283).?Thus,?our? findings? identify?Foxf2?as?a?novel? transcriptional?activator?of? the?
tumor?suppressor?Noxa.??
Besides? triggering? apoptosis? via? the? regulation? of? Noxa? expression,? Foxf2? is? also?
involved? in? the?negative? regulation?of? survival? signals?by?downregulation?of? EGFR?protein?
levels?as?well?as?transcriptional?repression?of? its? ligands?Betacellulin?and?Amphiregulin.?This?
leads?to?a?reduction?of?EGFR?phosphorylation?and?hence,?reduced?PKB?activation.?Blocking?of?
EGFR?signaling?has?been?shown?to?amplify?the?apoptotic?response?to?TGF??(192).?Here,?we?
show?that?both,?receptor?inhibition?by?use?of?a?chemical?inhibitor?as?well?as?repression?of?the?
three? EGFR? ligands? Betacellulin,? Epiregulin? and? Amphiregulin? increased? TGF??induced?
apoptosis? in?Foxf2?depleted?NMuMG?cells.?These? results? indicate? that,? in?addition? to?Noxa?
regulation,?Foxf2?mediates?its?apoptotic?effect?by?blocking?EGFR?mediated?survival?signaling.?
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Whether? the?TGF??mediated?and?Foxf2?dependent?reduction? in?survival?signaling? is?due? to?
reduced? ligand? expression? and/or? depends? on? increased? EGFR? internalization? and?
degradation?needs?further?investigation.?
To? support? the? importance? of? a? Foxf2? function? during? tumor? development? and?
progression,? we? have? performed? correlation? studies? for? Foxf2? on? two? breast? cancer?
databases? (57,? 269).? Analysis? of? the? lymph? node? negative? stratified? tumor? subset?
demonstrated? that? low? Foxf2? expression? significantly? correlates? with? early? metastasis?
formation.? Interestingly,? the? opposite? tendency? is? found? in? more? malignant? tumors?
displaying? lymph? node? metastases,? where? high? Foxf2? expression? correlates? with? worse?
prognosis.? Moreover,? studies? on? tumors,? stratified? for? the? ER? status? reveal? a? highly?
significant? correlation?of?high? Foxf2?expression? and?early?metastasis?onset,? coherent?with?
worse?overall?survival.?The?ER??tumors?represent?a?more?aggressive?breast?cancer?subtype,?
thus?identifying?high?levels?of?Foxf2?as?a?marker?correlating?with?good?prognosis?in?early?non?
invasive? stages? of? tumor? development,? but? with? poor? prognosis? in? a? highly? malignant?
background? (22).? These? findings? substantiate? the?dual? role?of? Foxf2? and? its? implication? in?
metastasis?formation.?
Stable? shRNA?mediated?downregulation?of? Foxf2? showed?an?attenuation?but?not?a?
complete?abrogation?of?the?observed?TGF??mediated?phenotypes.?As?in?all?presented?results?
the? function? of? Foxf2?was? clearly?dose? dependent,? a? knockout? of? the? transcription? factor?
would?probably?be?more?conclusive?about?its?role?in?EMT?and?cancer?progression.?However?
under?pathological?conditions,?complete?depletion?of?a?gene?is?not?always?physiological?and?
therefore? less? realistic? to? investigate.? In? this? study?we? show? that? Foxf2? is? a? transcription?
factor?with?a?dual?function:?on?one?hand?it?can?act,?most?likely?with?the?help?of?its?cofactors,?
as?a?tumor?suppressor?by?inducing?apoptosis.?On?the?other?hand,?as?a?pro?metastatic?factor?
by? conferring?migratory? capabilities? to? the? cells?which?have?overcome? the?apoptotic? crisis?
and?undergone?EMT.?Foxf2's? role? in?pre??and?post?EMT?cells? reflects? the?well?studied?dual?
role?of?TGF??in?cancer?progression.?Our?results?also?substantiate?findings?in?knockout?mouse?
models?where?Foxf2?was?found?to?play?an?important?role?in?EMT?associated?developmental?
processes?and?maintenance?of?the?epithelial?mesenchymal?structure?in?lung?and?gut?tissues?
(257,?258).?Hence,? fine?tuning?of?the?expression?of?Foxf2?and? its?cofactors?could?be?pivotal?
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during?cancer?development?and,?thus,?better?insights?in?its?regulation?and?molecular?function?
is?potentially?beneficial?for?future?therapeutical?strategies.??
?
Figure?22:?Schematic?model?of?TGF??mediated?Foxf2?upregulation?reflecting?its?dual?role?during?EMT.?Receptor?
activation? by? TGF?? leads? to? phosphorylation? of? receptor?bound? Smads?with? subsequent? Smad? complex? formation.? The?
trimeric?complex?enters? the?nucleus? to?activate? the?expression?of?TGF?? target?genes,? such?as? the? forkhead? transcription?
factor? Foxf2.? Subsequently,? Foxf2? directly? represses? the? transcription? of? the? EGFR? ligands? Betacellulin? (Btc)? and?
Amphiregulin? (Areg),?which? leads? to? reduced? EGFR?mediated? survival? signaling.? Furthermore,? Foxf2? directly? binds? and?
transcriptionally?activates?the?pro?apoptotic?gene?NOXA,?resulting?in?the?induction?of?Caspase?dependent?apoptosis.?On?the?
other?hand,?Foxf2?leads?to?the?downregulation?of?E?cadherin?(Ecad)?by?upregulating?the?transcriptional?repressors?ZEB1?and?
ZEB2?and?downregulating?the?Ecad?activator?Id2,?leading?to?the?disruption?of?adherens?junctions?and?subsequent?increase?of?
migratory?capabilities.??
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5 N?cadherin???a?marker?without?function??
5.1 Results?
5.1.1 Ablation?of?N?cadherin?expression?does?not?prevent?TGF??induced?EMT?in?NMuMG?
cells?
A? hallmark? of? EMT? is? the? change? of? expression? from? epithelial? E?cadherin? to? the?
expression?of?mesenchymal?N?cadherin,?which? is?accompanied?with?alterations? in?adhesive?
properties,? as? cells? lose? their? affinity? for?epithelial?neighbors? and? gain? affinity? for? stromal?
cells? (35).? The? cadherin? switch? induces? cell?migration? and? invasion? and? is? suspected? to?
support? the? transition? from? benign? to? invasive? malignant? tumors? (118?120).? Loss? of? E?
cadherin?function?has?been?shown?to?be?required?and?sufficient?to?induce?EMT?and?increase?
motility?and?invasiveness?in?several?cell?systems?(262,?284,?285).?As?the?loss?of?E?cadherin?is?
an? inducer? of? EMT? and? the? cadherin? switch? a?widely? observed? phenomenon? during? this?
transition,?we?wanted? to? assess?whether? the? expression? of? N?cadherin? is? of? comparable?
importance? in?this?process.?To? investigate,?whether?N?cadherin? (Ncad)?depletion? leads?to?a?
loss? of?mesenchymal? phenotype? or? even? the? induction? of?MET,?mesenchymal? cells?were?
transiently? transfected? with? siRNA? specific? for? N?cadherin.? Ablation? of? N?cadherin? in?
mesenchymal? murine? MT?Ecad? cells? did? not? lead? to? alterations? in? the? spindle?like?
fibroblastoid? phenotype,? even? though? a? substantial? knock? down? efficiency?was? achieved?
(Figure?23A/B).?Due?to?the?stable?and?complete?ablation?of?E?cadherin?by?Cre?recombinase,?
these? cells? can?be? regarded? as? an?endpoint? EMT? system? lacking? the? flexibility? to?undergo?
MET.?To?use?a?more?transient?model,?we?depleted?N?cadherin?in?mesenchymal?NMuMG?cells?
intitially? treated? for?more? than? 30?days?with? TGF?? (cells? known? as?NMuMG? LT)? to? assess?
potential?phenotypical?changes.?However,?N?cadherin?downregulation?did?neither? result? in?
alterations?of?the?cell?shape?nor? in?an? increase?of?E?cadherin?expression,?which?would?both?
indicate?an?induction?of?MET?(Figure?23C/D).??
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Figure?23:?N?cadherin?ablation?does?not?induce?MET.?(A/B)?N?cadherin?expression?was?depleted?in?mesenchymal?
MT?Ecad?by?use?of?siRNA.?(A)?Knockdown?efficiency?at?indicated?timepoints?after?transfection?with?either?control?(siCtrl)?or?
N?cadherin?specific? (siNcad)?siRNA?was?analyzed?by? immunoblotting.?Tubulin?was?used?as?a? loading?control.? (B)?MT?Ecad?
cells?at? indicated?time?after?siRNA?transfection?were?analyzed?by?phase?contrast?microscopy.?(C/D)?N?cadherin?expression?
was?downregulated?in?mesenchymal?NMuMG?LT?cells?by?use?of?siRNA.?(C)?Knockdown?efficiency?as?well?as?the?expression?of?
the?epithelial?marker?E?cadherin?at?indicated?timepoints?after?transfection?was?determined?by?immunoblotting.?Tubulin?was?
used?as?a?loading?control.?(D)?Phase?contrast?images?of?NMuMG?LT?cells?at?indicated?time?after?siRNA?transfection.?
?
To?assess?whether?the?ablation?of?N?cadherin?expression?is?sufficient?to?prevent?EMT,?
NMuMG? cells?were? transfected?with? siRNA? specific? for? N?cadherin.? NMuMG?siNcad? cells?
treated?with?TGF??show?a?clear?change?in?morphology?by?gaining?an?elongated?fibroblastoid?
phenotype? as? seen? in? the? control? siRNA? (siCtrl)? (Figure? 24A).? To? investigate?whether? the?
depletion? of? N?cadherin? had? an? effect? on? the? loss? of? epithelial?markers? and? the? gain? of?
mesenchymal? markers,? we? analyzed? the? expression? of? adherens? junction? proteins? E?
cadherin,?p120?catenin?and???catenin?and?the?mesenchymal?marker?NCAM.?Immunoblotting?
analysis?as?well?as?quantitative?RT?PCR?revealed?that?suppression?of?N?cadherin?upregulation?
in?TGF??induced?EMT?had?neither?an?impact?on?the?downregulation?of?epithelial?markers?nor?
on?the?upregulation?of?mesenchymal?proteins?(Figure?24B/C).??
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Figure?24:?Ablation?of?N?cadherin? is?not?sufficient?to?prevent?TGF??induced?EMT.?(A)?Phase?contrast? images?of?
NMuMG?cells?transfected?with??control?siRNA?(siCtrl)?or?N?cadherin?specific?siRNA?(siNcad),?and?treated?with?TGF??for?the?
indicated?times.?(B)?Immunoblot?analysis?of?the?epithelial?markers?E?cadherin?(Ecad),?p120?catenin?(p120)?and???catenin?as?
well?as?the?mesenchymal?markers?N?cadherin?(Ncad)?and?NCAM?in?NMuMG?cells?transfected?with?siCtrl?or?siNcad,?treated?
with?TGF?? for?the?times? indicated.?Tubulin?was?used?as?a? loading?control.? (C)?Expression? levels?of?N?cadherin,?NCAM?and?
p120?catenin?were?determined?by?quantitative?RT?PCR.?Values?were?normalized?to?endogenous?murine?RPL19.?
?
5.1.2 Downregulation?of?N?cadherin?does?not?affect?the?cytoskeletal?composition?
To?investigate?whether?a?downregulation?of?N?cadherin?during?EMT?has?an?impact?on?
EMT?associated?alterations? in?cell?adhesion?and/or?cytoskeletal?composition,?we?performed?
an?immunofluorescence?staining?for?the?cell?adhesion?proteins?E?cadherin,?N?cadherin,?p120?
catenin?and???catenin,?and?the?actin?cytoskeleton?(phalloidin).?In?NMuMG?cells?treated?with?
TGF??and?transfected?with?control?siRNA?(siCtrl),?a?normal?upregulation?of?the?mesenchymal?
marker?N?cadherin?was?observed,?which?was?repressed?efficiently?by? the? transfection?with?
siRNA? specific? for? N?cadherin? (siNcad)? (Figure? 25).? In? the? N?cadherin? depleted? cells,? we?
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observed? a? disorganized? localization? of? the? adherens? junction? protein? ??catenin,?which? is?
normally? functioning? as? a? linker? protein? between? cadherin? proteins? and? the? actin?
cytoskeleton.? The? disorganization? is? probably? due? to? the? lack? of? binding? partners? as? N?
cadherin?is?depleted?and?E?cadherin?is?internalized?and?transcriptionally?repressed?during?the?
EMT?process.?
?
Figure? 25:? Downregulation? of? N?cadherin? results? in? reduced? ??catenin? localization? at? the? cell? membrane.?
Maximum? intensity?projection?of?confocal?stacks?of?NMuMG?cells?transfected?with?control?siRNA?(siCtrl)?or?siRNA?specific?
for?N?cadherin?(siNcad)?treated?with?TGF??for?the?indicated?times,?stained?for?N?cadherin?(red)?and???catenin?(green).?The?
nuclei?are?visualized?by?staining?with?DAPI?(blue).?
?
Indeed,? we? were? able? to? show? that? the? downregulation? of? N?cadherin? does? not?
influence?the?loss?of?E?cadherin?during?TGF??induced?EMT?(Figure?26).?Concomitant?with?the?
downregulation? of? E?cadherin?we? observed? a? relocalization? of? p120?catenin? from? the? cell?
membrane?to?the?cytoplasm?in?NMuMG?cells?independent?of?the?expression?of?N?cadherin.??
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Figure?26:?Depletion?of?N?cadherin?does?not?affect?E?cadherin?downregulation?and?p120?catenin? localization?
during?EMT.?Maximum? intensity?projection?of? confocal? stacks?of?NMuMG?cells? transfected?with?control? siRNA? (siCtrl)?or?
siRNA? specific? for?N?cadherin? (siNcad)? treated?with?TGF?? for? the? indicated? times,? stained? for?E?cadherin? (red)?and?p120?
catenin?(green).?The?nuclei?are?visualized?by?staining?with?DAPI?(blue).?
?
Furthermore,?we? show? that? depletion? of?N?cadherin? does? not? influence? the? EMT?
associated? cytoskeletal? reorganization.? Compared? to? the? control? cells,? N?cadherin?
knockdown? cells? showed? a? similar? rearrangement? of? the? cortical? actin? to? stress? fibers?
resulting? in? a? spindle?like? elongated? cell? shape? upon? treatment?with? TGF?? (Figure? 27).? In?
summary,?the?data?show?that?the?upregulation?of?N?cadherin?during?EMT?is?not?essential?and?
that?the?depletion?of?N?cadherin?in?mesenchymal?cells?is?not?sufficient?to?induce?MET.?
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Figure?27:?N?cadherin?knockdown?does?not?affect? stress? fiber? fomation?during?TGF??induced?EMT.?Maximum?
intensity? projection? of? confocal? stacks? of?NMuMG? cells? transfected?with? control? siRNA? (siCtrl)? or? siRNA? specific? for?N?
cadherin?(siNcad)?treated?with?TGF??for?the?indicated?times,?stained?for?filamentous?actin?(red)?and???catenin?(green).?The?
nuclei?are?visualized?by?staining?with?DAPI?(blue).?
?
5.1.3 N?cadherin?depletion?in?mesenchymal?cells?has?no?impact?on?cell?motility?
The? switch? from?epithelial? to?mesenchymal?cadherin?expression? is?accompanied?by?
alterations?of?adhesive?properties?and? is? suspected? to? increase? the?migratory?capability?of?
tumor?cells?(118,?119).?We?have?shown?that?the?downregulation?of?E?cadherin?is?required?for?
an?EMT?associated? increase?of?motility? in?NMuMG? cells? (Figure?13).?Hence,?we?wanted? to?
investigate? the? importance?of?N?cadherin?upregulation? in?TGF??induced?cell?migration.?We?
performed?a?migration?assay?comparing?the?migratory?capability?of?N?cadherin?knockdown?
cells?to?the?mesenchymal?control?cells,?using?the? long?term?(LT)?NMuMG?and?the?MT?Ecad?
cells.?We?found?in?neither?cell?type?an?impact?of?N?cadherin?depletion?on?cell?motility.??
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Figure?28:?Depletion?of?N?cadherin?has?no?impact?on?cell?motility?of?mesenchymal?cells.?(A)?Migration?assay?with?
control? or? N?cadherin?depleted?mesenchymal? long? term? (LT)? TGF??treated? NMuMG? cells? through? transwell? filters.? (B)?
Migration?assay?with?control?or?N?cadherin?depleted?MT?Ecad?cells?through?transwell?filters.??
?
5.1.4 N?cadherin?depletion?does?not?affect?neurite?formation?in??T2?pancreatic?cells?
It? has? been? previously? shown? that? the? expression? of? the? immunoglobulin? family?
member?NCAM?is?upregulated?concomitantly?with?the?loss?of?E?cadherin?function?in?various?
cellular? systems,? and? that? ablation? of?NCAM? expression? inhibits? EMT? (262).? Furthermore,?
NCAM? has? been? shown? to? be? essential? for? the? formation? of? cellular? protrusions? (neurite?
outgrowth)?and? the? induction?of?matrix?adhesion?of? ??cells? from?pancreatic? tumors.?Both,?
neurite?formation?as?well?as?cell?matrix?adhesion?are?dependent?on?NCAM?induced?assembly?
of?a?signaling?complex?consisting?of?N?cadherin,? fibroblast?growth?factor? receptor?4? (FGFR?
4),?phospolipase?C??(PLC?),?the?adaptor?protein?FRS2,?pp60c?src,?cortactin?and?GAP?43?(133).?
Since?NCAM? is?potentially? implicated? in? the?prevention?of? the?dissemination?of?metastatic?
tumor?cells?and?its?function?is?essential?for?the?formation?of?cellular?protrusions,?we?wanted?
to?assess?whether?the?complex?component?N?cadherin?is?also?required?for?neurite?formation.?
Using?an?established?cell? line?derived?from?Rip1Tag2? induced?pancreatic???cell?tumors?(?T2?
cells),?we? investigated? the? effect? of? N?cadherin? depletion? on? the? ability? to? form? cellular?
protrusions.?Although?a?clear?attenuation?of?N?cadherin?protein? levels?was?achieved?by?the?
use?of? two?different?siRNAs,?we?did?not?observe?any?changes? in?cell?phenotype?or?neurite?
formation? capacity? (Figure? 29A/B).? Surprisingly,? immunofluorescence?microscopy? analyses?
not? only? showed? the? same? frequency? of? neurite? outgrowth? in? the? control? and? the? N?
cadherin?depleted? ?T2? cells? but? also? a? preferential? neurite? formation? in? the? control? cells?
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expressing? low? level? of? N?cadherin? (Figure? 29C).? These? results? suggest? that? N?cadherin?
expression?is?not?required?for?the?formation?of?cellular?protrusions?in??T2?cells.??
?
?
? ?
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Figure?29:?N?cadherin?knockdown?in??T2?cells?does?not?influence?neurite?formation?capacity.?(A)?Phase?contrast?
images?of????tumor?cells?(?T2)?transfected?with?control?siRNA?(siCtrl)?or?siRNA?specific?for?N?cadherin?(siNcad4,?siNcad6).?(B)?
Knock?down?efficiency?was?determined?by? immunoblotting?analysis,?showing?comparable?efficiencies?for?both?N?cadherin?
specific?siRNAs.?(C)? Immunofluorescence?microscopy?analysis?of?filamentous?actin?(red)?and?N?cadherin?(green)?of?control?
tumor? ??cells? (?T2)? or? ?T2? cells?with? downregulated?N?cadherin? (siNcad4,? siNcad6)? at? 48? hours? and? at? 72? hours? after?
transfection.?The?nuclei?are?visualized?by?staining?with?DAPI?(blue).?
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5.2 Discussion?
The?attenuation?of? the?expression?and/or?protein? function?of? the?cell?cell?adhesion?
molecule?E?cadherin? is?a?hallmark?of?EMT?and? is?found? in?the?majority?of?epithelial?cancers?
(132).?In?many?cancer?types,?the?loss?of?E?cadherin?is?accompanied?by?a?gain?of?expression?of?
the?mesenchymal? cadherin?N?cadherin.?The? cadherin? switch? is? thought? to?be? required? for?
tumor?cells?to?acquire?invasive?properties?and?N?cadherin?is?upregulated?in?aggressive?breast?
tumors,?but?its?function?in?tumor?progression?remains?unknown?(119,?132).?Recently,?Maeda?
and?coworkers?showed?that?the?manipulation?of?N?cadherin?expression?in?NMuMG?cells?did?
not?interfere?with?TGF??induced?morphological?changes?(261).?They?were?able?to?show?that?
ablation?of?N?cadherin?does?not?prevent?the?formation?of?stress?fibers?and?focal?adhesions?in?
short?term?(1?day)?TGF??treated?NMuMG?cells,?indicating?that?N?cadherin?is?not?required?for?
the? initiation? of? EMT.? However,? it? was? reported? that? N?cadherin? depletion? significantly?
reduced?the?migratory?capability?of?epithelial?NMuMG?cells.?There?are?several?publications?
showing,? that? N?cadherin? expression? promotes? motility? and? migration? in? different? cell?
systems?(118,?125,?286).?Inconsistent?with?these?findings?we?did?not?observe?any?significant?
alteration?of?the?migratory?ability?of?mesenchymal?MT?Ecad?and?NMuMG?LT?cells?upon?N?
cadherin?depletion.?
Given? that? the? upregulation? of?N?cadherin? during? EMT? is? not? an? immediate? early?
event?but?is?increasing?concomitantly?with?the?downregulation?of?E?cadherin,?depletion?of?N?
cadherin?during?ongoing?EMT?or? in?mesenchymal?cells,?was?performed?to?study? its?function?
and? implication? during? this? process.? Although? N?cadherin? expression? is? increased? in?
mesenchymal?cells,?we?show?that?it?is?not?required?to?maintain?the?mesenchymal?state?and?
that? its? attenuation? does? not? induce? the? reverse? mesenchymal? to? epithelial? transition.?
Furthermore,? the? depletion? of?N?cadherin? in? epithelial? cells?was? not? sufficient? to? prevent?
TGF??induced?EMT? in?NMuMG?cells?showing? the?characteristic? regulation?of?epithelial?and?
mesenchymal?marker?proteins?and?gain?of?a?spindle?like?cell?shape.?Interestingly,?consistent?
with? these? findings,? recent? studies? in?our? laboratory? showed? that? forced?expression?of?N?
cadherin?in?the?human?mammary?tumor?cell?line?MCF7?did?not?induce?EMT,?keeping?the?cells?
in?an?epithelial?state.?(Dr.?A.?Kunita,?unpublished?data).??
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Former?studies? in?our? laboratory?have? identified?N?cadherin?as?a?component?of?the?
NCAM?mediated?FGFR?4?signaling?complex,?which?has?been?shown?to?stimulate??1?integrin?
mediated? cell?matrix? adhesion? as? well? as? the? formation? of? cellular? protrusions? (133).?
Furthermore,? it? has? been? shown? that? neurite? outgrowth? but? not? cell?matrix? adhesion? is?
dependent?on?NCAM?expression?and?the?assembly?of?the?FGFR?4?signaling?complex?in???cells?
of?pancreatic? tumors? (?T2?cells).?Although?being?a?component?of? the?complex,?our?studies?
showed?that?N?cadherin?is?not?essential?for?the?formation?of?neurites?in??T2?cells.??
The?function?of?N?cadherin?during?EMT?is?still?ambiguous?and?may?also?be?influenced?
by?the?cell?type?and?the?extracellular?environment.?Our?studies?show?that?N?cadherin?is?not?a?
trigger?of?EMT?and? that? its?expression? is?not? required? to? retain? the?mesenchymal? state.? It?
remains?elusive,?whether? this? is?due? to? compensatory?effects?of?other?proteins.?However,?
proteolytic? processing? of?N?cadherin? and? subsequent? release? of? its? intracellular? fragment?
(Ncad/CTF2)? is? thought? to? play? an? important? role? in? the? regulation? of? cell? proliferation,?
invasion? and? differentiation? (136).? Ncad/CTF2? has? been? shown? to? interfere? with? gene?
transcription?via?the?regulation?of?transcription?complexes?such?as?CBP/CREB?by?binding?to?
CBP?or?TCF/LEF?via?the?regulation?of???catenin?(136,?137).?Hence,?it?remains?to?be?elucidated?
whether? the? loss? of?N?cadherin? and? its? cleavage? fragment?Ncad/CTF2? have? an? impact? on?
intracellular?signaling?and?gene?transcription?and?warrants?further?investigation.?
?
?
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6 Cancer?stem?cells???a?potential?outcome?of?EMT??
6.1 Results?
6.1.1 Mesenchymal?cells?show?increased?sphere?formation?capacity?
Due?to?hyperproliferation?combined?with?genetic?instability,?advanced?tumors?show?a?
high?grade?of?heterogeneity?regarding?their?differentiation?state.?Conclusive?studies?showed?
the?existence?of?cancer?stem?cells,?a?new?subclass?of?neoplastic?cells?within?tumors.?There?is?
substantial?evidence?suggesting?that?EMT? is?associated?with?the?generation?of?cancer?stem?
cells?(CSC),?primarily?due?to? its?ability?to?change?the?differentiation?state?of?cells?(207,?214,?
235,?236).??
To? investigate? whether? EMT? results? in? the? generation? of? a? cancer? stem? cell?
subpopulation?or?increased?stemness?of?the?whole?mesenchymal?population?we?analyzed?in?
vitro?EMT?systems? for? the?gain?of?cancer?stem?cell?properties.?The? three?EMT?cell?systems?
used? were? the? previously? described? epithelial? MTflEcad? cells? with? their? mesenchymal?
counterparts?MT?Ecad? with? Cre?mediated? E?cadherin? depletion? as? well? as? the? epithelial?
NMuMG?cells?and?NMuMG?cells?initially?treated?for?more?than?30?days?with?TGF??(NMuMG?
LT).? The? third? system? used? was? the? epithelial?murine? Py2T? cells,? an?MMTV?PyMT? (264)?
mammary?tumor?derived?cell? line,?and?their?mesenchymal?analog? initially?treated? for?more?
than?30?days?with?TGF?? (Py2T?LT)? (generated?by?Lorenz?Waldmeier,?unpublished?data).?To?
assess?whether? the?mesenchymal? cells? showed? an? alteration? in? stem? cell? properties?we?
investigated?their?mammosphere?formation?capacity.?The?mammosphere?formation?assay?is?
commonly? used? to? analyze? anchorage?independent? growth? of? self? renewing? cancer? stem?
cells.?The?ability? to? form?mammospheres?was? found? to?be?a? characteristic?of? cancer? stem?
cells?and?correlated?with?tumor?initiating?capacity?(267). A?common?observation?in?all?three?
cell? systems?was? the? increased? ability? of?mesenchymal? cells? to? form? smooth,? round? and?
relatively? large? spheres,? whereas? the? epithelial? counterparts? either? formed? clumpy?
aggregates?or?spheres?of?smaller?size?(Figure?30).?Specifically,?the?MTflEcad?formed?spheres?
of? various? sizes? and? sowed? increasing? sphere? forming? capacity?with? increasing? passages,?
indicating?a? selection? for? cells?with?anchorage? independent?growth? competence.?Whereas?
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the?mesenchymal?MT?Ecad? cells?grow?as? large? round? spheres?with?decreasing?number?of?
spheres?in?later?passages?(Figure?30A).??
?
?
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Figure?30:?Mesenchymal?cells?show?a?higher?tendency?to?form?smooth?mammospheres.?Phase?contrast?images?
of?mammospheres?formed?by?(A)?epithelial?MTflEcad?and?mesenchymal?MT?Ecad,?(B)?epithelial?NMuMG?and?mesenchymal?
NMuMG?LT?and?(C)?epithelial?Py2T?and?mesenchymal?Py2T?LT?cells?at?indicated?passages:?first?seeding?(M1),?first?passaging?
(M2),?second?passaging?(M3).??
?
A?similar?tendency?was?found?for?the?NMuMG?cells,?where?the?epithelial?cells?formed?
a? high? number? of? small? spheres? and? the?mesenchymal?NMuMG? LT? cells? generated? large,?
smooth?and?spheric?structures?(Figure?30B).?In?contrast?to?these?findings,?the?epithelial?Py2T?
cells? showed? a? poor? sphere? formation? capacity,? generating? cell? aggregates.? The?
mesenchymal? Py2T? LT? cells? were,? similar? to? other? systems,? able? to? form? large,? round?
mammospheres?(Figure?30C).?Due?to?the?inability?of?the?epithelial?Py2T?cells?to?form?spheres,?
we? did? not? further? characterize? the? shape? and? structure? of? these? bodies.? In? summary,?
mesenchymal? cells? show?a?higher? capability? to? form? large? spheres? indicating?an? increased?
anchorage?independent?growth?capacity?and?resistance?to?anoikis.?
6.1.2 TGF??mediated?EMT?increases?the?resistance?against?anoikis?
To? assess? the? survival? and/or?proliferation? capacity?of?epithelial? and?mesenchymal?
cells?grown?under?anchorage? independent?conditions,?spheres?were?disaggregated?and?the?
total? cell? number? determined? before? reseeding.? The? TGF??induced? EMT? cell? systems?
(NMuMG?and?Py2T)?clearly?showed?increased?survival?of?mesenchymal?cells?with?increasing?
cell?numbers?throughout?serial?plating? in?comparison?to?their?poorly?proliferating?epithelial?
counterparts? (Figure?31B,C).? In? contrast,?Cre?mediated?E?cadherin?ablation? resulted? in? low?
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survival? of? the?mesenchymal?MT?Ecad? cells? compared? to? the? proliferative? epithelial? cells?
(Figure? 31A).? From? these? data? we? can? infer? that? TGF??induced? EMT? leads? to? increased?
resistance?to?anoikis?and?higher?replicative?potential?upon?serial?passaging?under?anchorage?
independent?culturing?conditions,?suggesting?a?gain?in?self?renewal?capacitiy.?
?
Figure? 31:? TGF??mediated? EMT? increases? survival? under? anchorage? independent? growth? conditions.?
Mammospheres?generated?from?(A)?MTflEcad?and?MT?Ecad,?(B)?NMuMG?and?NMuMG?LT?and?(C)?Py2T?and?Py2T?LT?cells?
were?disaggregated?after?7?days?of?culturing,?and?cell?numbers?were?determined?by?counting?at?indicated?passages,?using?a?
Neubauer?chamber.?Data?are?means?of?two? independent?experiments? (A/B)?and?one?single?experiment? (C)?normalized?to?
the?number?of?initially?seeded?cells.?Statistical?values?were?calculated?by?using?an?unpaired?two?tailed?t?test.?P?values??0.05?
indicated?with?(*),?p?values???0.01?indicated?with?(**).??
?
To?characterize? the? spheres? formed?by?epithelial?and?mesenchymal?cells,?we? firstly?
determined? the? sphere? size.? Recent? publications? showed? that? the? ability? to? form? larger?
mammospheres? reflects? progenitor? cell? proliferation? and? correlates?with? the? potency? to?
form? tumors? in? severe? combined? immunodeficiency? disease? (SCID)? mice? (287,? 288).?
Measurement?of?the?mammosphere?areas?showed?a?significant?increase?in?the?average?size?
of?the?mesenchymal?cell?derived?spheres? (Figure?32C,D).?While?a?significant?difference?was?
only? seen? in? the? capability? to? form? large? spheres? in? the?MTflEcad? /?MT?Ecad? system,? the?
epithelial? NMuMG? cells? nearly? exclusively? gave? rise? to? small? spheric? structures? and? the?
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mesenchymal? NMuMG? LT? cells? primarily? formed? mainly? medium?sized? spheres? (Figure?
32A,B).?
?
Figure?32:?Mesenchymal? cells?give? rise? to? significantly? larger?mammospheres.? (A)?Size?distribution?of? spheres?
grown?from?MTflEcad?and?MT?Ecad?cells?was?determined?by?measuring?the?area.?Areas?were?divided?in?small???4'000?pixels?
(??3365?μm2),?4'000?pixels?>?medium???15'000?pixels?(??12'618?μm2)?and?large?>?15'000?pixels.?Data?is?shown?as?percentage?
of?total?spheres?counted?and?represents?the?mean?of?3? independent?experiments.?Statistical?values?were?calculated?using?
an?unpaired?two?tailed?t?test.?P?values???0.05? indicated?with? (*).(B)?Size?distribution?of?spheres?grown? from?NMuMG?and?
NMuMG?LT?cells?was?determined?by?measuring? the?area.?Areas?were?divided? in?small???2'000?pixels? (??1680?μm2),?2'000?
pixels?>?medium? ??15'000?pixels? (??12'618?μm2)?and? large?>?15'000?pixels.?Data? is?shown?as?percentage?of? total?spheres?
counted?and?represents?the?mean?of?3?independent?experiments.?Statistical?values?were?calculated?using?an?unpaired?two?
tailed?t?test.?P?values???0.05? indicated?with?(*),?p?values???0.01? indicated?with?(**),?p?values???0.001? indicated?with?(***).?
Sphere? sizes? of? (C)?MTflEcad? (N=417)? and?MT?Ecad? (N=227)? and? (D)? NMuMG? (N=299)? and? NMuMG? LT? (N=198)?were?
measured? in?pixels.?Statistical?values?were? calculated?using?an?unpaired? two?tailed? t?test.?P?values? ??0.01? indicated?with?
(**),?p?values???0.001?indicated?with?(***).?
?
We?further?characterized?the?spheres?by?determining?the?number?of?spheres?formed?
by? the? epithelial? and? mesenchymal? cells.?We? observed? a? significantly? lower? number? of?
mammospheres? generated?by? the?MT?Ecad? as?well? as? the?NMuMG? LT? cells? compared? to?
their? respective? epithelial? counterparts? (Figure? 33).? In? summary,? we? could? show? that?
mesenchymal? cells? form? less? but? larger? and? smoother? spheres? and? TGF??mediated? EMT?
clearly?increases?the?proliferative?capacity?in?anchorage?independent?culturing.?
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Figure?33:?Mesenchymal?cells?form?significantly?less?spheroids.?(A)?MTflEcad?and?MT?Ecad?and?(B)?NMuMG?and?
NMuMG?LT?cells?were?plated?in?triplicates?in?96?well?plates?and?mammospheres?were?counted?after?3?days.?Data?represents?
values?of? two? independent?experiments?normalized? to? the?mean? sphere?numbers?of?epithelial?MTflEcad? cells.?Statistical?
values?were?calculated?using?a?paired?two?tailed?t?test.?P?values???0.01?indicated?with?(**).??
?
6.2 Cancer?stem?cell?surface?marker?expression?
One?major?requirement?to?make?cancer?stem?cells?accessible?for?drug?targeting?is?the?
clear? identification?of?these?cells?by?defined?markers.?There?are?ongoing?studies? in?the?field?
to? designate? broadly? applicable? but? specific? surface? marker? proteins,? and? an? important?
number? of?marker? combinations? have? already? been? proposed? for? correlation?with? cancer?
stemness?and?tumorigenicity.??
6.2.1 Hyaluronate?receptor?(CD44)?is?not?an?applicable?murine?cancer?stem?cell?marker??
One?of? the? first?and?most?broadly?used?marker?combination? in?breast?cancer? is? the?
expression? of? CD44+? CD24low/?,? defining? a? subpopulation? with? increased? tumor? initiation?
capacity? in? limiting? dilution? experiments? and? elevated? drug? resistance? (207,? 223?225).?
Assessing?the?expression?of?this?population?during?EMT?revealed?that?cell?surface?expression?
of?CD44?in?NMuMG?cells?was?positive,?relatively?uniform?and?independent?of?their?epithelial?
or?mesenchymal? phenotype? or? culturing? conditions? (Figure? 34A).? However,? the? epithelial?
MTflEcad? cells? and? their?mesenchymal? counterparts?MT?Ecad? showed? very? low? levels? of?
CD44?expression,?which?was?again? independent?of?the?differentiation?state?(Figure?34B).? In?
neither? of? our? EMT? cell? systems?were?we? able? to? detect? a? CD44?defined? subpopulation,?
suggesting? that? this?marker?could?be?used? to? identify?human?cancer? stem?cells,?but? is?not?
applicable?for?mouse?cell?systems.?
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Figure?34:?CD44?does?not?define?a?cancer?stem?cell?subpopulation?and?does?not? increase?with?EMT.? (A)?FACS?
distribution?of?CD44?PE?stained?NMuMG?cells?treated?with?TGF??for?the?indicated?time?under?adherent?culture?conditions?
or? cultured? as?mammospheres? (M1).? The? gate? represents? the? CD44?positive? fraction? (B)? FACS? distribution? of? CD44?PE?
stained?MTflEcad?and?MT?Ecad?cells?either?cultured?under?adherent?or?non?adherent?(M1)?conditions.?The?bar?represents?
the?CD44?positive?fraction.?
?
6.2.2 CD24?surface?expression?varies?between?different?EMT?cell?systems?
CD24? is? a?widely? used?marker? in? human? and?mouse? breast? cancer? cell? lines? and?
tumors? and? is? used? in? combination? with? various? other?markers,? such? as? ?1?integrin,? ?6?
integrin,?CD133?or?Sca?1?to?selectively?define?the?cancer?stem?cell?subpopulation?(226,?227,?
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289,?290).? Therefore,?we? investigated?whether? the?expression?of?CD24?protein? correlated?
with? EMT? or? whether? mammosphere? culturing? conditions? selected? for? a? CD24?defined?
subpopulation.? FACS? analysis? of? CD24?stained? epithelial? NMuMG? and?mesenchymal? long?
term?TGF?? treated? (LT)? cells? showed? that?NMuMG? cells?expressed?CD24? independently?of?
their?epithelial?or?mesenchymal?state?or?culturing?conditions?(Figure?35).? In?mammosphere?
serial?plating?experiments?we?detected?a?slight?decreased?percentage?of?CD24+?cells? in?M1?
(significant)?and?M2?followed?by?an? increase? in?M3.?The?decrease?was?due?to?a?shift?of?the?
whole?population?and?we?were?unable?to?define?a?CD24?specific?subpopulation.?
?
Figure?35:?CD24?does?not?define?a?cancer?stem?cell?subpopulation? in?NMuMG?cells.?(A)?FACS?analysis?of?CD24?
stained?NMuMG?and?NMuMG?LT?cells?either?cultured?adherent?or?as?mammospheres?in?serial?passaging?(M1?M3).?The?gate?
represents?the?CD24?positive?fraction.?Data?were?quantified?in?panel?B.?(B)?Average?percentage?of?CD24+?stained?cells?(±?SD)?
of?adherent?cultures?or?during?serial?replating?of?NMuMG?and?NMuMG?LT?mammospheres?(M1?M3).?In?M1?NMuMG?cells?
show?a?significantly?higher?CD24?staining?(p?value?=?0.0309)?compared?to?NMuMG?LT.?Statistical?values?were?calculated?by?
using?an?unpaired?two?tailed?t?test.?
?
Furthermore,? we? analyzed? the? second? TGF??induced? EMT? cell? line? Py2T? for? the?
expression?of?CD24?and?observed?a?comparable?result?as?seen? in?the?NMuMG?cells? (Figure?
36).?Epithelial?Py2T?and?their?mesenchymal?counterparts?Py2T?LT?showed?a?positive?surface?
staining?for?CD24?with?slightly?decreased?levels?in?the?mesenchymal?Py2T?LT?during?passage?
M1?and?M2?of?the?non?adherent?cultured?cells.??
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Figure?36:?Epithelial?and?mesenchymal?Py2T?and?Py2T?LT?cells?show?a?relatively?uniform?CD24?expression?.?(A)?
FACS?analysis?of?cell?surface?expression?of?CD24? in?adherent?cultured?or?mammosphere?serial?passaging?(M1?M3)?of?Py2T?
and?Py2T?LT?cells.?The?gate?represents?the?CD24?positive?fraction.?(B)?Average?percentage?of?CD24+?stained?cells?(±?SD)?of?
adherent?cultures?or?mammosphere?serial?replating?(M1?M3)?of?Py2T?and?Py2T?LT?cells?
?
Assessing? the?same?surface?marker?expression? in? the?epithelial?MTflEcad?compared?
to? the?mesenchymal?MT?Ecad? cells? showed? a? high? variability? in? the? expression? of? CD24?
(Figure?37).? In?this?EMT?cell?system?we?observed?a?significant? increase? in?the?CD24?positive?
fraction? in?the?mesenchymal?MT?Ecad?cells?compared?to?their?epithelial?counterpart?when?
the?cells?were?cultured?under?adherent?conditions.?The?same?tendency?was?observed?when?
the?cells?were?cultured?as?mammospheres,?though?this?culturing?condition?resulted?in?a?high?
variability?of?the?marker?expression?levels.?These?data?indicate?that?CD24?cannot?be?used?as?
a?general?cancer?stem?cell?marker?throughout?different?mouse?mammary?cell?lines.??
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Figure? 37:? Mesenchymal? MT?Ecad? cells? show? increased? levels? of? CD24? compared? to? their? epithelial?
counterparts.?(A)?FACS?analysis?of?cell?surface?expression?of?CD24?in?adherent?cultured?or?mammosphere?serial?passaging?
(M1?M3)?of?MTflEcad?and?MT?Ecad?cells.?The?gate?represents?the?CD24?positive?fraction.?(B)?Quantification?of?FACS?data?
shown?in?(A)?of?CD24+?stained?cells?(±?SD)?of?adherent?cultures?or?mammosphere?serial?replating?(M1?M3)?of?MTflEcad?and?
MT?Ecad?cells.?Adherent?cultures?of?MT?Ecad?cells?show?a?significantly?higher?CD24?staining?(p?value?=?0.0002)?compared?
to?MTflEcad.?Statistical?values?were?calculated?by?using?an?unpaired?two?tailed?t?test.?
?
6.2.3 CD29?shows?uniformly?high?surface?expression?in?EMT?cell?systems??
In?various?studies?high?expression?of??1?integrin?(CD29)?in?combination?with?medium?
to? high? expression? of?CD24?was? shown? to? identify? a? subpopulation?with? increased? tumor?
initiation? capacity? and? cancer? stem? cell? properties? (229?231).?We? therefore? investigated?
whether?we?were?able?to?identify?a?CSC?subpopulation?in?our?EMT?cell?systems?by?assessing?
the?surface?expression?of?CD29.?FACS?analysis?for?the?CD29?marker?in?NMuMG?cells?showed?
a? uniformly? high? expression? in? the? epithelial? as? well? as? in? the? mesenchymal? cells?
independently?of?the?culturing?conditions?(Figure?38).?
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Figure?38:?NMuMG?and?NMuMG?LT?cells? show?a?uniformly?positive?CD29? staining.? (A)?FACS?analysis?of?CD29?
surface?expression? in?NMuMG?and?NMuMG?LT?cells?either? in?adherent?cultures?or?as?mammospheres? in?serial?passaging?
(M1?M3).?The?gate?represents?the?CD29?positive?fraction.?Data?was?quantified? in?panel?B.?(B)?Quantification?of?FACS?data?
shown? in?(A)?of?CD29+?stained?cells?(±?SD)?of?NMuMG?and?NMuMG?LT?cells?either?adherent?cultures?or?serial?passages?of?
mammosphere?culturing.??
?
Moreover,?we?observed?the?same?expression?pattern?in?Py2T?cells,?the?second?TGF??
inducible?EMT?system,?showing?a?high?surface?expression?of?CD29?in?epithelial?Py2T?cells?as?
well?as? in?mesenchymal?Py2T?LT?cells?(Figure?39).? In?both?cell?systems?we?could?not?detect?
any?discrete?subpopulation?defined?by?the?expression?of?CD29.?
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Figure?39:?Py2T?and?Py2T? LT? cells?express?high? levels?of?CD29?on? the? cell? surface.? (A)? FACS?analysis?of?CD29?
surface?expression? in?Py2T?and?Py2T?LT?cells?either?cultured?adherent?or?as?mammospheres? in?serial?passaging?(M1?M3).?
The?CD29?positive?fraction?is?marked?by?a?bar.?Data?was?quantified?in?panel?B.?(B)?Quantification?of?FACS?data?shown?in?(A)?
of? CD29+? stained? cells? (±? SD)? of? Py2T? and? Py2T? LT? cells? either? adherent? cultured? or? serial? passages? of?mammosphere?
culturing.?
?
Lastly,? we? investigated? whether? we? were? able? to? identify? a? cancer? stem? cell?
population? by? the? expression? of? CD29? in? the? epithelial? MTflEcad? and? its? mesenchymal?
counterpart?MT?Ecad.?Consistent?with?the?data?found?in?the?other?cell?systems?we?detected?
a?high?and?uniform?surface?expression?of?CD29? independent?of? the?differentiation?state?of?
the?cells?or?the?culturing?conditions(Figure?40).?
Results?? Cancer?stem?cells???a?potential?outcome?of?EMT??
98?
?
?
Figure? 40:? CD29? is? uniformly? expressed? by?MTflEcad? and?MT?Ecad? cells.? (A)? FACS? analysis? of? cell? surface?
expression?of?CD29? in?adherent?cultured?or?mammosphere?serial?passaging?(M1?M3)?of?MTflEcad?and?MT?Ecad?cells.?The?
bar?represents?positive?CD29?staining?and?data?is?quantified?in?panel?B.?
?
6.2.4 CD49f?is?not?expressed?in?all?EMT?systems?
Several? studies? determined? ?6?integrin? (CD49f),? another? member? of? the? integrin?
family,?as?a?surface?marker?for?cancer?stem?cells.?It?was?demonstrated?that?a?breast?cancer?
cell? subpopulation,? sorted? by? CD24+/CD49fhigh? expression? showed? increased? colony?
formation? and? enhanced? tumor? initiation? capacity? (226,? 229).? By? FACS? analysis? of? CD49f?
stained?epithelial?and?mesenchymal?cells?we?assessed?whether?this?surface?marker?identified?
a? subpopulation? or? showed? a? difference? in? surface? expression? between? epithelial? and?
mesenchymal? cells.? we? did? not? detect? any? expression? of? CD49f? on? the? cell? surface? of?
epithelial?NMuMG?cells?nor?of?mesenchymal?NMuMG?LT?cells?(data?not?shown).?In?contrast,?
the? genetically?mediated? EMT? cell? system? MTflEcad? /? MT?Ecad? showed? a? high? surface?
expression?of?CD49f,?which?was?of?the?same?intensity?in?the?epithelial?and?mesenchymal?cells?
and? independent?of? the?culturing?conditions? (Figure?41).?These?data? indicate? that?CD49f? is?
not?applicable?to?determine?cancer?stem?cells?in?our?EMT?cell?systems.?
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Figure?41:?CD49f? is?highly?expressed?on? the? surface?of?MTflEcad?and?MT?Ecad? cells.? (A)?FACS?analysis?of? cell?
surface?expression?of?CD49f? in?adherent?cultured?or?mammosphere?serial?passaging? (M1?M3)?of?MTflEcad?and?MT?Ecad?
cells.?The?gate?represents?positive?CD49f?staining?and?data?is?quantified?in?panel?B.??
?
?
Discussion? Cancer?stem?cells???a?potential?outcome?of?EMT??
100?
?
6.3 Discussion?
There? is? substantial? evidence? suggesting? an? association?between? cancer? stem? cells?
and?a?specific?state?of?differentiation.?It?has?indeed?been?demonstrated?that?the?induction?of?
EMT?via?the?overexpression?of?the?transcription?factor?Snail?in?trophoblast?stem?cells?results?
in? a?metastable? phenotype? of? preserved? self?renewal? and?multipotency,? and? the? loss? of?
epithelial?maintenance?(236).?Furthermore,? it?has?been?shown?that?the? induction?of?EMT? in?
transformed? mammary? epithelial? cells? generates? a? side?population? enriched? for? CSC?
properties,?such?as?increased?tumorigenicity,?mammosphere?formation?capacity,?cell?surface?
marker?expression?and? increased?drug?resistance?(214,?238).?These?findings?suggest?a?close?
connection?between?EMT?and?cancer?stem?cells?and?a?better?understanding?of?the?biological?
processes?leading?to?the?generation?and?maintenance?of?CSCs?might?offer?new?perspectives?
into?future?cancer?treatments.?Thus,?proving?the?coherence?between?EMT?and?cancer?stem?
cells,?as?well?as?the?identification?of?this?population,?is?of?major?interest?for?ongoing?research.??
In?the?present?study,?we?have?assessed?whether?EMT? increases?stem?cell?properties?
by? use? of? different? in? vitro? EMT?model? systems.? To? address? this? question? we? analyzed?
epithelial? and? mesenchymal? cells? for? their? ability? to? form? mammospheres.? The?
mammosphere? formation? assay? is?well? approved? to? assay? anchorage?independent? growth?
capacity.?Sphere?formation?was?found?to?be?characteristic?of?cancer?stem?cells?and?correlates?
with?tumor?initiation?capacity?(267).?Consistent?with?former?findings,?we?demonstrated?that?
mesenchymal? cells?when? compared? to? their? epithelial? counterparts,? showed? an? increased?
capacity? to? form?smooth?and? large?spheres,?which?has?been?previously? reported? to? reflect?
progenitor? cell? proliferation? and? correlate? with? increased? tumorigenicity? (287,? 288).?
Furthermore,?we?demonstrate?increased?proliferation?of?the?mesenchymal?cells?of?the?TGF??
induced? EMT? systems?when? cultured? under? anchorage?independent? conditions,? indicating?
that? EMT? mediates? increased? resistance? to? anoikis.? Interestingly,? consistent? with? these?
findings,?recent?studies?in?our?laboratory?have?shown?an?increased?tumor?initiation?capacity?
for? the?mesenchymal?MT?Ecad? cells? compared?with? the? epithelial?MTflEcad? cells? (Dr.? A.?
Fantozzi?and?D.?Maaß,?unpublished?data).??
Next,?we?wanted? to? assess?whether? EMT? functions? as? a? selection? process? for? an?
underlying? presence? of? cancer? stem? cells? which? would? give? rise? to? a? defined? CSC?
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subpopulation.? An? alternative? consequence? of? EMT? could? be? an? increase? in? stem? cell?
properties?of?the?entire?population?due?to?the?dedifferentiation?process.?Using?FACS?analysis?
for? CSC? markers? this? would? either? result? in? the? appearance? or? an? increase? of? a? small?
subpopulation?or?in?a?shift?of?the?entire?population?due?to?EMT.?To?answer?this?question?we?
analyzed?the?three?in?vitro?EMT?cell?systems?for?the?expression?of?different?surface?markers,?
such? as? CD44,? CD24,? CD29,? CD49f,? which? were? formerly? identified? to? define? CSC?
subpopulations? (223,? 225?227,? 229,? 230,? 289).? Surprisingly,? most? markers? tested? were?
uniformly? and? highly? expressed? throughout? all? cell? systems? independently? of? the?
differentiation? state? of? the? cells.? Consistent? with? former? publications? and? recent? tumor?
transplantation? studies,? only? CD24? showed? a? significant? increased? surface? expression? in?
MT?Ecad? cells? compared? to? their? epithelial? counterparts,? indicating? increased? CSC?
properties.?Substantiation?of?this?assumption?warrants?further?investigation?including?sorting?
of? the? CD24high? fraction? and? transplantation? experiments? of? the? sorted? cells? in? mouse?
models.?With? the?marker?combinations? tested,?we?were?not?able? to?define?a?discrete?CSC?
subpopulation?which?would?suggest?an?increase?of?cancer?stem?cell?properties?of?the?entire?
population? as? a? consequence? of? EMT.? Nevertheless,? it? remains? unclear? whether? the?
subpopulation?is?non?existent?or?not?detectable?with?the?marker?combinations?used.??
These? data? show? that? conclusive? results? are? still? lacking? to? define? the? connection?
between?EMT?and?cancer?stemness.?The?unavailability?of?general?surface?marker?proteins?to?
define?cancer?stem?cells?reveal?the?need?for?further?research?to?define?prevalent?but?specific?
CSC?markers? in? order? to?make? these? cells? accessible? for? therapy? and? by? this? to? prevent?
patient?relapse.?
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